
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Application of the Mass Spectrometry–High‐Throughput Technique Over the Immunohistochemical Analysis for Human Brain Tumor Diagnosis and Prognosis: Insights Into Biomarkers&#x27; Identification for the Case Study of Grade IV Astrocytomas and Meningiomas - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4838B8AEEF72305838B000350D0D2.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="blackwellopen">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12326238/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Biomedical Chromatography">
<meta name="citation_title" content="Application of the Mass Spectrometry–High‐Throughput Technique Over the Immunohistochemical Analysis for Human Brain Tumor Diagnosis and Prognosis: Insights Into Biomarkers&#x27; Identification for the Case Study of Grade IV Astrocytomas and Meningiomas">
<meta name="citation_author" content="Kaouthar Louati">
<meta name="citation_author_institution" content="Faculty of Pharmacy, Laboratory of Chemical, Galenic and Pharmacological Drug Development, University of Monastir, Monastir, Tunisia">
<meta name="citation_author" content="Fatma Kolsi">
<meta name="citation_author_institution" content="Department of Neurosurgery, Habib Bourguiba University Hospital, Sfax, Tunisia">
<meta name="citation_author_institution" content="Faculty of Medicine, University of Sfax, Sfax, Tunisia">
<meta name="citation_author" content="Manel Mellouli">
<meta name="citation_author_institution" content="Laboratory of Pathological Anatomy and Cytology, Habib Bourguiba University Hospital, Sfax, Tunisia">
<meta name="citation_author_institution" content="Faculty of Medicine, University of Sfax, Sfax, Tunisia">
<meta name="citation_author" content="Hanen Louati">
<meta name="citation_author_institution" content="College of Administrative and Financial Sciences, Saudi Electronic University, Riyadh, Saudi Arabia">
<meta name="citation_author" content="Rim Kallel">
<meta name="citation_author_institution" content="Laboratory of Pathological Anatomy and Cytology, Habib Bourguiba University Hospital, Sfax, Tunisia">
<meta name="citation_author_institution" content="Faculty of Medicine, University of Sfax, Sfax, Tunisia">
<meta name="citation_author" content="Rania Zribi">
<meta name="citation_author_institution" content="Faculty of Letters and Humanities, University of Sfax, Sfax, Tunisia">
<meta name="citation_author" content="Mahdi Borni">
<meta name="citation_author_institution" content="Department of Neurosurgery, Habib Bourguiba University Hospital, Sfax, Tunisia">
<meta name="citation_author_institution" content="Faculty of Medicine, University of Sfax, Sfax, Tunisia">
<meta name="citation_author" content="Leila Sellami Hakim">
<meta name="citation_author_institution" content="Laboratory of Pathological Anatomy and Cytology, Habib Bourguiba University Hospital, Sfax, Tunisia">
<meta name="citation_author" content="Amina Maalej">
<meta name="citation_author_institution" content="Laboratory of Environmental Bioprocesses, Centre of Biotechnology of Sfax, Sfax, Tunisia">
<meta name="citation_author" content="Sirine Choura">
<meta name="citation_author_institution" content="Laboratory of Environmental Bioprocesses, Centre of Biotechnology of Sfax, Sfax, Tunisia">
<meta name="citation_author" content="Mohamed Chamkha">
<meta name="citation_author_institution" content="Laboratory of Environmental Bioprocesses, Centre of Biotechnology of Sfax, Sfax, Tunisia">
<meta name="citation_author" content="Sami Sayadi">
<meta name="citation_author_institution" content="Biotechnology Program, Center for Sustainable Development, College of Arts and Sciences, Qatar University, Doha, Qatar">
<meta name="citation_author" content="Zouheir Khemakhem">
<meta name="citation_author_institution" content="Legal Medicine Department, Habib Bourguiba University Hospital, Sfax, Tunisia">
<meta name="citation_author_institution" content="Faculty of Medicine, University of Sfax, Sfax, Tunisia">
<meta name="citation_author" content="Tahya Sellami Boudawara">
<meta name="citation_author_institution" content="Laboratory of Pathological Anatomy and Cytology, Habib Bourguiba University Hospital, Sfax, Tunisia">
<meta name="citation_author_institution" content="Faculty of Medicine, University of Sfax, Sfax, Tunisia">
<meta name="citation_author" content="Mohamed Zaher Boudawara">
<meta name="citation_author_institution" content="Department of Neurosurgery, Habib Bourguiba University Hospital, Sfax, Tunisia">
<meta name="citation_author_institution" content="Faculty of Medicine, University of Sfax, Sfax, Tunisia">
<meta name="citation_author" content="Kaouthar Zribi">
<meta name="citation_author_institution" content="Faculty of Pharmacy, Laboratory of Chemical, Galenic and Pharmacological Drug Development, University of Monastir, Monastir, Tunisia">
<meta name="citation_author" content="Fathi Safta">
<meta name="citation_author_institution" content="Faculty of Pharmacy, Laboratory of Chemical, Galenic and Pharmacological Drug Development, University of Monastir, Monastir, Tunisia">
<meta name="citation_publication_date" content="2025 Aug 6">
<meta name="citation_volume" content="39">
<meta name="citation_issue" content="9">
<meta name="citation_firstpage" content="e70170">
<meta name="citation_doi" content="10.1002/bmc.70170">
<meta name="citation_pmid" content="40765374">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12326238/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12326238/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12326238/pdf/BMC-39-e70170.pdf">
<meta name="description" content="Human brain tumors were commonly monitored in hospital/clinical laboratories by immunohistochemistry (IHC) technique, which provides major insights into their classification. However, this technique remains laborious and still shows pitfalls. ...">
<meta name="og:title" content="Application of the Mass Spectrometry–High‐Throughput Technique Over the Immunohistochemical Analysis for Human Brain Tumor Diagnosis and Prognosis: Insights Into Biomarkers&#x27; Identification for the Case Study of Grade IV Astrocytomas and Meningiomas">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Human brain tumors were commonly monitored in hospital/clinical laboratories by immunohistochemistry (IHC) technique, which provides major insights into their classification. However, this technique remains laborious and still shows pitfalls. ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12326238/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12326238">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1002/bmc.70170"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/BMC-39-e70170.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12326238%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12326238/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12326238/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12326238/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-blackwellopen.png" alt="Wiley Open Access Collection logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Wiley Open Access Collection" title="Link to Wiley Open Access Collection" shape="default" href="https://doi.org/10.1002/bmc.70170" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Biomed Chromatogr</button></div>. 2025 Aug 6;39(9):e70170. doi: <a href="https://doi.org/10.1002/bmc.70170" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1002/bmc.70170</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Biomed%20Chromatogr%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Biomed%20Chromatogr%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Biomed%20Chromatogr%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Biomed%20Chromatogr%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Application of the Mass Spectrometry–High‐Throughput Technique Over the Immunohistochemical Analysis for Human Brain Tumor Diagnosis and Prognosis: Insights Into Biomarkers' Identification for the Case Study of Grade IV Astrocytomas and Meningiomas</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Louati%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Kaouthar Louati</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Kaouthar Louati</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Faculty of Pharmacy, Laboratory of Chemical, Galenic and Pharmacological Drug Development, University of Monastir, Monastir, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Louati%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kaouthar Louati</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kolsi%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Fatma Kolsi</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Fatma Kolsi</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Department of Neurosurgery, Habib Bourguiba University Hospital, Sfax, Tunisia</div>
<div class="p">
<sup>
<sup>9</sup>
</sup>Faculty of Medicine, University of Sfax, Sfax, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kolsi%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Fatma Kolsi</span></a>
</div>
</div>
<sup>2,</sup><sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mellouli%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Manel Mellouli</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Manel Mellouli</span></h3>
<div class="p">
<sup>
<sup>3</sup>
</sup>Laboratory of Pathological Anatomy and Cytology, Habib Bourguiba University Hospital, Sfax, Tunisia</div>
<div class="p">
<sup>
<sup>9</sup>
</sup>Faculty of Medicine, University of Sfax, Sfax, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mellouli%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Manel Mellouli</span></a>
</div>
</div>
<sup>3,</sup><sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Louati%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Hanen Louati</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Hanen Louati</span></h3>
<div class="p">
<sup>
<sup>4</sup>
</sup>College of Administrative and Financial Sciences, Saudi Electronic University, Riyadh, Saudi Arabia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Louati%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hanen Louati</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kallel%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Rim Kallel</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Rim Kallel</span></h3>
<div class="p">
<sup>
<sup>3</sup>
</sup>Laboratory of Pathological Anatomy and Cytology, Habib Bourguiba University Hospital, Sfax, Tunisia</div>
<div class="p">
<sup>
<sup>9</sup>
</sup>Faculty of Medicine, University of Sfax, Sfax, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kallel%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Rim Kallel</span></a>
</div>
</div>
<sup>3,</sup><sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zribi%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Rania Zribi</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Rania Zribi</span></h3>
<div class="p">
<sup>
<sup>5</sup>
</sup>Faculty of Letters and Humanities, University of Sfax, Sfax, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zribi%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Rania Zribi</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Borni%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Mahdi Borni</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Mahdi Borni</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Department of Neurosurgery, Habib Bourguiba University Hospital, Sfax, Tunisia</div>
<div class="p">
<sup>
<sup>9</sup>
</sup>Faculty of Medicine, University of Sfax, Sfax, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Borni%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mahdi Borni</span></a>
</div>
</div>
<sup>2,</sup><sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hakim%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Leila Sellami Hakim</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Leila Sellami Hakim</span></h3>
<div class="p">
<sup>
<sup>3</sup>
</sup>Laboratory of Pathological Anatomy and Cytology, Habib Bourguiba University Hospital, Sfax, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hakim%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Leila Sellami Hakim</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Maalej%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Amina Maalej</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Amina Maalej</span></h3>
<div class="p">
<sup>
<sup>6</sup>
</sup>Laboratory of Environmental Bioprocesses, Centre of Biotechnology of Sfax, Sfax, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Maalej%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Amina Maalej</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Choura%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Sirine Choura</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Sirine Choura</span></h3>
<div class="p">
<sup>
<sup>6</sup>
</sup>Laboratory of Environmental Bioprocesses, Centre of Biotechnology of Sfax, Sfax, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Choura%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sirine Choura</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chamkha%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Mohamed Chamkha</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Mohamed Chamkha</span></h3>
<div class="p">
<sup>
<sup>6</sup>
</sup>Laboratory of Environmental Bioprocesses, Centre of Biotechnology of Sfax, Sfax, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chamkha%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mohamed Chamkha</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sayadi%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Sami Sayadi</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Sami Sayadi</span></h3>
<div class="p">
<sup>
<sup>7</sup>
</sup>Biotechnology Program, Center for Sustainable Development, College of Arts and Sciences, Qatar University, Doha, Qatar</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sayadi%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sami Sayadi</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Khemakhem%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Zouheir Khemakhem</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Zouheir Khemakhem</span></h3>
<div class="p">
<sup>
<sup>8</sup>
</sup>Legal Medicine Department, Habib Bourguiba University Hospital, Sfax, Tunisia</div>
<div class="p">
<sup>
<sup>9</sup>
</sup>Faculty of Medicine, University of Sfax, Sfax, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Khemakhem%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zouheir Khemakhem</span></a>
</div>
</div>
<sup>8,</sup><sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boudawara%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Tahya Sellami Boudawara</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Tahya Sellami Boudawara</span></h3>
<div class="p">
<sup>
<sup>3</sup>
</sup>Laboratory of Pathological Anatomy and Cytology, Habib Bourguiba University Hospital, Sfax, Tunisia</div>
<div class="p">
<sup>
<sup>9</sup>
</sup>Faculty of Medicine, University of Sfax, Sfax, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boudawara%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tahya Sellami Boudawara</span></a>
</div>
</div>
<sup>3,</sup><sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boudawara%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Mohamed Zaher Boudawara</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Mohamed Zaher Boudawara</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Department of Neurosurgery, Habib Bourguiba University Hospital, Sfax, Tunisia</div>
<div class="p">
<sup>
<sup>9</sup>
</sup>Faculty of Medicine, University of Sfax, Sfax, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boudawara%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mohamed Zaher Boudawara</span></a>
</div>
</div>
<sup>2,</sup><sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zribi%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Kaouthar Zribi</span></a><div hidden="hidden" id="id16">
<h3><span class="name western">Kaouthar Zribi</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Faculty of Pharmacy, Laboratory of Chemical, Galenic and Pharmacological Drug Development, University of Monastir, Monastir, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zribi%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kaouthar Zribi</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Safta%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Fathi Safta</span></a><div hidden="hidden" id="id17">
<h3><span class="name western">Fathi Safta</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Faculty of Pharmacy, Laboratory of Chemical, Galenic and Pharmacological Drug Development, University of Monastir, Monastir, Tunisia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Safta%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Fathi Safta</span></a>
</div>
</div>
<sup>1</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="bmc70170-aff-0001">
<sup>
<sup>1</sup>
</sup>Faculty of Pharmacy, Laboratory of Chemical, Galenic and Pharmacological Drug Development, University of Monastir, Monastir, Tunisia</div>
<div id="bmc70170-aff-0002">
<sup>
<sup>2</sup>
</sup>Department of Neurosurgery, Habib Bourguiba University Hospital, Sfax, Tunisia</div>
<div id="bmc70170-aff-0003">
<sup>
<sup>3</sup>
</sup>Laboratory of Pathological Anatomy and Cytology, Habib Bourguiba University Hospital, Sfax, Tunisia</div>
<div id="bmc70170-aff-0004">
<sup>
<sup>4</sup>
</sup>College of Administrative and Financial Sciences, Saudi Electronic University, Riyadh, Saudi Arabia</div>
<div id="bmc70170-aff-0005">
<sup>
<sup>5</sup>
</sup>Faculty of Letters and Humanities, University of Sfax, Sfax, Tunisia</div>
<div id="bmc70170-aff-0006">
<sup>
<sup>6</sup>
</sup>Laboratory of Environmental Bioprocesses, Centre of Biotechnology of Sfax, Sfax, Tunisia</div>
<div id="bmc70170-aff-0007">
<sup>
<sup>7</sup>
</sup>Biotechnology Program, Center for Sustainable Development, College of Arts and Sciences, Qatar University, Doha, Qatar</div>
<div id="bmc70170-aff-0008">
<sup>
<sup>8</sup>
</sup>Legal Medicine Department, Habib Bourguiba University Hospital, Sfax, Tunisia</div>
<div id="bmc70170-aff-0009">
<sup>
<sup>9</sup>
</sup>Faculty of Medicine, University of Sfax, Sfax, Tunisia</div>
<div class="author-notes p">
<div class="fn" id="correspondenceTo">
<sup>*</sup><p class="display-inline">

<strong>Correspondence:</strong>
 
Kaouthar Louati (<span>kaouthar.louati@fphm.u-monastir.tn</span>)
</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Revised 2025 Jun 23; Received 2025 Mar 1; Accepted 2025 Jul 11; Issue date 2025 Sep.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Author(s). <em>Biomedical Chromatography</em> published by John Wiley &amp; Sons Ltd.</div>
<p>This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12326238  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40765374/" class="usa-link">40765374</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>ABSTRACT</h2>
<p>Human brain tumors were commonly monitored in hospital/clinical laboratories by immunohistochemistry (IHC) technique, which provides major insights into their classification. However, this technique remains laborious and still shows pitfalls. Therefore, the current study was endeavored to reveal the assets of the application of high‐throughput mass spectrometry (MS) for medical diagnosis. In this study, we focused on the Grade IV astrocytoma and meningioma brain tumors. The collected specimens were first monitored for histopathological diagnosis, followed by IHC staining for the characterization of stemness gene marker, then analyzed by a shotgun proteomic–based approach with high‐resolution tandem MS. The IHC analysis only confirmed the histopathological diagnosis, whereas the proteomic analysis unraveled several differently expressed proteins. By bioinformatics, the major enriched pathways and the significance of each protein with its meaningful relationships were identified. The key hub genes were allied for prognostic biomarkers of malignant, metastatic, and invasive forms of cancer with poor prognosis. Overall, the high‐throughput MS technique is the most powerful tool to achieve medical analysis at high sensitivity and accuracy and in a very straightforward and timely manner. Hence, its medical implementation in the hospital management system is imperative to counteract the caveats of traditional diagnostic methods and improve the quality of healthcare performance and therapeutic targets.</p>
<section id="Ace_Pre_23" class="kwd-group"><p><strong>Keywords:</strong> biomarkers, brain tumors, immunohistochemistry, mass spectrometry, proteomics</p></section></section><hr class="headless">
<h3>Abbreviations</h3>
<dl class="def-list" id="bmc70170-dl-0001">
<dt id="bmc70170-li-0001">2HG</dt>
<dd id="bmc70170-li-0002"><p>2‐hydroxyglutarate</p></dd>
<dt id="bmc70170-li-0003">ABC</dt>
<dd id="bmc70170-li-0004"><p>ATP‐binding cassette subfamily</p></dd>
<dt id="bmc70170-li-0005">ACAA</dt>
<dd id="bmc70170-li-0006"><p>acetyl‐CoA acyltransferases</p></dd>
<dt id="bmc70170-li-0007">ACO</dt>
<dd id="bmc70170-li-0008"><p>aconitases</p></dd>
<dt id="bmc70170-li-0009">ACT</dt>
<dd id="bmc70170-li-0010"><p>actin superfamily</p></dd>
<dt id="bmc70170-li-0011">ALDH</dt>
<dd id="bmc70170-li-0012"><p>aldehyde dehydrogenase family,</p></dd>
<dt id="bmc70170-li-0013">ANXA</dt>
<dd id="bmc70170-li-0014"><p>annexins</p></dd>
<dt id="bmc70170-li-0015">APO</dt>
<dd id="bmc70170-li-0016"><p>apolipoprotein</p></dd>
<dt id="bmc70170-li-0017">ARHGAP</dt>
<dd id="bmc70170-li-0018"><p>rho GTPase‐activating proteins</p></dd>
<dt id="bmc70170-li-0019">BP</dt>
<dd id="bmc70170-li-0020"><p>biological process (BP),</p></dd>
<dt id="bmc70170-li-0021">CAV1</dt>
<dd id="bmc70170-li-0022"><p>caveolin</p></dd>
<dt id="bmc70170-li-0023">CaMKII</dt>
<dd id="bmc70170-li-0024"><p>calcium/calmodulin‐dependent protein kinase II</p></dd>
<dt id="bmc70170-li-0025">CAPN</dt>
<dd id="bmc70170-li-0026"><p>calpain</p></dd>
<dt id="bmc70170-li-0027">CFL1</dt>
<dd id="bmc70170-li-0028"><p>cofilin</p></dd>
<dt id="bmc70170-li-0029">COL</dt>
<dd id="bmc70170-li-0030"><p>collagen superfamily</p></dd>
<dt id="bmc70170-li-0031">COX</dt>
<dd id="bmc70170-li-0032"><p>cytochrome c oxidase,</p></dd>
<dt id="bmc70170-li-0033">CPX</dt>
<dd id="bmc70170-li-0034"><p>carboxypeptidase</p></dd>
<dt id="bmc70170-li-0035">CRMP</dt>
<dd id="bmc70170-li-0036"><p>collapsin response mediator protein</p></dd>
<dt id="bmc70170-li-0037">CTNNB</dt>
<dd id="bmc70170-li-0038"><p>beta‐catenin</p></dd>
<dt id="bmc70170-li-0039">DDB</dt>
<dd id="bmc70170-li-0040"><p>damage‐specific DNA‐binding protein</p></dd>
<dt id="bmc70170-li-0041">DPYSL</dt>
<dd id="bmc70170-li-0042"><p>dihydropyrimidinase,</p></dd>
<dt id="bmc70170-li-0043">EEF</dt>
<dd id="bmc70170-li-0044"><p>eukaryotic translation elongation factor</p></dd>
<dt id="bmc70170-li-0045">EIF</dt>
<dd id="bmc70170-li-0046"><p>eukaryotic initiation factor</p></dd>
<dt id="bmc70170-li-0047">ELISA</dt>
<dd id="bmc70170-li-0048"><p>enzyme‐linked immunosorbent assay</p></dd>
<dt id="bmc70170-li-0049">EMA</dt>
<dd id="bmc70170-li-0050"><p>epithelial membrane antigen</p></dd>
<dt id="bmc70170-li-0051">EMT</dt>
<dd id="bmc70170-li-0052"><p>epithelial–mesenchymal transition</p></dd>
<dt id="bmc70170-li-0053">ENO</dt>
<dd id="bmc70170-li-0054"><p>enolases</p></dd>
<dt id="bmc70170-li-0055">ER</dt>
<dd id="bmc70170-li-0056"><p>endoplasmic reticulum</p></dd>
<dt id="bmc70170-li-0057">ERK</dt>
<dd id="bmc70170-li-0058"><p>extracellular signal–regulated kinase</p></dd>
<dt id="bmc70170-li-0059">ERLIN</dt>
<dd id="bmc70170-li-0060"><p>ER lipid raft</p></dd>
<dt id="bmc70170-li-0061">FLN</dt>
<dd id="bmc70170-li-0062"><p>filamin</p></dd>
<dt id="bmc70170-li-0063">G6PDH</dt>
<dd id="bmc70170-li-0064"><p>glucose‐6‐phosphate dehydrogenase</p></dd>
<dt id="bmc70170-li-0065">GATA</dt>
<dd id="bmc70170-li-0066"><p>trans‐acting T‐cell‐specific transcription factor</p></dd>
<dt id="bmc70170-li-0067">GBMs</dt>
<dd id="bmc70170-li-0068"><p>glioblastomas</p></dd>
<dt id="bmc70170-li-0069">GFAP</dt>
<dd id="bmc70170-li-0070"><p>glial fibrillary acidic protein</p></dd>
<dt id="bmc70170-li-0071">GLUT</dt>
<dd id="bmc70170-li-0072"><p>glucose transporters</p></dd>
<dt id="bmc70170-li-0073">GNA</dt>
<dd id="bmc70170-li-0074"><p>guanine nucleotide‐binding proteins</p></dd>
<dt id="bmc70170-li-0075">GO</dt>
<dd id="bmc70170-li-0076"><p>Gene Ontology</p></dd>
<dt id="bmc70170-li-0077">GPCRs</dt>
<dd id="bmc70170-li-0078"><p>G protein–coupled receptors</p></dd>
<dt id="bmc70170-li-0079">GSS</dt>
<dd id="bmc70170-li-0080"><p>glutathione synthetase</p></dd>
<dt id="bmc70170-li-0081">GST</dt>
<dd id="bmc70170-li-0082"><p>glutathione transferase</p></dd>
<dt id="bmc70170-li-0083">HE</dt>
<dd id="bmc70170-li-0084"><p>h<a href="https://en.wikipedia.org/wiki/Haematoxylin" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">ematoxylin</a> and <a href="https://en.wikipedia.org/wiki/Eosin" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">eosin</a>
</p></dd>
<dt id="bmc70170-li-0085">HIST</dt>
<dd id="bmc70170-li-0086"><p>histones</p></dd>
<dt id="bmc70170-li-0087">HLA</dt>
<dd id="bmc70170-li-0088"><p>major histocompatibility complex</p></dd>
<dt id="bmc70170-li-0089">HMG</dt>
<dd id="bmc70170-li-0090"><p>high mobility group of proteins</p></dd>
<dt id="bmc70170-li-0091">hnRNPs</dt>
<dd id="bmc70170-li-0092"><p>heterogeneous nuclear ribonucleoproteins</p></dd>
<dt id="bmc70170-li-0093">HSD</dt>
<dd id="bmc70170-li-0094"><p>hydroxysteroid dehydrogenase,</p></dd>
<dt id="bmc70170-li-0095">HSP</dt>
<dd id="bmc70170-li-0096"><p>heat shock protein family</p></dd>
<dt id="bmc70170-li-0097">IDH</dt>
<dd id="bmc70170-li-0098"><p>isocitrate dehydrogenase</p></dd>
<dt id="bmc70170-li-0099">IHC</dt>
<dd id="bmc70170-li-0100"><p>immunohistochemistry</p></dd>
<dt id="bmc70170-li-0101">ITG</dt>
<dd id="bmc70170-li-0102"><p>integrin superfamily</p></dd>
<dt id="bmc70170-li-0103">LAMB</dt>
<dd id="bmc70170-li-0104"><p>laminin</p></dd>
<dt id="bmc70170-li-0105">LMN</dt>
<dd id="bmc70170-li-0106"><p>lamins</p></dd>
<dt id="bmc70170-li-0107">MAPKs</dt>
<dd id="bmc70170-li-0108"><p>mitogen‐activated protein kinases</p></dd>
<dt id="bmc70170-li-0109">MF</dt>
<dd id="bmc70170-li-0110"><p>molecular function</p></dd>
<dt id="bmc70170-li-0111">MMPs</dt>
<dd id="bmc70170-li-0112"><p>matrix metalloproteinases</p></dd>
<dt id="bmc70170-li-0113">MNGs</dt>
<dd id="bmc70170-li-0114"><p>meningiomas</p></dd>
<dt id="bmc70170-li-0115">MRPS</dt>
<dd id="bmc70170-li-0116"><p>mitochondrial ribosomal proteins</p></dd>
<dt id="bmc70170-li-0117">MS</dt>
<dd id="bmc70170-li-0118"><p>mass spectrometry</p></dd>
<dt id="bmc70170-li-0119">MS/MS</dt>
<dd id="bmc70170-li-0120"><p>tandem mass spectrometry</p></dd>
<dt id="bmc70170-li-0121">MYH/MYO</dt>
<dd id="bmc70170-li-0122"><p>myosin</p></dd>
<dt id="bmc70170-li-0123">NKA</dt>
<dd id="bmc70170-li-0124"><p>Na<sup>+</sup>/K<sup>+</sup>‐ATPase transporting</p></dd>
<dt id="bmc70170-li-0125">NES</dt>
<dd id="bmc70170-li-0126"><p>nestin</p></dd>
<dt id="bmc70170-li-0127">PABPs</dt>
<dd id="bmc70170-li-0128"><p>poly(A)‐binding protein cytoplasmic</p></dd>
<dt id="bmc70170-li-0129">PAK</dt>
<dd id="bmc70170-li-0130"><p>protein kinases</p></dd>
<dt id="bmc70170-li-0131">PC</dt>
<dd id="bmc70170-li-0132"><p>protein class</p></dd>
<dt id="bmc70170-li-0133">PFN1</dt>
<dd id="bmc70170-li-0134"><p>profilin</p></dd>
<dt id="bmc70170-li-0135">PFKM</dt>
<dd id="bmc70170-li-0137"><p>phosphofructokinases</p></dd>
<dt id="bmc70170-li-0138">PI3K/AKT/mTOR</dt>
<dd id="bmc70170-li-0139"><p>phosphoinositide‐3‐kinaseserine‐threonine kinase/mammalian target of rapamycin</p></dd>
<dt id="bmc70170-li-0140">PRDX</dt>
<dd id="bmc70170-li-0141"><p>peroxiredoxin peroxidase</p></dd>
<dt id="bmc70170-li-0142">PSMB</dt>
<dd id="bmc70170-li-0143"><p>proteasome subunit beta</p></dd>
<dt id="bmc70170-li-0144">PTMs</dt>
<dd id="bmc70170-li-0145"><p>posttranslational modifications</p></dd>
<dt id="bmc70170-li-0146">ROBO</dt>
<dd id="bmc70170-li-0147"><p>roundabout</p></dd>
<dt id="bmc70170-li-0148">MRPL/MRPS</dt>
<dd id="bmc70170-li-0149"><p>mitochondrial ribosomal protein</p></dd>
<dt id="bmc70170-li-0150">SLC</dt>
<dd id="bmc70170-li-0151"><p>solute carrier</p></dd>
<dt id="bmc70170-li-0152">snRPs</dt>
<dd id="bmc70170-li-0153"><p>small nuclear ribonucleoprotein polypeptide</p></dd>
<dt id="bmc70170-li-0154">SNX</dt>
<dd id="bmc70170-li-0155"><p>sorting nexin family member proteins</p></dd>
<dt id="bmc70170-li-0156">SOX2</dt>
<dd id="bmc70170-li-0157"><p>SRY‐box transcription factor 2</p></dd>
<dt id="bmc70170-li-0158">SRP</dt>
<dd id="bmc70170-li-0159"><p>signal recognition particles</p></dd>
<dt id="bmc70170-li-0160">SRSF</dt>
<dd id="bmc70170-li-0161"><p>serine and arginine‐rich splicing factor</p></dd>
<dt id="bmc70170-li-0162">STRING</dt>
<dd id="bmc70170-li-0163"><p>Search Tool for the Retrieval of Interacting Genes/Proteins</p></dd>
<dt id="bmc70170-li-0164">TMEM</dt>
<dd id="bmc70170-li-0165"><p>transmembrane protein</p></dd>
<dt id="bmc70170-li-0166">tPA</dt>
<dd id="bmc70170-li-0167"><p>tissue plasminogen activator</p></dd>
<dt id="bmc70170-li-0168">TPM</dt>
<dd id="bmc70170-li-0169"><p>tropomyosin</p></dd>
<dt id="bmc70170-li-0170">TUBB</dt>
<dd id="bmc70170-li-0171"><p>tubulins</p></dd>
<dt id="bmc70170-li-0172">TXN</dt>
<dd id="bmc70170-li-0173"><p>thioredoxin</p></dd>
<dt id="bmc70170-li-0174">UQCR</dt>
<dd id="bmc70170-li-0175"><p>ubiquinol–cytochrome c reductase</p></dd>
<dt id="bmc70170-li-0176">UHPLC</dt>
<dd id="bmc70170-li-0177"><p>ultra‐high performance liquid chromatography</p></dd>
<dt id="bmc70170-li-0178">VEGF</dt>
<dd id="bmc70170-li-0179"><p>vascular endothelial growth factor</p></dd>
<dt id="bmc70170-li-0180">VIM</dt>
<dd id="bmc70170-li-0181"><p>vimentin</p></dd>
<dt id="bmc70170-li-0182">VPS</dt>
<dd id="bmc70170-li-0183"><p>vacuolar protein sorting,</p></dd>
<dt id="bmc70170-li-0184">WHO</dt>
<dd id="bmc70170-li-0185"><p>World Health Organization</p></dd>
<dt id="bmc70170-li-0186">Wt</dt>
<dd id="bmc70170-li-0187"><p>wildtype</p></dd>
<dt id="bmc70170-li-0188">YWHA</dt>
<dd id="bmc70170-li-0189"><p>tyrosine 3‐monooxygenase/tryptophan 5‐monooxygenase activation protein beta</p></dd>
</dl>
<section id="bmc70170-sec-0001"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Brain tumors, as one of the most important causes of death, represent the 17th most common cancer worldwide and account for 1%–2% of all tumors. Because of their increased incidence and death rates in many developed countries, brain tumors should be accurately diagnosed and monitored (Mohammed et al. <a href="#bmc70170-bib-0122" class="usa-link" aria-describedby="bmc70170-bib-0122">2019</a>).</p>
<p>Meningiomas (MNGs), derived from arachnoid cells, are the most common intracranial tumor. They are classified into three different grades, according to the World Health Organization (WHO). The recurrence rate and the risk of malignant transformation depend on the histopathological type. Grade I is the most common type of MNG and is considered benign, whereas Grade III is the most aggressive form and is considered malignant, associated with a higher risk of recurrence and shorter survival times (Torp et al. <a href="#bmc70170-bib-0177" class="usa-link" aria-describedby="bmc70170-bib-0177">2022</a>).</p>
<p>Gliomas are characterized by diffuse infiltration into the surrounding brain parenchyma. They are the most common brain astrocytomas, constituting about 40% of all the primary intracranial tumors. They exhibit various genetic alterations along with phenotypic diversity, contributing to numerous dysregulated pathways. Glioblastoma multiforme, previously categorized under Grade IV gliomas, is the most aggressive, infiltrative, and highly vascularized malignant astrocytoma with very poor prognosis that cannot be completely eliminated by surgery (Joo et al. <a href="#bmc70170-bib-0078" class="usa-link" aria-describedby="bmc70170-bib-0078">2013</a>; Niclou et al. <a href="#bmc70170-bib-0133" class="usa-link" aria-describedby="bmc70170-bib-0133">2010</a>). It occurs mainly in adults with very low survival rates after diagnosis (6 months to 2 years) even if an aggressive treatment involving a combination of surgery, radiotherapy, and chemotherapy is given (Bhatia et al. <a href="#bmc70170-bib-0015" class="usa-link" aria-describedby="bmc70170-bib-0015">2012</a>; Friedman et al. <a href="#bmc70170-bib-0051" class="usa-link" aria-describedby="bmc70170-bib-0051">2000</a>). Moreover, these aggressive tumors express local metastases, with relapse and resistance against a wide range of chemotherapeutic agents (Stupp et al. <a href="#bmc70170-bib-0164" class="usa-link" aria-describedby="bmc70170-bib-0164">2007</a>; Uribe et al. <a href="#bmc70170-bib-0180" class="usa-link" aria-describedby="bmc70170-bib-0180">2017</a>).</p>
<p>Based on the 5th edition of the WHO new classification (2021) of brain tumors and the isolation of isocitrate dehydrogenase (IDH) mutant forms, glioblastomas (GBMs) are now considered biologically and molecularly distinct entities, namely, GBM IDH‐wildtype (IDH‐wt), which account for more than 90% of all gliomas with a poor prognosis, and Grade IV astrocytomas IDH‐mutant (IDH‐mut) (Louis et al. <a href="#bmc70170-bib-0108" class="usa-link" aria-describedby="bmc70170-bib-0108">2021</a>). Although IDH‐mutated gliomas generally exhibit a better disease outcome with prolonged median survival (IDH‐wt: 15 months vs. IDH‐mut: 31 months), tumor recurrence is inevitable over time despite gross total resection and adjuvant chemoradiotherapy (Han and Batchelor <a href="#bmc70170-bib-0061" class="usa-link" aria-describedby="bmc70170-bib-0061">2017</a>; Han et al. <a href="#bmc70170-bib-0062" class="usa-link" aria-describedby="bmc70170-bib-0062">2020</a>).</p>
<p>Thus, early diagnosis of cancers is still a major challenge worldwide. The prompt diagnosis and understanding of the severity of tumors would not only reduce their associated morbidity and mortality but also help achieve a better future management of the patient (Buerki et al. <a href="#bmc70170-bib-0025" class="usa-link" aria-describedby="bmc70170-bib-0025">2018</a>; Lim et al. <a href="#bmc70170-bib-0097" class="usa-link" aria-describedby="bmc70170-bib-0097">2013</a>).</p>
<p>Brain tumors are usually diagnosed based on the examination of hematoxylin and eosin (HE) stained sections of formalin‐fixed and paraffin‐embedded biopsy specimens. However, many brain tumors contain so few mitoses that an accurate mitotic index is impossible in biopsy specimens. This dilemma is improved by immunohistochemistry (IHC) staining, which provides major insights into potential tumor growth as well as tumor classification through the identification of stemness gene markers (Madabhushi et al. <a href="#bmc70170-bib-0113" class="usa-link" aria-describedby="bmc70170-bib-0113">2015</a>). However, this technique remains a very time‐consuming, laborious, and cost‐effective process, as it requires the use of primary and secondary antibodies as well as plenty of materials and complex workflows to allow only the detection of a limited number of antigens simultaneously. In addition, a large amount of human workforce is needed (Mebratie and Dagnaw <a href="#bmc70170-bib-0119" class="usa-link" aria-describedby="bmc70170-bib-0119">2024</a>). Similarly, other traditional methods based on antibodies, namely, ELISA (enzyme‐linked immunosorbent assay), Western Blotting, and immunofluorescence, still display limitations and pitfalls, such as the insufficient blocking of immobilized antigens leading to the risk of false positive/negative results, antibody instability, cross‐reactivity, epitope occlusion, lack of accuracy, expensive culture media, and the lack of specific antibodies or their exorbitant costs (Ghosh et al. <a href="#bmc70170-bib-0055" class="usa-link" aria-describedby="bmc70170-bib-0055">2014</a>; Jiang et al. <a href="#bmc70170-bib-0075" class="usa-link" aria-describedby="bmc70170-bib-0075">2021</a>; Sakamoto et al. <a href="#bmc70170-bib-0152" class="usa-link" aria-describedby="bmc70170-bib-0152">2017</a>; Thomas et al. <a href="#bmc70170-bib-0174" class="usa-link" aria-describedby="bmc70170-bib-0174">2019</a>).</p>
<p>Therefore, the improvement of diagnostic performance is required as it plays a key role in achieving accurate results by reducing subjectivity, increasing standardized diagnosis, as well as predicting prognosis and planning better individual treatment with minimal side effects.</p>
<p>To this end, the application of new technologies in medical analyses is warranted in order to overcome the caveats associated with traditional methods, ameliorate the quality of healthcare performance in the hospital management system (HMS) and resolve current health problems alleged by the majority of patients (e.g., the lack of chemical reagents, the lack of specific tumor antibodies, human errors, overseeing employees, funds and resources, long‐time processing in workflow analysis, or for the acquisition of specific reagents, or in lending rapid and reliable results) (Hristova and Svinarov <a href="#bmc70170-bib-0068" class="usa-link" aria-describedby="bmc70170-bib-0068">2022</a>; Sinha <a href="#bmc70170-bib-0158" class="usa-link" aria-describedby="bmc70170-bib-0158">2024</a>; Unger and Kather <a href="#bmc70170-bib-0179" class="usa-link" aria-describedby="bmc70170-bib-0179">2024</a>).</p>
<p>Currently, mass spectrometry (MS) has steadily emerged to be implemented in routine analyses from various disciplines, including the development of reference methods, therapeutic drug monitoring, toxicology, endocrinology, pediatrics, immunology, and microbiology to identify and quantify biomolecules in a variety of biological specimens (Baghel et al. <a href="#bmc70170-bib-0010" class="usa-link" aria-describedby="bmc70170-bib-0010">2017</a>; Y. Chen, Chen, et al. <a href="#bmc70170-bib-0032" class="usa-link" aria-describedby="bmc70170-bib-0032">2022</a>; Fung et al. <a href="#bmc70170-bib-0052" class="usa-link" aria-describedby="bmc70170-bib-0052">2019</a>; Maekawa and Mano <a href="#bmc70170-bib-0114" class="usa-link" aria-describedby="bmc70170-bib-0114">2022</a>; Zhang and Garg <a href="#bmc70170-bib-0204" class="usa-link" aria-describedby="bmc70170-bib-0204">2023</a>). It is the most powerful technique that has offered significant advantages over traditional methods, thanks to its high‐throughput screening, qualitative and quantitative analysis at high sensitivity, accuracy, and robustness, making it an advantageous tool in a wide range of biological and clinical applications. More interestingly, it has been recently involved in omics studies, including specific genes (genomics), mRNAs (transcriptomics), proteins (proteomics) and metabolites (metabolomics) for screening, diagnosis, and prognosis, as well as in drug discovery and clinical trials through the assessment of toxicity and efficacy in diagnosed patients compared to healthy volunteers (Agulló et al. <a href="#bmc70170-bib-0216" class="usa-link" aria-describedby="bmc70170-bib-0216">2024</a>; Birhanu <a href="#bmc70170-bib-0019" class="usa-link" aria-describedby="bmc70170-bib-0019">2023</a>; Girolamo et al. <a href="#bmc70170-bib-0058" class="usa-link" aria-describedby="bmc70170-bib-0058">2013</a>; Lin and Garcia <a href="#bmc70170-bib-0098" class="usa-link" aria-describedby="bmc70170-bib-0098">2012</a>; Noberini et al. <a href="#bmc70170-bib-0135" class="usa-link" aria-describedby="bmc70170-bib-0135">2021</a>; Rochat <a href="#bmc70170-bib-0151" class="usa-link" aria-describedby="bmc70170-bib-0151">2018</a>; Zaikin and Borisov <a href="#bmc70170-bib-0202" class="usa-link" aria-describedby="bmc70170-bib-0202">2021</a>). Strikingly, it has enabled the discovery of cancer biomarker panels along with their quantitative measurement in an unbiased manner (Fan et al. <a href="#bmc70170-bib-0047" class="usa-link" aria-describedby="bmc70170-bib-0047">2024</a>; Son et al. <a href="#bmc70170-bib-0159" class="usa-link" aria-describedby="bmc70170-bib-0159">2024</a>).</p>
<p>In this respect, we have opted for the state of the art proteomics in our clinical investigation of human brain tumors as it has held great promise in cancer‐related scientific research, due to the recent advances in the high‐throughput MS technique with the powerful research algorithms that have facilitated the identification and characterization of proteins even expressed at low abundance in complex biological mixtures, along with their key encoding hub genes (Carrillo‐Rodriguez et al. <a href="#bmc70170-bib-0029" class="usa-link" aria-describedby="bmc70170-bib-0029">2023</a>; Cho <a href="#bmc70170-bib-0035" class="usa-link" aria-describedby="bmc70170-bib-0035">2017</a>; Kwon et al. <a href="#bmc70170-bib-0087" class="usa-link" aria-describedby="bmc70170-bib-0087">2021</a>; Wenk et al. <a href="#bmc70170-bib-0189" class="usa-link" aria-describedby="bmc70170-bib-0189">2024</a>). These genes are envisaged as obvious diagnostic biomarkers and pivotal predictors of pathology progression and prognosis, whose mapping and characterization constitute a critical field of study with great interest in both disease and drug discovery as they help gain two potential benefits: first, better understanding of the key molecular mechanisms implicated in pathogenesis, which is imperative for establishing standardized diagnosis, and second, optimization of treatment guidelines for the development of new therapeutic targets at the most basic level of gene expressions (Åkesson et al. <a href="#bmc70170-bib-0003" class="usa-link" aria-describedby="bmc70170-bib-0003">2023</a>; Ciocan‐Cartita et al. <a href="#bmc70170-bib-0038" class="usa-link" aria-describedby="bmc70170-bib-0038">2019</a>; Teunissen et al. <a href="#bmc70170-bib-0171" class="usa-link" aria-describedby="bmc70170-bib-0171">2011</a>).</p>
<p>Overall, our investigation as a multiomic study was endeavored to make the differential diagnosis of human brain tumors, namely, Grade IV astrocytomas and MNGs, as the most commonly occurring types in our hospital medium, by proteome‐wide profiling and mapping using a shotgun proteomic–based approach with high‐resolution tandem MS.</p>
<p>Our aim is to highlight the advantages and the usefulness of this technique in clinical analyses compared to the traditional method based on IHC staining through the assessment of pivotal diagnostic biomarkers of malignant, metastatic, and invasive forms of cancer with poor prognosis. The framework adaptive strategy for our proteomics analysis of human brain tumors is illustrated in Figure <a href="#bmc70170-fig-0001" class="usa-link">1</a>.</p>
<figure class="fig xbox font-sm" id="bmc70170-fig-0001"><h3 class="obj_head">FIGURE 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/045d/12326238/056a54be096c/BMC-39-e70170-g007.jpg" loading="lazy" id="jats-graphic-1" height="1005" width="709" alt="FIGURE 1"></p>
<div class="p text-right font-secondary"><a href="figure/bmc70170-fig-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>A flowchart depicting the process of a typical shotgun proteomic–based approach for the analysis of human brain tumors.</p></figcaption></figure></section><section id="bmc70170-sec-0002"><h2 class="pmc_sec_title">2. Materials and Methods</h2>
<section id="bmc70170-sec-0003"><h3 class="pmc_sec_title">2.1. Characteristics of Patient Cohort Study</h3>
<p>Our clinical study was conducted on patients operated on for brain tumors in the neurosurgery department of the Habib Bourguiba Hospital medium during the period from January 1 to May 30, 2024. We have mainly focused on gliomas and MNGs because both were the most frequent types of brain tumors. Each patient was exposed to image examinations, such as magnetic resonance imaging (MRI), presurgery and postsurgery for the identification and evaluation of tumor growth and recurrence.</p></section><section id="bmc70170-sec-0004"><h3 class="pmc_sec_title">2.2. Samples Collection</h3>
<p>For our analysis, human specimens were collected immediately after the surgical resection of brain tumors. The samples of the control group consisted of some collected specimens taken from brain tissues derived from temporal lobe epilepsy surgeries, which are generally described as experimental controls in research studies (Polisetty et al. <a href="#bmc70170-bib-0146" class="usa-link" aria-describedby="bmc70170-bib-0146">2012</a>).</p></section><section id="bmc70170-sec-0005"><h3 class="pmc_sec_title">2.3. Chemicals and Materials</h3>
<p>All the used chemicals and compounds were pure (&gt; 95%) for HPLC analysis.</p>
<p>DL‐dithiothreitol (DTT) (3483‐12‐3), iodoacetamide (IAA) (144‐48‐9), formic acid (FA) (64‐18‐6), ammonium bicarbonate (1066‐33‐7), acetonitrile (ACN) (75–05‐8), and methanol (67‐56‐1) were supplied by Sigma Aldrich (St. Louis, MO, USA). Trypsin (V5280) derived from porcine pancreas was supplied by Promega (Madison, WI, USA). Ultrapure water was prepared by the Millipore purification system (Billerica, MA, USA).</p></section><section id="bmc70170-sec-0006"><h3 class="pmc_sec_title">2.4. IHC Staining</h3>
<p>Primary cell identity was confirmed prior to use by IHC staining for neuronal cell markers namely, CD133 (BD Biosciences Cat# 747569, RRID: AB_2744141), CD44 (BD Biosciences Cat# 558739, RRID: AB_397098), NES (Nestin) (IMGENEX Cat# IMG‐6492A, RRID: AB_2033866), VIM (Vimentin) (Abcam Cat# 4211–1, RRID: AB_765097) SOX2 (SRY‐Box Transcription Factor 2) (BD Biosciences Cat# 560291, RRID: AB_1645334), βIII‐tubulin (Promega Cat# G7121, RRID: AB_430874), GFAP (Glial Fibrillary Acidic Protein) (Aeonian Biotech Cat# AE00178, RRID: AB_2750965), and IDH1 (Proteintech Cat# 12332–1‐AP, RRID: AB_2123159) genes for glioma brain tumors.</p>
<p>The EMA (epithelial membrane antigen) (Bio‐Rad Cat# MCA1908, RRID: AB_322557) and VIM were used as stemness markers of MNG diagnosis. GATA3 (Trans‐acting T‐cell‐specific transcription factor) (BD Biosciences Cat# 563349, RRID: AB_2738152) and keratin (RayBiotech Cat# DS‐MB‐01725, RRID:AB_854575) were adapted for the diagnosis of brain metastases from carcinoma.</p>
<p>Human brain tumor tissues were harvested and processed into histological blocks that, after standard fixation and embedding procedures, were sectioned to produce slides for IHC staining, which the detailed protocol is described in the <a href="#bmc70170-supitem-0001" class="usa-link">Supporting Information</a>.</p></section><section id="bmc70170-sec-0007"><h3 class="pmc_sec_title">2.5. Sample Preparation Using a Shotgun Proteomic‐Based Approach</h3>
<p>Brain tumor tissues were harvested, pooled in a centrifuge tube, washed with cold PBS at 4°C, centrifuged at 2500 rpm for 10 min, and then collected and lyophilized by a freeze dryer (CHRIST). The following steps of cell lysis, protein extraction, reduction, alkylation, and then trypsin digestion were processed in the same way as the detailed protocol described in our previously published studies (Louati et al. <a href="#bmc70170-bib-0106" class="usa-link" aria-describedby="bmc70170-bib-0106">2023</a>, <a href="#bmc70170-bib-0107" class="usa-link" aria-describedby="bmc70170-bib-0107">2024</a>). The resulted extracted peptides were lyophilized to near dryness, then resuspended in 20 μL of 0.1% FA for analysis by MS technique.</p></section><section id="bmc70170-sec-0008"><h3 class="pmc_sec_title">2.6. Analysis by Nanoflow UHPLC‐ESI‐MS/MS</h3>
<p>Samples were analyzed on the same day by a high‐resolution tandem MS consisting of an Ultimate 3000 nano‐ultra‐high performance liquid chromatography (UHPLC) system (ThermoFisher Scientific, USA), electrospray ionization (ESI) nanospray source, a Q Exactive HF mass spectrometer (Thermo Fisher Scientific, USA), and a higher energy collision‐induced dissociation (HCD) fragmentation mode. The nanocolumn associated a trapping column (PepMap C18, 100 Å, 100 μm × 2 cm, 5 μm) and an analytical column (PepMap C18, 100 Å, 75 μm × 50 cm, 2 μm). The loaded sample volume was 1 μg, and the total flow rate was 250 nL/min. The mobile phase was a combination of solvent A (0.1% FA in water) and solvent B (0.1% FA in 80% acetonitrile) by linear gradient: from 2% to 8% buffer B in 3 min, from 8% to 20% buffer B in 56 min, from 20% to 40% buffer B in 37 min, and then from 40% to 90% buffer B in 4 min. The full scan was performed between 300 and 1650 m/z at a resolution of 60,000 at 200 m/z. The automatic gain control target for the full scan was set to 3e6.</p>
<p>The MS/MS scan was operated in Top 20 mode using the following settings: resolution 15,000 at 200 m/z; automatic gain control target 1e5; maximum injection time 19 ms; normalized collision energy at 28%; isolation window of 1.4 Th; charge state exclusion: unassigned, 1, &gt; 6; dynamic exclusion 30 s.</p></section><section id="bmc70170-sec-0009"><h3 class="pmc_sec_title">2.7. Data MS Analysis and Protein Identification</h3>
<p>Raw MS files were analyzed and searched against the human protein database based on the species of the samples using the MaxQuant software (V.1.6.1.14, RRID: SCR_014485). The setting parameters were as follows: The protein modifications were carbamidomethylation (C) (fixed) and methionine oxidation (variable); the enzyme specificity was set to trypsin with two maximum missed cleavages allowed; the precursor ion mass tolerance was 10 ppm, and the MS/MS fragment ion tolerance was 0.6 Da. Proteins were identified with a high confidence interval at 95%, containing at least one identified peptide. Only proteins identified three times were considered. Scaffold (Version 4.10.0, Proteome Software Inc., Portland, OR) was used to validate the MS/MS‐based peptide and protein identification.</p></section><section id="bmc70170-sec-0010"><h3 class="pmc_sec_title">2.8. Bioinformatics Analysis</h3>
<p>We scrutinized protein/gene names by the use of Human Protein Atlas, which is a freely available interactive resource offering the possibility to explore the proteomes in tissues and organs (The Human Protein Atlas <a href="#bmc70170-bib-0172" class="usa-link" aria-describedby="bmc70170-bib-0172">2024</a>, online available: <a href="https://www.proteinatlas.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.proteinatlas.org/</a>). Annotations of the identified proteins to their ontology terms were carried out based on their biological processes (BPs), molecular functions (MFs), and protein classes (PCs).</p>
<p>The Gene Ontology (GO) enrichment analysis was performed by PANTHER database (Version 19.0, <a href="#bmc70170-bib-0141" class="usa-link" aria-describedby="bmc70170-bib-0141">2025</a>), which provides comprehensive information about the evolution of protein‐coding gene families (online available: <a href="http://www.pantherdb.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.pantherdb.org</a>). Then, for a better understanding of the molecular relationships between each protein/gene function from their various biological processes, a pathway enrichment analysis of regulated proteins at proteomic levels was performed by METASCAPE (<a href="#bmc70170-bib-0121" class="usa-link" aria-describedby="bmc70170-bib-0121">2019</a>) and PANTHER databases (Y. Zhou, Yu, et al. <a href="#bmc70170-bib-0210" class="usa-link" aria-describedby="bmc70170-bib-0210">2019</a>; online available:<a href="https://metascape.org/gp/index.html#/main/step1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://metascape.org/gp/index.html#/main/step1</a>). Further, to ensure consistency between the GO and pathways enrichment, a ClueGO (Version 2.5.10) and CluePedia (Version 2.5.10) of Cytoscape plugin module (Software 3.10.3) analysis integrating both GO terms and pathways annotation was performed to create interrelational networks (Bindea et al. <a href="#bmc70170-bib-0017" class="usa-link" aria-describedby="bmc70170-bib-0017">2009</a>; Bindea et al. <a href="#bmc70170-bib-0018" class="usa-link" aria-describedby="bmc70170-bib-0018">2013</a>; online available: <a href="https://string-db.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://string‐db.org</a>).</p>
<p>In addition, hub genes were predicted by the protein–protein interaction (PPI) network analysis using the STRING (Search Tool for the Retrieval of Interacting Genes/Proteins) database (Version 12.0, <a href="#bmc70170-bib-0163" class="usa-link" aria-describedby="bmc70170-bib-0163">2023</a>) (online available: <a href="https://string-db.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://string‐db.org</a>) in order to reveal their relevance as well as their meaningful relationship and regulation. The minimum combined score of the hub gene network was set to 0.4 by default, but only interactions with a confidence score larger than 0.9 were selected.</p></section></section><section id="bmc70170-sec-0011"><h2 class="pmc_sec_title">3. Results</h2>
<section id="bmc70170-sec-0012"><h3 class="pmc_sec_title">3.1. Characteristics of Patient Cohort Study</h3>
<p>Following our study's population, we found that the incidence of gliomas was higher in men than in women, occurring across all age groups, especially between 45 and 65 years old. IDH1 was the most detected isoform. High‐grade gliomas, including Grade IV astrocytomas and GBMs, were the most abundant and deadly forms in our patients.</p>
<p>MNGs, as the most prevalent intracranial type of tumor, occurred at the highest female‐to‐male ratio. Their incidence increased along with age, which was especially observed in middle‐aged women between 40 and 70 years old, with a median age of 65 years. Grade I represented the most frequent type in our study's population. The high‐grade form (MNG‐Grade III) was only observed in people around 60 years old. Demographics and clinical characteristics of some of our selected participants are summarized in Table <a href="#bmc70170-tbl-0001" class="usa-link">1</a>.</p>
<section class="tw xbox font-sm" id="bmc70170-tbl-0001"><h4 class="obj_head">TABLE 1.</h4>
<div class="caption p"><p>Demographics and characteristics of some selected patients for our case study on human brain tumors.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Patient no.</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Age (years)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Sex</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Residence</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Histology</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Clinical diagnosis</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Neurological clinical symptoms</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Surgical therapy</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Recurrent tumor?</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Outcome and survival</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">59</td>
<td align="center" valign="top" rowspan="1" colspan="1">M</td>
<td align="center" valign="top" rowspan="1" colspan="1">Sidi‐Bouzid</td>
<td align="center" valign="top" rowspan="1" colspan="1">Diffuse astocytoma</td>
<td align="center" valign="top" rowspan="1" colspan="1">Grade IV astrocytoma (IDH1‐mutant high‐grade gliomas)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Dizziness, diplopia, vomiting</td>
<td align="center" valign="top" rowspan="1" colspan="1">Gross total resection</td>
<td align="center" valign="top" rowspan="1" colspan="1">No</td>
<td align="center" valign="top" rowspan="1" colspan="1">Clinically stable</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">68</td>
<td align="center" valign="top" rowspan="1" colspan="1">M</td>
<td align="center" valign="top" rowspan="1" colspan="1">DOUZ</td>
<td align="center" valign="top" rowspan="1" colspan="1">Diffuse astocytoma</td>
<td align="center" valign="top" rowspan="1" colspan="1">Grade IV astrocytoma (IDH1‐mutant high‐grade gliomas)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Intracranial hypertension during 1 month, nausea, vomiting</td>
<td align="center" valign="top" rowspan="1" colspan="1">The mass was devascularized, gross total resection.</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="top" rowspan="1" colspan="1">Patient recovery was uneventful.</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">3</td>
<td align="center" valign="top" rowspan="1" colspan="1">49</td>
<td align="center" valign="top" rowspan="1" colspan="1">M</td>
<td align="center" valign="top" rowspan="1" colspan="1">Kbeli</td>
<td align="center" valign="top" rowspan="1" colspan="1">Diffuse astocytoma</td>
<td align="center" valign="top" rowspan="1" colspan="1">Grade IV astrocytoma (IDH1‐mutant high‐grade gliomas)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Headache, nausea, vomiting, epileptic seizures, dizziness, impaired vision, and speech problems</td>
<td align="center" valign="top" rowspan="1" colspan="1">Gross total resection</td>
<td align="center" valign="top" rowspan="1" colspan="1">No</td>
<td align="center" valign="top" rowspan="1" colspan="1">Alive and well</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">4</td>
<td align="center" valign="top" rowspan="1" colspan="1">53</td>
<td align="center" valign="top" rowspan="1" colspan="1">M</td>
<td align="center" valign="top" rowspan="1" colspan="1">Gafsa</td>
<td align="center" valign="top" rowspan="1" colspan="1">Diffuse astocytoma</td>
<td align="center" valign="top" rowspan="1" colspan="1">Grade IV astrocytoma (IDH1‐mutant high‐grade gliomas)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Epileptic seizures, dizziness, impaired vision</td>
<td align="center" valign="top" rowspan="1" colspan="1">Craniotomy with complete removal of tumor</td>
<td align="center" valign="top" rowspan="1" colspan="1">No</td>
<td align="center" valign="top" rowspan="1" colspan="1">Clinically stable</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">5</td>
<td align="center" valign="top" rowspan="1" colspan="1">62</td>
<td align="center" valign="top" rowspan="1" colspan="1">F</td>
<td align="center" valign="top" rowspan="1" colspan="1">Sidi‐Bouzid</td>
<td align="center" valign="top" rowspan="1" colspan="1">Diffuse astocytoma</td>
<td align="center" valign="top" rowspan="1" colspan="1">Grade IV astrocytoma (IDH1‐mutant high‐grade gliomas)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Headache, nausea, speech problems, ataxia</td>
<td align="center" valign="top" rowspan="1" colspan="1">Gross total resection</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="top" rowspan="1" colspan="1">Clinically stable</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">6</td>
<td align="center" valign="top" rowspan="1" colspan="1">70</td>
<td align="center" valign="top" rowspan="1" colspan="1">M</td>
<td align="center" valign="top" rowspan="1" colspan="1">Sfax</td>
<td align="center" valign="top" rowspan="1" colspan="1">Diffuse astocytoma</td>
<td align="center" valign="top" rowspan="1" colspan="1">Grade IV astrocytoma (IDH1‐mutant high‐grade gliomas)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Headache, dizziness, diplopia, vomiting</td>
<td align="center" valign="top" rowspan="1" colspan="1">Craniotomy with complete removal of tumor</td>
<td align="center" valign="top" rowspan="1" colspan="1">No</td>
<td align="center" valign="top" rowspan="1" colspan="1">Patient recovery was uneventful</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">7</td>
<td align="center" valign="top" rowspan="1" colspan="1">58</td>
<td align="center" valign="top" rowspan="1" colspan="1">F</td>
<td align="center" valign="top" rowspan="1" colspan="1">Mednin</td>
<td align="center" valign="top" rowspan="1" colspan="1">Meningothelial whorls</td>
<td align="center" valign="top" rowspan="1" colspan="1">Grade I MNG</td>
<td align="center" valign="top" rowspan="1" colspan="1">Headaches, nausea, vomiting</td>
<td align="center" valign="top" rowspan="1" colspan="1">Gross total resection (100%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No</td>
<td align="center" valign="top" rowspan="1" colspan="1">Clinically stable</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">8</td>
<td align="center" valign="top" rowspan="1" colspan="1">63</td>
<td align="center" valign="top" rowspan="1" colspan="1">F</td>
<td align="center" valign="top" rowspan="1" colspan="1">Kairouan</td>
<td align="center" valign="top" rowspan="1" colspan="1">Low‐density proliferation</td>
<td align="center" valign="top" rowspan="1" colspan="1">Grade I MNG</td>
<td align="center" valign="top" rowspan="1" colspan="1">Nausea, speech problems</td>
<td align="center" valign="top" rowspan="1" colspan="1">Gross total resection (100%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No</td>
<td align="center" valign="top" rowspan="1" colspan="1">Alive and well</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">9</td>
<td align="center" valign="top" rowspan="1" colspan="1">55</td>
<td align="center" valign="top" rowspan="1" colspan="1">F</td>
<td align="center" valign="top" rowspan="1" colspan="1">Tataouin</td>
<td align="center" valign="top" rowspan="1" colspan="1">Low proliferation with a lack of anaplastic features</td>
<td align="center" valign="top" rowspan="1" colspan="1">Grade I MNG</td>
<td align="center" valign="top" rowspan="1" colspan="1">Headache, dizziness, vomiting</td>
<td align="center" valign="top" rowspan="1" colspan="1">Gross total resection (100%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No</td>
<td align="center" valign="top" rowspan="1" colspan="1">Clinically stable</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">10</td>
<td align="center" valign="top" rowspan="1" colspan="1">65</td>
<td align="center" valign="top" rowspan="1" colspan="1">F</td>
<td align="center" valign="top" rowspan="1" colspan="1">Metloui</td>
<td align="center" valign="top" rowspan="1" colspan="1">Left frontal in progression as sheet‐like growth.</td>
<td align="center" valign="top" rowspan="1" colspan="1">Grade II MNG</td>
<td align="center" valign="top" rowspan="1" colspan="1">Headaches and episodes of generalized tonic–clonic seizures</td>
<td align="center" valign="top" rowspan="1" colspan="1">Gross total resection (100%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No</td>
<td align="center" valign="top" rowspan="1" colspan="1">Clinically stable</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">11</td>
<td align="center" valign="top" rowspan="1" colspan="1">59</td>
<td align="center" valign="top" rowspan="1" colspan="1">F</td>
<td align="center" valign="top" rowspan="1" colspan="1">Sidi‐Bouzid</td>
<td align="center" valign="top" rowspan="1" colspan="1">Brain infiltration, with increased cellularity</td>
<td align="center" valign="top" rowspan="1" colspan="1">Grade II MNG</td>
<td align="center" valign="top" rowspan="1" colspan="1">Headache, bilateral diplopia</td>
<td align="center" valign="top" rowspan="1" colspan="1">Gross total resection (100%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">No</td>
<td align="center" valign="top" rowspan="1" colspan="1">Clinically stable</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">12</td>
<td align="center" valign="top" rowspan="1" colspan="1">67</td>
<td align="center" valign="top" rowspan="1" colspan="1">F</td>
<td align="center" valign="top" rowspan="1" colspan="1">Sfax</td>
<td align="center" valign="top" rowspan="1" colspan="1">Proliferation as tongue‐like growth, necrosis</td>
<td align="center" valign="top" rowspan="1" colspan="1">Grade II MNG</td>
<td align="center" valign="top" rowspan="1" colspan="1">Epileptic seizures, dizziness, and nausea</td>
<td align="center" valign="top" rowspan="1" colspan="1">Gross total resection (100%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="top" rowspan="1" colspan="1">Worsening in the state of consciousness</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">13</td>
<td align="center" valign="top" rowspan="1" colspan="1">68</td>
<td align="center" valign="top" rowspan="1" colspan="1">F</td>
<td align="center" valign="top" rowspan="1" colspan="1">Gabes</td>
<td align="center" valign="top" rowspan="1" colspan="1">
<p>Atypical proliferation, increased mitoses</p>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">Grade III MNG</td>
<td align="center" valign="top" rowspan="1" colspan="1">Focal motor seizures, bilateral diplopia, and speech problems</td>
<td align="center" valign="top" rowspan="1" colspan="1">Gross total resection (100%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="top" rowspan="1" colspan="1">Patient recovery was uneventful.</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">14</td>
<td align="center" valign="top" rowspan="1" colspan="1">70</td>
<td align="center" valign="top" rowspan="1" colspan="1">F</td>
<td align="center" valign="top" rowspan="1" colspan="1">Tozeur</td>
<td align="center" valign="top" rowspan="1" colspan="1">Anaplastic proliferation</td>
<td align="center" valign="top" rowspan="1" colspan="1">Grade III MNG</td>
<td align="center" valign="top" rowspan="1" colspan="1">Left lower extremity weakness, ataxia, nausea, vomiting</td>
<td align="center" valign="top" rowspan="1" colspan="1">Gross total resection (100%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="top" rowspan="1" colspan="1">Worsening in the state of consciousness</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">15</td>
<td align="center" valign="top" rowspan="1" colspan="1">72</td>
<td align="center" valign="top" rowspan="1" colspan="1">F</td>
<td align="center" valign="top" rowspan="1" colspan="1">Gafsa</td>
<td align="center" valign="top" rowspan="1" colspan="1">Malignant growth of cells</td>
<td align="center" valign="top" rowspan="1" colspan="1">Grade III MNG</td>
<td align="center" valign="top" rowspan="1" colspan="1">Dizziness, impaired vision, weakness, loss of power in limbs</td>
<td align="center" valign="top" rowspan="1" colspan="1">Gross total resection (100%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">Yes</td>
<td align="center" valign="top" rowspan="1" colspan="1">Patient recovery was uneventful.</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/bmc70170-tbl-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="bmc70170-note-0003"><p>Abbreviations: F: female; IDH: isocitrate dehydrogenase; M: male; MNG: meningioma.</p></div></div></section></section><section id="bmc70170-sec-0013"><h3 class="pmc_sec_title">3.2. Sample Collection</h3>
<p>Nine freshly resected human specimens were collected from patients diagnosed with MNGs Grades I, II, and III, and six samples were collected from patients diagnosed with Grade IV astrocytomes.</p></section><section id="bmc70170-sec-0014"><h3 class="pmc_sec_title">3.3. Histopathological Diagnosis and IHC Staining of Human Brain Tumors</h3>
<p>Microphotographs of H&amp;E stains after formalin fixation and paraffin embedding procedures are shown in Figures <a href="#bmc70170-fig-0002" class="usa-link">2A</a> and <a href="#bmc70170-fig-0003" class="usa-link">3A–C</a>, identifying respectively the histopathological diagnosis of WHO Grade IV astrocytomas and MNGs for our collected brain tumor tissues. In addition, the histopathological grading of MNGs was also identified following the WHO classification, as follows:</p>
<figure class="fig xbox font-sm" id="bmc70170-fig-0002"><h4 class="obj_head">FIGURE 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/045d/12326238/51f0bcfcfc2d/BMC-39-e70170-g009.jpg" loading="lazy" id="jats-graphic-3" height="966" width="672" alt="FIGURE 2"></p>
<div class="p text-right font-secondary"><a href="figure/bmc70170-fig-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A) Histopathological diagnosis of high‐grade gliomas (WHO Grade IV astrocytomas): high cellularity diffuse proliferation with hyperplastic endothelial cells (shown on hematoxylin and eosin (H&amp;E) × 200). (B) Immunoreactivity of tumour cells with the isoform IDH‐1, confirming the diagnosis of IDH‐mutant WHO Grade IV astrocytomas (IHS × 200). HE: <a href="https://en.wikipedia.org/wiki/Haematoxylin" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">hematoxylin</a> and e<a href="https://en.wikipedia.org/wiki/Eosin" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">osin</a>; IHS: immunohistochemical staining.</p></figcaption></figure><figure class="fig xbox font-sm" id="bmc70170-fig-0003"><h4 class="obj_head">FIGURE 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/045d/12326238/b570c898dc54/BMC-39-e70170-g008.jpg" loading="lazy" id="jats-graphic-5" height="476" width="709" alt="FIGURE 3"></p>
<div class="p text-right font-secondary"><a href="figure/bmc70170-fig-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Histological diagnosis and grading of meningiomas (MNGs) following the WHO classification, shown on H&amp;E stains by formalin fixation–paraffin embedding technique: MNG Grade I: The tumor proliferation is regular with low density of meningothelial whorls (magnification × 50 μm and × 100 μm). MNG Grade II: meningiomal infiltration of adjacent brain tissue by tumor proliferation, giving the appearance of irregular protrusion (tongue‐like) (magnification × 200 μm and × 400 μm). MNG Grade III: Tumor cells are large and round with atypical proliferation, sometimes pleomorphic with prominent eosinophilic nucleolus (magnification × 400 μm).</p></figcaption></figure><p>Grade I (benign) MNGs were recognized by meningothelial whorls with low‐density proliferation and lack of anaplastic features, whereas Grade II (atypical) MNGs were characterized by brain infiltration, increased cellularity, sheet‐ or tongue‐like growth, and necrosis.</p>
<p>Grade III (anaplastic/malignant) MNGs resembled the histological characteristics of carcinomas, melanomas, or high‐grade sarcomas, by atypical proliferation, increased mitoses, and pleomorphic and prominent eosinophilic nucleoli.</p>
<p>Furthermore, in order to identify tumor cell markers, the IHC staining confirmed the isoform IDH1 mutation for the WHO Grade IV astrocytomas (Figure <a href="#bmc70170-fig-0002" class="usa-link">2B</a>) and the positivity for EMA and VIM for atypical MNGs (Figure <a href="#bmc70170-fig-0004" class="usa-link">4A,B</a>). Glioma tumor cells also showed positive expression of VIM, Nestin, CD44, GFAP, and βIII‐tubulin but negative expression of CD133+ and SOX2 genes, confirmed later by proteomics analysis. In addition, MNG tumor cells showed negative expression of keratin and GATA3 (Figure <a href="#bmc70170-fig-0005" class="usa-link">5A–C</a>).</p>
<figure class="fig xbox font-sm" id="bmc70170-fig-0004"><h4 class="obj_head">FIGURE 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/045d/12326238/51f9a8f1cdc1/BMC-39-e70170-g005.jpg" loading="lazy" id="jats-graphic-7" height="352" width="709" alt="FIGURE 4"></p>
<div class="p text-right font-secondary"><a href="figure/bmc70170-fig-0004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Immunohistochemical staining for atypical MNG tissues: Representative microphotographs showing positive immunoreactivity with epithelial membrane antigen (EMA) (A: magnification × 200 μm) and vimentin (B: magnification × 200 μm) compatible with human MNGs.</p></figcaption></figure><figure class="fig xbox font-sm" id="bmc70170-fig-0005"><h4 class="obj_head">FIGURE 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/045d/12326238/6ae258e23602/BMC-39-e70170-g003.jpg" loading="lazy" id="jats-graphic-9" height="236" width="709" alt="FIGURE 5"></p>
<div class="p text-right font-secondary"><a href="figure/bmc70170-fig-0005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Immunohistochemical staining for meningioma metastasis of carcinoma: Positivity of tumor cells with Keratin (A, B: magnification × 100 μm) and GATA3 (trans‐acting T‐cell‐specific transcription factor) (C: magnification × 100 μm).</p></figcaption></figure></section><section id="bmc70170-sec-0015"><h3 class="pmc_sec_title">3.4. Proteomic Analysis</h3>
<p>Our proteomic analysis identified a total of 2906 differently expressed proteins in MNG and a sum of 836 differently expressed proteins in Grade IV‐astrocytoma brain tumors, as shown in the Venn diagrams illustrating their relative encoding genes (Figure <a href="#bmc70170-supitem-0001" class="usa-link">S1</a>). Based on bioinformatics in the GO enrichment analysis, all the differentially expressed proteins were mapped to their enriched GO terms and categorized into three different classes (BP, MF, and PC). For our case study dealing with two types of brain tumors, in terms of MF, the majority of enriched GO terms were involved in binding, catalytic, and structural molecular activity. As for BP, genes were relevant to cellular and metabolic processes as well as biological regulation. Concerning the class of proteins, in glioma brain tumors, most proteins were related to metabolite interconversion enzymes and binding activities. In MNGs, the majority of proteins were involved in DNA metabolism, cytoskeletal activities, and metabolite interconversion enzymes and protein binding activity.</p>
<p>By the METASCAPE pathway enrichment analysis of the differentially expressed proteins, the biological significance of enriched pathways for the annotated genes involved in our case studies of brain tumors was identified. In Grade IV astrocytomas, proteins were relevant to the immune response, hemostasis, signaling by Rho GTPase, angiogenesis, and neurogenesis (illustrated in Figure <a href="#bmc70170-supitem-0001" class="usa-link">S2</a>), whereas in MNGs, genes were mainly involved in the immunity response, metabolic process, neurogenesis, angiogenesis, and signaling by the Rho GTPases, micro‐GTPases, and RHOBTB3 (illustrated in Figure <a href="#bmc70170-supitem-0001" class="usa-link">S3</a>).</p>
<p>The resultant PPI network analysis conducted by the STRING database showed several nodes as well as the mapping of all the subsets of proteins exhibiting physical interactions and expressed at a high confidence score of 0.9, along with their degree of connectivity.</p>
<p>In the Grade IV astrocytomas, there were 714 nodes as illustrated in Figure <a href="#bmc70170-fig-0006" class="usa-link">6A,B</a>, in which the key hub genes associated in modules were encoding for mitochondrial metabolic enzymes, ATP‐binding cassette subfamily (ABC) and solute carrier (SLC) transporters, Ca<sup>2+</sup>‐binding proteins (ANXA, S100A, CAMK2), protein transport and transmembrane trafficking (RAB GTPases), chaperone/co‐chaperone proteins (HSP), protein biosynthesis (EIF/EEF), mitochondrial ribosomal protein (RPL/RPS), angiogenic proteins (MMP), histone superfamily (HIST), SERPIN superfamily, DNA‐binding proteins, mRNA processing–mRNA splicing proteins (snRPs and hnRNPs), RNA‐binding, cytokinesis proteins (TUBB, actin‐capping/actin‐binding proteins, and SEPTIN family), cell adhesion molecules (integrins subfamily, LAMB1, COL, and CD44), signal transducer and adaptor proteins (GNB, GNG, and YWHA), downstream effectors of signaling pathways involved in tumorigenesis (DPYSL, MAPKs, LAMTOR, and CAV1), coagulation factors, family of Na<sup>+</sup>/K<sup>+</sup>‐ATPase transporting, and some adaptive immunity‐response proteins (HLA‐A, HLA‐B, and HLA‐DR).</p>
<figure class="fig xbox font-sm" id="bmc70170-fig-0006"><h4 class="obj_head">FIGURE 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/045d/12326238/2ac57bff69a4/BMC-39-e70170-g001.jpg" loading="lazy" id="jats-graphic-11" height="879" width="709" alt="FIGURE 6"></p>
<div class="p text-right font-secondary"><a href="figure/bmc70170-fig-0006/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A) PPI (protein–protein interaction) networks for Grade IV astrocytoma tumors established by the STRING database, (B) PPI networks for Grade IV astrocytoma tumors visualized by Cytoscape.</p></figcaption></figure><p>Table <a href="#bmc70170-tbl-0002" class="usa-link">2</a> resumes in detail these key identified hub genes along with their main molecular functions, involved in gliomagenesis.</p>
<section class="tw xbox font-sm" id="bmc70170-tbl-0002"><h4 class="obj_head">TABLE 2.</h4>
<div class="caption p"><p>The key identified hub genes involved in the tumorigenesis of gliomas.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th style="background-color:#538135" align="left" valign="bottom" rowspan="1" colspan="1">Genes name</th>
<th align="center" colspan="2" style="border-bottom:solid 1px #000000; background-color:#538135" valign="bottom" rowspan="1">Biological/molecular function</th>
</tr></thead>
<tbody valign="top">
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">
<p>ACO, ACY, ADAM, AKR, ALDO, ALDH, APO, CTS, ENO, FAB, G6PDH, IDH1,</p>
<p>PAFAH1, PRDX, SOD, SPT</p>
</td>
<td align="center" colspan="2" valign="top" rowspan="1">Mitochondrial metabolic enzymes</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">ATP‐binding cassette subfamily (ABC) and SLC transporters</td>
<td align="center" colspan="2" valign="top" rowspan="1">Drug transporters</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">ANXA, CAMK2 (A, B, D), S100A</td>
<td align="center" colspan="2" valign="top" rowspan="1">Calcium‐binding proteins</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">DYNL, GDI, Rab GTPase, TMEM, TOMM, SEC</td>
<td align="center" colspan="2" valign="top" rowspan="1">Protein transport/transmembrane trafficking</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">CCT, FKBP, HSP, PDIA</td>
<td align="center" colspan="2" valign="top" rowspan="1">Chaperone/co‐chaperone proteins that assist in the folding of proteins</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">EEF, EIF</td>
<td align="center" colspan="2" valign="top" rowspan="1">mRNA translation/protein biosynthesis</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">RPL, RPS</td>
<td align="center" colspan="2" valign="top" rowspan="1">Mitochondrial ribosomal protein</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">MMP</td>
<td align="center" colspan="2" valign="top" rowspan="1">Angiogenesis</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">HIST, LMNA, LMNB, PPP, SERPIN, MAPKs, DPYSL, DDX, NES</td>
<td align="center" valign="top" rowspan="1" colspan="1">Neuronal growth, cell differentiation, transcription regulation, nuclear membrane and telomere dynamics, DNA repair</td>
<td align="center" rowspan="3" valign="top" colspan="1">Neurogenesis</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">DDX, H2AFV</td>
<td align="center" valign="top" rowspan="1" colspan="1">DNA‐binding proteins</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">SEC, snRPs, hnRNPs</td>
<td align="center" valign="top" rowspan="1" colspan="1">mRNA processing, mRNA splicing, mRNA transport</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">snRPs, hnRNPs, DDX, TPM</td>
<td align="center" colspan="2" valign="top" rowspan="1">RNA‐binding proteins</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">ARHGAP, CAPN, TUBB, VIM, ACTA, ACTB, CFL1</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cell shape/cytoskeletal organization</td>
<td align="center" rowspan="3" valign="top" colspan="1">Cytokinesis</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">ACTN, CAPZ, MYH, FLNA, PFN1</td>
<td align="center" valign="top" rowspan="1" colspan="1">Actin capping/actin binding</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">SEPTIN, ARP, PPP1C</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cell cycle/cell division</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">CD44, COL, FBLN1, LAMB1, ITGA, ITGB</td>
<td align="center" colspan="2" valign="top" rowspan="1">Cell adhesion</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">GNB, GNG</td>
<td align="center" valign="top" rowspan="1" colspan="1">Transducer proteins</td>
<td align="center" rowspan="2" valign="top" colspan="1">Signal transduction</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">SYN, YWHA</td>
<td align="center" valign="top" rowspan="1" colspan="1">Adaptor proteins</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">MAPKs, LAMTOR, DPYSL, CAV1</td>
<td align="center" colspan="2" valign="top" rowspan="1">Effectors of cellular signaling pathway</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">F2, F9, F12, F13A</td>
<td align="center" colspan="2" valign="top" rowspan="1">Hemostasis</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">NDUFA, UQCR, ATPase</td>
<td align="center" colspan="2" valign="top" rowspan="1">Redox reaction/electron transport</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">HLA‐A, HLA‐B, HLA‐DRB1, IGH, IGK, LAMP</td>
<td align="center" colspan="2" valign="top" rowspan="1">Adaptive immunity response</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/bmc70170-tbl-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>In MNG brain tumors, there were 959 nodes as shown in Figure <a href="#bmc70170-fig-0007" class="usa-link">7A,B</a>. The key hub genes were encoding drug transporters, mainly, ATP‐binding cassette subfamily (ABC) and SLC transporters, mitochondrial metabolic enzymes, Ca<sup>2+</sup>‐binding proteins (ANXA, S100A, and CAMK2), protein transport and transmembrane trafficking (RAB GTPases, SNX, TMED, VPS), chaperone/co‐chaperone proteins (HSP and FKBP), protein biosynthesis (EIF/EEF), mitochondrial ribosomal protein (RPL/RPS), histone superfamily (HIST), SERPIN superfamily, DNA‐binding proteins (HMGA and HMGB), mRNA processing–mRNA splicing proteins (snRPs and hnRNPs), RNA‐binding proteins (LSM, SRP, SRSF, and PABPs), cytokinesis proteins (TUBB, Rho family of Ras small GTPases, SEPTIN family, and actin‐capping/actin‐binding proteins), cell adhesion molecules (integrins subfamily, LAM, PGM, and CD44), signal transducer and adaptor proteins (GNA, GNB, GNAS, and YWHA), downstream effectors of signaling pathways involved in tumorigenesis (MAPK, LAMTOR, and CTNNB), family of Na<sup>+</sup>/K<sup>+</sup>‐ATPase transporting (ATP), and adaptive immunity–response proteins (HLA‐A and HLA‐B).</p>
<figure class="fig xbox font-sm" id="bmc70170-fig-0007"><h4 class="obj_head">FIGURE 7.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/045d/12326238/3ac82b4af8db/BMC-39-e70170-g002.jpg" loading="lazy" id="jats-graphic-13" height="882" width="709" alt="FIGURE 7"></p>
<div class="p text-right font-secondary"><a href="figure/bmc70170-fig-0007/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A) PPI networks for MNGs established by the STRING database. (B) PPI networks for MNGs visualized by Cytoscape.</p></figcaption></figure><p>Table <a href="#bmc70170-tbl-0003" class="usa-link">3</a> resumes in detail these key identified genes along with their main molecular functions, involved in MNG tumorigenesis.</p>
<section class="tw xbox font-sm" id="bmc70170-tbl-0003"><h4 class="obj_head">TABLE 3.</h4>
<div class="caption p"><p>The key identified hub genes involved in the tumorigenesis of meningiomas.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th style="background-color:#538135" align="left" valign="bottom" rowspan="1" colspan="1">Genes name</th>
<th align="center" colspan="2" style="border-bottom:solid 1px #000000; background-color:#538135" valign="bottom" rowspan="1">Biological/molecular function</th>
</tr></thead>
<tbody valign="top">
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">ALDH1, ACAA, ACO, AKR, APO, CBR, CPX, GSTM, ENO, ERLIN, HSD, G6PDH, GSS, IDH, NDUF, HSD, PFKM, PRDX, PYCR1, FAB</td>
<td align="center" colspan="2" valign="top" rowspan="1">Mitochondrial metabolic enzymes</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">ATP‐binding cassette subfamily (ABC) and SLC transporters</td>
<td align="center" colspan="2" valign="top" rowspan="1">Drug transporters</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">Annexins (ANXA1 and ANXA2), S100A, CAMK2(A, B, and D)</td>
<td align="center" colspan="2" valign="top" rowspan="1">Calcium‐binding proteins</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">Rab GTPase, VPS, TOMM, TMED, TMEM, SNX, and DYNL</td>
<td align="center" colspan="2" valign="top" rowspan="1">Protein transport/transmembrane trafficking</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">DNAJ, HSP, CCT, and FKBP</td>
<td align="center" colspan="2" valign="top" rowspan="1">Chaperone/co‐chaperone proteins that assist in the folding of proteins</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">EEF, EIF, DHX</td>
<td align="center" colspan="2" valign="top" rowspan="1">mRNA translation/protein biosynthesis</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">MRPL, MRPS</td>
<td align="center" colspan="2" valign="top" rowspan="1">Mitochondrial ribosomal protein</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">DPYSL2, NAP1L1, NME1, NME2, KRT, PAFAH1B, CRMP1, DCTN, PPP, SERPIN, HIST, MACROH2A1, DDB, WDR, CTNNA, LMNA, LMNB, MAPKs, NES</td>
<td align="center" valign="top" rowspan="1" colspan="1">Neuronal growth, cell differentiation, transcription regulation, nuclear membrane and telomere dynamics, DNA repair</td>
<td align="center" rowspan="3" valign="top" colspan="1">Neurogenesis</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">HMGA, HMGB, PCBP1, MACROH2A1, DDX</td>
<td align="center" valign="top" rowspan="1" colspan="1">DNA‐binding proteins</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">SF3A3, SF3B, PRPF, snRPs, hnRNPs, SEC</td>
<td align="center" valign="top" rowspan="1" colspan="1">mRNA processing, mRNA splicing, mRNA transport</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">LSM, SRP, SRSF, PABPs, snRPs, hnRNPs, PCBP1, DDX</td>
<td align="center" colspan="2" valign="top" rowspan="1">RNA‐binding proteins</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">TUBB, CRMP1, EZR, VIM</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cell shape/cytoskeletal organization</td>
<td align="center" rowspan="3" valign="top" colspan="1">Cytokinesis</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">EPB41L, FLNA, TPM, ARPC, ACTN, CAPZ, RDX, MYH, MYO</td>
<td align="center" valign="top" rowspan="1" colspan="1">Actin‐capping/actin‐binding</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">Ras small GTPases (RHOA, RHOB), PAFAH1B, SEPTIN, PPP1C</td>
<td align="center" valign="top" rowspan="1" colspan="1">Cell cycle/cell division</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">LAM, PGM, CD44, CTNNA, COL, integrin supfamily (ITGAM, ITGAV, ITGB)</td>
<td align="center" colspan="2" valign="top" rowspan="1">Cell adhesion</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">GNAS, GNA, GNAQ</td>
<td align="center" valign="top" rowspan="1" colspan="1">Transducer proteins</td>
<td align="center" rowspan="2" valign="top" colspan="1">Signal transduction</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">YWHA, micro GTPases</td>
<td align="center" valign="top" rowspan="1" colspan="1">Adaptor proteins</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">MAPKs, LAMTOR, DPYSL, CAV1</td>
<td align="center" colspan="2" valign="top" rowspan="1">Effectors of cellular signaling pathway</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">TXN/ATPase</td>
<td align="center" colspan="2" valign="top" rowspan="1">Redox reaction/electron transport/ATP synthesis</td>
</tr>
<tr>
<td style="background-color:#A8D08D" align="left" valign="top" rowspan="1" colspan="1">Major histocompatibility complex (HLA‐B, HLA‐A, HLA‐DRB1), IGHG, IGKV</td>
<td align="center" colspan="2" valign="top" rowspan="1">Adaptive immunity response</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/bmc70170-tbl-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Afterward, to ensure consistency between GO and enriched pathways, the interrelational analysis performed using the ClueGO and CluePedia module of Cytoscape with the predicted PPI networks revealed for the Grade IV astrocytoma tumors the overexpression of caveolin‐mediated endocytosis, AMP metabolic process, peptidase regulation process, structural constituent of cytoskeleton, homeostasis, collagen fibril organization, actin filament assembly, pyrimidine metabolic process, cell matrix adhesion, and actin nucleation (as demonstrated in Figure <a href="#bmc70170-fig-0008" class="usa-link">8</a>). For MNGs, genes were found relevant to Bergman glial cell differentiation, regulation of telomere maintenance, homeostasis (regulation of granulocytes chemotaxis), cell–cell adhesion mediated by integrins and cadherin, positive regulation of metabolic process, regulation of Type 2 immune response, vesicle transport along actin filament, protein localization to plasma membrane, pseudopodium organization, biocellular tight junction assembly, and negative regulation of oxidative stress–induced cell death (as illustrated in Figure <a href="#bmc70170-fig-0009" class="usa-link">9A,B</a>).</p>
<figure class="fig xbox font-sm" id="bmc70170-fig-0008"><h4 class="obj_head">FIGURE 8.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/045d/12326238/28223e3fa9db/BMC-39-e70170-g010.jpg" loading="lazy" id="jats-graphic-15" height="434" width="709" alt="FIGURE 8"></p>
<div class="p text-right font-secondary"><a href="figure/bmc70170-fig-0008/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Interrelational pathway enrichment analysis visualized by the ClueGO and CluePedia Cytoscape plug‐in module for the differentially expressed proteins in Grade IV astrocytoma tumors.</p></figcaption></figure><figure class="fig xbox font-sm" id="bmc70170-fig-0009"><h4 class="obj_head">FIGURE 9.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/045d/12326238/4dc43d597b9f/BMC-39-e70170-g006.jpg" loading="lazy" id="jats-graphic-17" height="920" width="709" alt="FIGURE 9"></p>
<div class="p text-right font-secondary"><a href="figure/bmc70170-fig-0009/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A, B) Interrelational pathway enrichment analysis visualized by the ClueGO and CluePedia Cytoscape plug‐in module by using different layouts for the differentially expressed proteins in MNGs.</p></figcaption></figure></section></section><section id="bmc70170-sec-0016"><h2 class="pmc_sec_title">4. Discussion</h2>
<section id="bmc70170-sec-0017"><h3 class="pmc_sec_title">4.1. Characteristics of the Study Population</h3>
<p>Gliomas and MNGs were the most frequent types of brain tumors in our neurosurgery department. For the case of gliomas, based on our IHC analysis, we have selected the IDH mutations because they are involved in the earliest genetic events in gliomas' development and in order to conduct uniformity analysis by avoiding any ambiguities and misleading results with IDH wild‐type (GBMs). For MNGs, we have untangled our analysis on all the histopathological grades classified following the WHO into three classes: Grade I (benign), Grade II (atypical), and Grade III (malignant and the most aggressive form associated with the highest risk of recurrence and shortest survival times) because we were unable to conduct a homogenate study by selecting a specific grade due to the fact that the incidence of MNGs increases with age, being most common in females aged 65 years old and relatively uncommon in children, whereas our study's population differentiated by age and sex. In addition, the brain tissue and memory could be degenerated with advancing age.</p>
<p>From this clinical study, our investigation, as a multiomic study, was endeavored to make the differential diagnosis of human brain tumors, namely, Grade IV astrocytomas and MNGs by proteome‐wide profiling and mapping using a shotgun proteomic–based approach with high‐resolution tandem MS.</p>
<p>Our aim is to highlight the advantages and the usefulness of this technique in clinical analyses when compared to the traditional method based on IHC staining through the assessment of pivotal diagnostic biomarkers of malignant, metastatic, and invasive forms of cancer with poor prognosis.</p></section><section id="bmc70170-sec-0018"><h3 class="pmc_sec_title">4.2. IHC Analysis of Human Brain Tumors</h3>
<p>By applying the IHC staining as the most widely used method for histopathological diagnosis and following the availability of some antibodies in our laboratory, we have focused on glioma brain tumors regarding the expressions of CD133, CD44, Nestin, VIM, and SOX2 as indicative of stemness cell markers (Ehteram et al. <a href="#bmc70170-bib-0043" class="usa-link" aria-describedby="bmc70170-bib-0043">2022</a>; Favaro et al. <a href="#bmc70170-bib-0048" class="usa-link" aria-describedby="bmc70170-bib-0048">2014</a>; Neradil and Veselska <a href="#bmc70170-bib-0132" class="usa-link" aria-describedby="bmc70170-bib-0132">2015</a>; Xiao et al. <a href="#bmc70170-bib-0194" class="usa-link" aria-describedby="bmc70170-bib-0194">2018</a>), IDH1 as a diagnostic marker of gliomas (Han et al. <a href="#bmc70170-bib-0062" class="usa-link" aria-describedby="bmc70170-bib-0062">2020</a>), GFAP as an astrocytic marker (Brehar et al. <a href="#bmc70170-bib-0023" class="usa-link" aria-describedby="bmc70170-bib-0023">2014</a>) and βIII‐tubulin as a representative of neuronal differentiated cells (Mariani et al. <a href="#bmc70170-bib-0116" class="usa-link" aria-describedby="bmc70170-bib-0116">2015</a>). For MNG diagnosis, we have scrutinized the expression of EMA and VIM as the most widely used markers.</p>
<p>Based on the literature review, CD133 is one of the most immunohistochemical markers observed in stem cells that are related to cell proliferation and the differentiation of various cancer types (Ehteram et al. <a href="#bmc70170-bib-0043" class="usa-link" aria-describedby="bmc70170-bib-0043">2022</a>; Xiao et al. <a href="#bmc70170-bib-0194" class="usa-link" aria-describedby="bmc70170-bib-0194">2018</a>). Nestin (NES), a Type VI intermediate filament, is an important cancer stem cell marker for CNS tumor growth, migration, and invasion (Alamir et al. <a href="#bmc70170-bib-0004" class="usa-link" aria-describedby="bmc70170-bib-0004">2018</a>), detected at higher levels in grades II and III MNGs, compared to Grade I (Galani et al. <a href="#bmc70170-bib-0053" class="usa-link" aria-describedby="bmc70170-bib-0053">2015</a>). The transcription factor SOX2 has been observed in several central nervous system cancer stem cells (Alamir et al. <a href="#bmc70170-bib-0004" class="usa-link" aria-describedby="bmc70170-bib-0004">2018</a>; Favaro et al. <a href="#bmc70170-bib-0048" class="usa-link" aria-describedby="bmc70170-bib-0048">2014</a>).</p>
<p>VIM is highly associated with MNGs. It is a class III intermediate protein, expressed in mesenchymal cells and involved in neurogenesis and cytoskeleton structure (Alamir et al. <a href="#bmc70170-bib-0004" class="usa-link" aria-describedby="bmc70170-bib-0004">2018</a>; Bouamrani et al. <a href="#bmc70170-bib-0020" class="usa-link" aria-describedby="bmc70170-bib-0020">2010</a>). GFAP is a Class III intermediate filament and a cell‐specific marker that distinguishes astrocytes from other glial cells during the development of the CNS (Mariani et al. <a href="#bmc70170-bib-0116" class="usa-link" aria-describedby="bmc70170-bib-0116">2015</a>). βIII‐tubulin is a neuron‐specific microtubule required for neuronal axon guidance, maintenance, and development (Xiao et al. <a href="#bmc70170-bib-0194" class="usa-link" aria-describedby="bmc70170-bib-0194">2018</a>).</p>
<p>EMA is one of the most widely used immunohistochemical markers to facilitate histological detection and assist in determining brain‐invasive growth of MNGs (Backer‐Grøndahl et al. <a href="#bmc70170-bib-0008" class="usa-link" aria-describedby="bmc70170-bib-0008">2014</a>; Boulagnon‐Rombi et al. <a href="#bmc70170-bib-0021" class="usa-link" aria-describedby="bmc70170-bib-0021">2017</a>). GATA3 is a transcription factor involved in epithelial cell differentiation. It is one of the most commonly mutated genes in breast cancer. It is used as an immunostaining diagnostic marker for breast and urothelial cancers to support the origin of MNG starting from the primary breast carcinoma (Klotz et al. <a href="#bmc70170-bib-0085" class="usa-link" aria-describedby="bmc70170-bib-0085">2018</a>; Reiswich et al. <a href="#bmc70170-bib-0150" class="usa-link" aria-describedby="bmc70170-bib-0150">2023</a>).</p>
<p>For patients without a clinical history of <a href="https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/carcinoma" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">carcinoma</a>, malignant MNGs can morphologically simulate metastatic carcinoma, which necessitates an IHC study of <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/cytokeratin" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">cytokeratin</a>s to achieve a correct diagnosis. Keratins represent the intermediate filament‐forming proteins of epithelial cells that are widely used as diagnostic markers for tumor invasion and metastasis because epithelial malignancies largely maintain the specific keratin patterns associated with their respective cells of origin (Karantza <a href="#bmc70170-bib-0081" class="usa-link" aria-describedby="bmc70170-bib-0081">2010</a>). However, this type of immunohistochemical marker was not reliable to separate a malignant MNG from metastatic carcinoma (Liu et al. <a href="#bmc70170-bib-0099" class="usa-link" aria-describedby="bmc70170-bib-0099">2004</a>).</p>
<p>Thus, our results based on IHC analysis have only confirmed the presence of some basic neural tumor stemness markers for our case study of brain tumors, for example, positivity expression to VIM, Nestin, CD44, IDH1, but lack of CD133+, GFAP, βIII‐tubulin, and SOX2 genes for the diagnosis of glioma brain tumor. For human MNGs, we detected only positivity to EMA and VIM as the most widely used markers. The negativity expression to keratin and GATA3 has confirmed the differential diagnosis of MNGs from brain metastasis of carcinoma.</p>
<p>Despite its low cost, the IHC staining technique still shows pitfalls and caveats, namely, a very time‐consuming process, a laborious and unreliable procedure as it requires the use of primary and secondary antibodies as well as multiple other materials. In addition, a larger human workforce is needed for complex workflows. Similarly, other traditional methods based on antibodies, namely, the ELISA and gel‐electrophoresis techniques, still exhibit limitations, such as insufficient blocking of immobilized antigens leading to the risk of false positive/negative results, antibody instability, cross‐reactivity, epitope occlusion, lack of accuracy, expensive culture media, and the lack of specific antibodies or their exorbitant costs (Ghosh et al. <a href="#bmc70170-bib-0055" class="usa-link" aria-describedby="bmc70170-bib-0055">2014</a>; Jiang et al. <a href="#bmc70170-bib-0075" class="usa-link" aria-describedby="bmc70170-bib-0075">2021</a>; Sakamoto et al. <a href="#bmc70170-bib-0152" class="usa-link" aria-describedby="bmc70170-bib-0152">2017</a>; Thomas et al. <a href="#bmc70170-bib-0174" class="usa-link" aria-describedby="bmc70170-bib-0174">2019</a>). Moreover, the biological mechanisms underlying brain‐invasive growth are still incompletely understood. Therefore, there is an urgent need for more prognostic biomarkers that can identify aggressive and recurrent forms of cancer.</p></section><section id="bmc70170-sec-0019"><h3 class="pmc_sec_title">4.3. Proteomics Analysis of Human Brain Tumors</h3>
<p>The proteomics analysis could be achieved by using one of these approaches, either the “<em>Top‐Down</em>” or the “<em>Middle‐Down</em>” or the “<em>Bottom‐Up</em>” approach. The “Top‐Down” approach involves the analysis of the intact protein. However, it has faced challenges, namely, lower analytical throughput, difficulties in protein identification, and posttranslational modifications (PTMs) localization because many proteins involved in human diseases share similar masses, which makes this approach ineffective for distinct clinical subtyping (Melby et al. <a href="#bmc70170-bib-0120" class="usa-link" aria-describedby="bmc70170-bib-0120">2021</a>; Top‐Down Proteomics, <a href="#bmc70170-bib-0130" class="usa-link" aria-describedby="bmc70170-bib-0130">2024</a>). The middle‐down approach, although offering advantages like improved sequence coverage and better handling of PTMs, still exhibits limitations, including challenges in achieving consistent reproducibility and robustness when compared to the “Bottom‐Up” approach (Sidoli and Garcia <a href="#bmc70170-bib-0157" class="usa-link" aria-describedby="bmc70170-bib-0157">2017</a>). The latter is the most efficient technique for analyzing complex protein mixtures, allowing their comprehensive identification and quantification in an unbiased manner. It relies on the proteolytic digestion of proteins into peptide fragments for their identification (Zhang et al. <a href="#bmc70170-bib-0206" class="usa-link" aria-describedby="bmc70170-bib-0206">2013</a>).</p>
<p>The “shotgun proteomics” refers to the use of the “Bottom‐Up” approach in combination with the HPLC–MS technique. It remains the most popular approach that could be applied to consistently identify the relative abundance of proteins as well as their qualitative and quantitative analysis, including co‐occurring PTMs taken from complex matrices (Cassidy et al. <a href="#bmc70170-bib-0030" class="usa-link" aria-describedby="bmc70170-bib-0030">2021</a>). Hence, by adopting this strategy in our analyses, the differentially expressed proteins have been identified by proteome‐wide profiling and mapping after extraction from human brain tumor tissues and enzymatic digestion by trypsin. The yielded peptides were then analyzed by a nanoflow‐UHPLC coupled with high‐resolution tandem MS and identified using a spectra MS/MS comparison with theoretical spectra generated from the in silico digested protein databases, using the MaxQuant software that matches the experimental spectra to the most likely theoretical matching peptides. Hence, the corresponding proteins from which these peptides originated have been identified.</p>
<p>Afterward, using the bioinformatics analysis, we deciphered the relative abundance of the differently expressed proteins, their relevance as well as their meaningful relationship, degree of connectivity, and regulation.</p>
<p>Accordingly, we have identified several differently expressed proteins, of which the majority of encoding genes were key members implicated in human brain carcinogenesis. Our detailed description of the crucial roles of these proteins specific to each type of tumor is as follows:</p></section><section id="bmc70170-sec-0020"><h3 class="pmc_sec_title">4.4. Analysis of Glioma Brain Tumors</h3>
<p>Following our previously published study on gliomas (Louati et al. <a href="#bmc70170-bib-0107" class="usa-link" aria-describedby="bmc70170-bib-0107">2024</a>), the initiation and progression of this type of brain tumor arise from various molecular abnormalities, including mutations in oncogenes and tumor suppressor genes, as well as disruptions in signaling pathways and key regulatory networks.</p>
<p>These genetic and epigenetic alterations consequently lead to uncontrolled cell growth and division, as a main characteristic of brain tumors. In this respect, mitochondrial metabolism, drug transporters, calcium influx, protein transport and trafficking, protein folding and biosynthesis, angiogenesis, neurogenesis, cytokinesis, cell adhesion, signal transduction, hemostasis, electron transport, and adaptive immunity response are the major identified aberrant processes underpinning gliomagenesis.</p>
<p>By way of elucidation, gliomas undergo metabolic reprogramming to support their rapid growth and proliferation (Strickland and Stroll <a href="#bmc70170-bib-0162" class="usa-link" aria-describedby="bmc70170-bib-0162">2017</a>). Several mitochondrial metabolic enzymes involved in the development and progression of tumors were revealed at altered in expression in our previous study on gliomas (Louati et al. <a href="#bmc70170-bib-0107" class="usa-link" aria-describedby="bmc70170-bib-0107">2024</a>). These alterations include shifts in energy metabolism, like the Warburg effect, by which cells favor glycolysis over oxidative phosphorylation. Additionally, mutations in enzymes like IDH are frequent in several glioma subtypes (e.g., Grade IV astrocytomas) to generate 2‐hydroxyglutarate (2HG) via α‐ketoglutarate (α‐KG) inhibition. This overproduction of 2HG consequently inhibits histone and DNA demethylases, resulting in a hypermethylation phenotype, blockage of cellular differentiation, and alterations in epigenetic status. Hence, genome transcription and DNA are the two main ways that occur to a greater extent in the IDH‐mutated gliomas (Han et al. <a href="#bmc70170-bib-0062" class="usa-link" aria-describedby="bmc70170-bib-0062">2020</a>).</p>
<p>Drug transporters, particularly the ABC and SLC families, play a crucial role in glioma drug resistance and treatment efficacy (Phon et al. <a href="#bmc70170-bib-0145" class="usa-link" aria-describedby="bmc70170-bib-0145">2025</a>).</p>
<p>Calcium‐binding proteins, specifically, Annexins (ANXA), S100A family, and calcium/calmodulin‐dependent protein kinase II (CaMKII), play fundamental roles in cancer progression by mediating cell proliferation, migration, invasion, and treatment resistance (He and Li <a href="#bmc70170-bib-0064" class="usa-link" aria-describedby="bmc70170-bib-0064">2021</a>; H. Lee et al. <a href="#bmc70170-bib-0090" class="usa-link" aria-describedby="bmc70170-bib-0090">2021</a>; H. Wang, Mao, et al. <a href="#bmc70170-bib-0185" class="usa-link" aria-describedby="bmc70170-bib-0185">2022</a>) as we have previously explained in our published study on gliomas (Louati et al. <a href="#bmc70170-bib-0107" class="usa-link" aria-describedby="bmc70170-bib-0107">2024</a>). ANXA2 is often overexpressed in gliomas, correlated with poorer prognosis (X. Li et al. <a href="#bmc70170-bib-0094" class="usa-link" aria-describedby="bmc70170-bib-0094">2021</a>; Ma et al. <a href="#bmc70170-bib-0111" class="usa-link" aria-describedby="bmc70170-bib-0111">2021</a>).</p>
<p>Rab GTPases are a family of small GTPases involved in intracellular vesicle trafficking, whose dysregulation is closely related to the development and progression of tumors (Jin et al. <a href="#bmc70170-bib-0077" class="usa-link" aria-describedby="bmc70170-bib-0077">2021</a>; Xu et al. <a href="#bmc70170-bib-0196" class="usa-link" aria-describedby="bmc70170-bib-0196">2024</a>).</p>
<p>Protein folding is a crucial process for tumor growth and survival. The heat shock proteins (HSPs) with other molecular chaperones that assist in protein folding are frequently found dysregulated in gliomas (Xu et al. <a href="#bmc70170-bib-0197" class="usa-link" aria-describedby="bmc70170-bib-0197">2025</a>).</p>
<p>Dysregulation of eukaryotic translation and elongation initiation factors (EIF/EEF) leads to protein synthesis reprogramming, which promotes <a href="https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/tumor-initiation" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">tumor initiation</a>, progression, chemoresistance, and poor prognosis (Chu et al. <a href="#bmc70170-bib-0036" class="usa-link" aria-describedby="bmc70170-bib-0036">2016</a>). EEF‐2 kinase is frequently found at upregulation in several types of malignancies, including gliomas (Zhang et al. <a href="#bmc70170-bib-0205" class="usa-link" aria-describedby="bmc70170-bib-0205">2011</a>).</p>
<p>Mitochondrial ribosomal proteins (MRPS) involved in protein synthesis within the mitochondrion have been implicated in tumor cell proliferation, migration, and invasion through modulating oxidative stress levels, metabolic reprogramming, disrupting cell cycle regulation, inhibiting apoptosis, promoting mitophagy, and remodeling the tumor microenvironment. MRPS were found at altered expression patterns in many cancers, adapted as prognostic biomarkers for predicting patient survival and response to treatment (Hao et al. <a href="#bmc70170-bib-0063" class="usa-link" aria-describedby="bmc70170-bib-0063">2018</a>; Z. Li et al. <a href="#bmc70170-bib-0096" class="usa-link" aria-describedby="bmc70170-bib-0096">2025</a>; Wu et al. <a href="#bmc70170-bib-0193" class="usa-link" aria-describedby="bmc70170-bib-0193">2025</a>; Zhu et al. <a href="#bmc70170-bib-0213" class="usa-link" aria-describedby="bmc70170-bib-0213">2025</a>).</p>
<p>Matrix metalloproteinases (MMPs) are involved in breaking down the extracellular matrix to facilitate tumor cell invasion, angiogenesis (formation of new blood vessels), and overall tumor growth. The enhanced expressions of MMP‐2 and MMP‐9, as detected in our case study, were associated with poor prognosis in glioma patients (W. Zhou, Zhou, et al. <a href="#bmc70170-bib-0209" class="usa-link" aria-describedby="bmc70170-bib-0209">2019</a>).</p>
<p>Epigenetic alterations are primordial in glioma genesis. Among epigenetic marks, histones (HIST) are involved in most biological processes, and their misregulation may perturb chromatin contacts and alter DNA‐binding properties, leading to aberrant gene expression that is closely related to many human diseases, especially in cancerogenesis (Kim <a href="#bmc70170-bib-0084" class="usa-link" aria-describedby="bmc70170-bib-0084">2014</a>; J. Lee et al. <a href="#bmc70170-bib-0089" class="usa-link" aria-describedby="bmc70170-bib-0089">2017</a>). Lamins (LMNA and LMNB) provide a framework for the nuclear envelope and play an important role in nuclear assembly, chromatin organization, and telomere dynamics (The Human Protein Atlas <a href="#bmc70170-bib-0172" class="usa-link" aria-describedby="bmc70170-bib-0172">2024</a>, online available: <a href="https://www.proteinatlas.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.proteinatlas.org/</a>). Hence, mutations in lamins are associated with gliomagenesis by affecting nuclear shape, cell proliferation, and invasion (Pei et al. <a href="#bmc70170-bib-0144" class="usa-link" aria-describedby="bmc70170-bib-0144">2021</a>). DNA‐binding proteins assist in regulating gene expression, DNA repair, and other cellular processes. Dysregulation or mutation of these proteins can disrupt normal cellular functions and lead to aberrant gene expression, consequently resulting in tumor initiation, progression, and resistance to treatment (Papavassiliou and Papavassiliou <a href="#bmc70170-bib-0142" class="usa-link" aria-describedby="bmc70170-bib-0142">2021</a>).</p>
<p>SERPIN genes, which encode serine protease inhibitors, may promote tumor growth, although described for opposing roles in cancer (Valiente et al. <a href="#bmc70170-bib-0182" class="usa-link" aria-describedby="bmc70170-bib-0182">2014</a>). For example, the SERPINA1 identified in our case study was reported to be expressed abundantly in gliomas, predicting unfavorable prognosis (Liu et al. <a href="#bmc70170-bib-0101" class="usa-link" aria-describedby="bmc70170-bib-0101">2022</a>).</p>
<p>Spliceosome is frequently altered in tumors associated with changes in the expression and activity of heterogeneous nuclear ribonucleoproteins (hnRNPs) and small nuclear ribonucleoproteins (snRNPs). These latter mediate cancer development and progression by aberrant splicing and other RNA processing events, resulting in the production of altered proteins with oncogenic properties (Mrid et al. <a href="#bmc70170-bib-0126" class="usa-link" aria-describedby="bmc70170-bib-0126">2025</a>). Similarly, dysregulation of RNA‐binding proteins can lead to altered RNA splicing, stability, and translation, contributing to tumor formation and aggressiveness (Z. Wang et al. <a href="#bmc70170-bib-0183" class="usa-link" aria-describedby="bmc70170-bib-0183">2020</a>).</p>
<p>Several proteins regulating cytokinesis have been linked to glioma pathogenesis (Zottel et al. <a href="#bmc70170-bib-0214" class="usa-link" aria-describedby="bmc70170-bib-0214">2021</a>). Among which, actin (ACT) is a key structural protein that makes up the cytoskeleton of cells and plays crucial roles such as division, migration, and vesicle trafficking (Suresh and Diaz <a href="#bmc70170-bib-0168" class="usa-link" aria-describedby="bmc70170-bib-0168">2021</a>). Cancer cell movement is possible because of the development of invasive structures like invadopodia, lamellipodia, and filopodia, which are dependent on the reorganization of the actin cytoskeleton. In many tumor cells, the actin and actin‐associated proteins may affect the progression of cancer by regulating gene expression (Izdebska et al. <a href="#bmc70170-bib-0072" class="usa-link" aria-describedby="bmc70170-bib-0072">2018</a>). In addition, the aberrant expression of actin subunits can confer cells with greater proliferation ability, increased migratory capability, and chemoresistance by incorporation into the normal cellular F‐actin network (Suresh and Diaz <a href="#bmc70170-bib-0168" class="usa-link" aria-describedby="bmc70170-bib-0168">2021</a>). Cofilin‐1 (CFL1) protein assists in the control of actin dynamics in the nucleus, and it may promote the formation of invasive structures, such as filopodia, involved in tumor proliferation and migration. Elevated levels of CFL1 expression were associated with tumor progression and increased invasiveness in breast, urothelial, prostate, and gastric cancer (Izdebska et al. <a href="#bmc70170-bib-0072" class="usa-link" aria-describedby="bmc70170-bib-0072">2018</a>).</p>
<p>Tubulins (TUBB) are the major constituent of microtubules, and calpains (CAPN) are microtubule‐stabilizing proteins. Both proteins play a crucial role in cell support and cell movement (Breuss et al. <a href="#bmc70170-bib-0024" class="usa-link" aria-describedby="bmc70170-bib-0024">2017</a>). Notably, TUBB2B has been identified to interact with VIM, a protein involved in cell structure and movement, to facilitate epithelial–mesenchymal transition (EMT) and promote glioma cell invasion and migration (J. Li et al. <a href="#bmc70170-bib-0095" class="usa-link" aria-describedby="bmc70170-bib-0095">2024</a>). Additionally, other beta‐tubulin isotypes like TUBA1B and TUBA1A have also been implicated in glioma cell proliferation, migration, and invasion (Sun et al. <a href="#bmc70170-bib-0167" class="usa-link" aria-describedby="bmc70170-bib-0167">2025</a>).</p>
<p>The Rho GTPases are key regulators of cell migration and survival through effects on actin cytoskeleton rearrangement during the EMT, in which epithelial cells lose their polarity and junctions and gain migratory potential and invasiveness (Izdebska et al. <a href="#bmc70170-bib-0072" class="usa-link" aria-describedby="bmc70170-bib-0072">2018</a>). These proteins, along with their regulators, Rho GTPase‐activating proteins (ARHGAP), exhibit pivotal roles in glioma development and progression (Fortin Ensign et al. <a href="#bmc70170-bib-0044" class="usa-link" aria-describedby="bmc70170-bib-0044">2013</a>).</p>
<p>Filamin A (FLNA) is an actin‐binding protein involved in various cellular processes, including cell migration, adhesion, proliferation, and DNA repair. The overexpression of this protein was confirmed by samples from patients with numerous oncological diseases (Zawadka et al. <a href="#bmc70170-bib-0203" class="usa-link" aria-describedby="bmc70170-bib-0203">2024</a>). Profilin (PFN1) is also a critical actin‐binding protein that was found to be dysregulated in many cancers. Its high expression was associated with worse prognosis, which makes it possible to be used as a biomarker for tumor diagnosis and prognosis (Y. Wang et al. <a href="#bmc70170-bib-0184" class="usa-link" aria-describedby="bmc70170-bib-0184">2021</a>).</p>
<p>Myosins (MYH) are involved in cell migration, invasion, extracellular matrix production, and EMT in various cancers (L. Liu, Chen, et al. <a href="#bmc70170-bib-0103" class="usa-link" aria-describedby="bmc70170-bib-0103">2023</a>). It was reported that LAMC2 forms complexes with MYH9 and MYH10 in order to promote endoplasmic reticulum (ER)–mitochondria interaction to alleviate ER stress and allow cancer cells to adapt and proliferate under stressful conditions (Tong et al. <a href="#bmc70170-bib-0176" class="usa-link" aria-describedby="bmc70170-bib-0176">2023</a>). Septins (SEPTIN) are required for normal organization of the actin cytoskeleton and dynamics by interacting with actin and microtubules; consequently, they may be implicated in the growth and migration of glioma cells (Spiliotis and Nakos <a href="#bmc70170-bib-0160" class="usa-link" aria-describedby="bmc70170-bib-0160">2021</a>).</p>
<p>Integrins (ITG), known as “bridge” proteins, are highly expressed in glioma stem cells and play a vital role in self‐renewal, differentiation, high drug resistance, and chemo‐radiotherapy resistance through cell adhesion and signaling (Valdembri and Serini <a href="#bmc70170-bib-0181" class="usa-link" aria-describedby="bmc70170-bib-0181">2021</a>; M. Wang, Shen, et al. <a href="#bmc70170-bib-0186" class="usa-link" aria-describedby="bmc70170-bib-0186">2022</a>). Collagen (COL) plays a multifaceted role in tumor progression, acting as a scaffold for cell adhesion and migration. Elevated collagen levels are often observed in gliomas, correlating with tumor progression and affecting cell proliferation, migration, and invasion (Y. Wang, Ichinose, and Nakada <a href="#bmc70170-bib-0187" class="usa-link" aria-describedby="bmc70170-bib-0187">2022</a>).</p>
<p>Laminins (LAMB) are a family of extracellular matrix proteins that are involved in many biological activities such as cell adhesion, differentiation, migration, signaling, neurite outgrowth, and metastasis. They promote the invasive phenotype of cancer cells, whose effects are mediated via receptors that are categorized into two different groups, namely, integrin and nonintegrin receptors (Givant‐Horwitz et al. <a href="#bmc70170-bib-0059" class="usa-link" aria-describedby="bmc70170-bib-0059">2004</a>; Patarroyo et al. <a href="#bmc70170-bib-0143" class="usa-link" aria-describedby="bmc70170-bib-0143">2002</a>). The expression of laminin subunit beta 1 (LAMB1) was elevated in several cancers. Thus, it could serve as a potential biomarker and therapeutic target (H. Lee et al. <a href="#bmc70170-bib-0090" class="usa-link" aria-describedby="bmc70170-bib-0090">2021</a>). Laminin‐5, fibronectin, and Type IV collagen were reported as potential biomarkers of brain glioma malignancy (Oldak et al. <a href="#bmc70170-bib-0139" class="usa-link" aria-describedby="bmc70170-bib-0139">2022</a>).</p>
<p>The CD44 is a cell surface receptor involved in cell adhesion, migration, and interaction, which are crucial for cancer cell invasion. It is also linked to the survival and proliferation of glioma stem‐like cells, thought to be responsible for tumor recurrence (Inoue et al. <a href="#bmc70170-bib-0071" class="usa-link" aria-describedby="bmc70170-bib-0071">2023</a>).</p>
<p>High CD44 expression was associated with increased tumor aggressiveness, poor patient prognosis, and resistance to therapy (Mooney et al. <a href="#bmc70170-bib-0124" class="usa-link" aria-describedby="bmc70170-bib-0124">2016</a>).</p>
<p>G proteins (GNB and GNG) are involved as modulators or transducers in various transmembrane signaling systems, whose mutations can lead to aberrant activation of downstream signaling pathways, promoting cell growth, survival, and potentially contributing to glioma malignancy (Cherry and Stella <a href="#bmc70170-bib-0034" class="usa-link" aria-describedby="bmc70170-bib-0034">2014</a>).</p>
<p>Some adapter proteins, for example, YWHA, play a multifaceted role in glioma development and progression through influencing cell cycle control, apoptosis, and DNA damage response. For example, by interacting with key proteins involved in cell cycle progression, such as cyclin‐dependent kinases (CDKs) and their inhibitors (CKIs), YWHA proteins influence the transition of cells through different phases of the cell cycle to promote uncontrolled proliferation (X. Zhou, Chen, and Zhang <a href="#bmc70170-bib-0215" class="usa-link" aria-describedby="bmc70170-bib-0215">2023</a>).</p>
<p>The PI3K/Akt/mTOR and RAS/MAPK/ERK are the key signaling pathways involved in cell proliferation, survival, and differentiation that are closely related to tumorigenesis (Krishna et al. <a href="#bmc70170-bib-0086" class="usa-link" aria-describedby="bmc70170-bib-0086">2020</a>; Salles et al. <a href="#bmc70170-bib-0153" class="usa-link" aria-describedby="bmc70170-bib-0153">2022</a>; Stachyra and Grzybowska‐Szatkowska <a href="#bmc70170-bib-0161" class="usa-link" aria-describedby="bmc70170-bib-0161">2025</a>). LAMTOR protein is involved in regulating the mTORC1 pathway, which mediates tumor growth and progression (Gamallat et al. <a href="#bmc70170-bib-0054" class="usa-link" aria-describedby="bmc70170-bib-0054">2024</a>). Its activity was revealed to be enhanced by the activation of transmembrane protein TMEM9 (S. Zhang, Lee, et al. <a href="#bmc70170-bib-0208" class="usa-link" aria-describedby="bmc70170-bib-0208">2022</a>). Dihydropyrimidinase (DPYSL) proteins are involved in tumorigenesis by mediating signals for numerous intracellular/extracellular pathways and by stimulating a variety of cellular processes, including cell migration, neurite extension, axonal growth and guidance, dendritic spine development, and synaptic plasticity through their phosphorylation status (Pooladi et al. <a href="#bmc70170-bib-0147" class="usa-link" aria-describedby="bmc70170-bib-0147">2014</a>). Caveolin‐1 (CAV1), as a major structural protein of caveolae, activates the PI3K/Akt signaling pathway and promotes the proliferation and metastasis of brain tumors, particularly the malignant glial subtype, through enhanced EMT and angiogenesis (Moriconi et al. <a href="#bmc70170-bib-0125" class="usa-link" aria-describedby="bmc70170-bib-0125">2021</a>; Ocak et al. <a href="#bmc70170-bib-0138" class="usa-link" aria-describedby="bmc70170-bib-0138">2019</a>; Z. Wang et al. <a href="#bmc70170-bib-0188" class="usa-link" aria-describedby="bmc70170-bib-0188">2024</a>).</p>
<p>Tumor patients often show aberrant coagulation and <a href="https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/fibrinolysis" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">fibrinolysis</a> activation due to the fact that tumor cells directly activate hemostasis by producing tissue factor as the principal activator of the blood coagulation process, promoting thrombin generation and facilitating fibrin deposition, hence creating a microenvironment in solid tumors that protects cancer cells from the immune system attack (Mandoj et al. <a href="#bmc70170-bib-0115" class="usa-link" aria-describedby="bmc70170-bib-0115">2019</a>). In particular, GBM is associated with a state of <a href="https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/hypercoagulability" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">hypercoagulability</a> and <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/venous-thromboembolism" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">venous thromboembolism</a> as a common complication of this cancer and its treatment (Navone et al. <a href="#bmc70170-bib-0131" class="usa-link" aria-describedby="bmc70170-bib-0131">2018</a>).</p>
<p>Proton pump ATPase subunits are frequently found upregulated in gliomas, especially in cancer stem cells, to sustain their viability and tumorigenicity by maintaining a suitable intracellular pH homeostasis that facilitates some processes like autophagy (S. Lu et al. <a href="#bmc70170-bib-0110" class="usa-link" aria-describedby="bmc70170-bib-0110">2021</a>). These ATPases have been allied with tumor aggressiveness and poor patient prognosis (Giambra et al. <a href="#bmc70170-bib-0057" class="usa-link" aria-describedby="bmc70170-bib-0057">2024</a>; L. Li et al. <a href="#bmc70170-bib-0093" class="usa-link" aria-describedby="bmc70170-bib-0093">2017</a>).</p>
<p>The UQCR (ubiquinol–cytochrome c reductase) gene family plays a role in gliomas, particularly in relation to mitochondrial function and cancer stem cell‐like properties. Notably, the UQCRB gene, which encodes a subunit of the mitochondrial respiratory chain complex III, has been identified as a potential prognostic marker and therapeutic target in gliomas (Jung et al. <a href="#bmc70170-bib-0079" class="usa-link" aria-describedby="bmc70170-bib-0079">2017</a>).</p>
<p>Finally, cancer cells evade attacks from the immune system through various mechanisms in order to fuel their growth and resistance. By way of illustration, human leucocyte (HLA) genes of the major histocompatibility complex play a crucial role by adjusting the tumor microenvironment and modulating the immune response to gliomas through restricting the presentation of tumor antigens to immune cells. Expression of HLA‐DR genes could be used as a biomarker for patient prognosis as well as to predict the tumor grade in gliomas (Diao et al. <a href="#bmc70170-bib-0041" class="usa-link" aria-describedby="bmc70170-bib-0041">2015</a>; Fan et al. <a href="#bmc70170-bib-0046" class="usa-link" aria-describedby="bmc70170-bib-0046">2017</a>).</p></section><section id="bmc70170-sec-0021"><h3 class="pmc_sec_title">4.5. Analysis of MNG Brain Tumors</h3>
<p>The most relevant encoding genes underpinning the tumorigenesis of MNGs are described as follows:</p>
<p>The mitochondrial metabolic enzymes, including aldehyde dehydrogenase family (ALDH), acetyl‐CoA acyltransferases (ACAA), aconitases (ACO), apolipoprotein (APO), enolases (ENO), ER lipid raft (ERLIN), cytochrome c oxidase (COX), carboxypeptidase (CPX), glucose‐6‐phosphate dehydrogenase (G6PDH), glutathione synthetase/transferase (GSS/GST), deshydrogenases (IDH and HSD), peroxiredoxin peroxidase (PRDX), reductases (AKR, CBR, NDUF, and PYCR1), phosphofructokinases (PFKM), were expressed to the greatest extent in MNG tumors, which reflect the alteration in the metabolic process by cancer cells in order to satisfy their biosynthetic needs of high energy, fuel their growth, rapid proliferation and seed in secondary organs from the aberrant and reprogrammed metabolism such as changes in glycolysis, oxidative phosphorylation, lipid oxidation and synthesis, and amino acid metabolism. This altered expression of metabolic enzymes was chiefly explained in our previously published study on glioma brain tumors (Louati et al. <a href="#bmc70170-bib-0106" class="usa-link" aria-describedby="bmc70170-bib-0106">2023</a>).</p>
<p>The ABC and SLC transporters that facilitate the movement of diverse molecules across cellular membranes, including blood–brain barrier, were expressed to a great extent, as reported by studies in the literature showing that their expression and function are altered in brain pathologies and are involved in drug resistance (Baltira et al. <a href="#bmc70170-bib-0011" class="usa-link" aria-describedby="bmc70170-bib-0011">2024</a>; Jia et al. <a href="#bmc70170-bib-0074" class="usa-link" aria-describedby="bmc70170-bib-0074">2020</a>).</p>
<p>The Ca<sup>2+</sup>‐binding proteins (S100A) play a crucial role in a number of cellular processes such as cell cycle progression and differentiation, inflammation, migration and/or invasion, <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/programmed-cell-death" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">apoptosis</a>, Ca<sup>2+</sup>
<a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/homeostasis" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">homeostasis</a>, and energy metabolism (Zhu et al. <a href="#bmc70170-bib-0212" class="usa-link" aria-describedby="bmc70170-bib-0212">2024</a>). As we have explained in our previously published study on gliomas, S100A4 interacts with tropomyosin (TPM4) implicated in the stability of filaments and other actin‐binding proteins, and with myosins (MYH9) involved in cytokinesis, cell motility, and cell shape maintenance, thus suggesting it affects the cytoskeleton of the tumor cells (Mazzucchelli <a href="#bmc70170-bib-0118" class="usa-link" aria-describedby="bmc70170-bib-0118">2002</a>; Zhu et al. <a href="#bmc70170-bib-0212" class="usa-link" aria-describedby="bmc70170-bib-0212">2024</a>). The complex formed between ANXA2/S100A10 and the nucleoprotein AHNAK was reported to regulate the actin cytoskeleton and cell membrane architecture (Benaud et al. <a href="#bmc70170-bib-0013" class="usa-link" aria-describedby="bmc70170-bib-0013">2003</a>). Changes in the calcium‐related proteins and their interactors imply cytoskeletal changes leading to tumor cell proliferation and metastasis in a calcium‐dependent manner.</p>
<p>Annexin (ANXA), a calcium‐dependent phospholipid‐binding protein, is endowed with a key role in the brain as it is expressed in many neurovascular unit cells, including brain endothelial cells, microglial cells, astrocytes, pericytes, and neurons, to provide neuroprotective and repair functions (Sheikh and Solito <a href="#bmc70170-bib-0155" class="usa-link" aria-describedby="bmc70170-bib-0155">2018</a>). As we have explained in our previously published study on IDH‐mutant high‐grade gliomas (Louati et al. <a href="#bmc70170-bib-0106" class="usa-link" aria-describedby="bmc70170-bib-0106">2023</a>), ANXA is highly expressed in gliomas, and it is positively correlated with malignancy, tumor progression, and metastasis as calcium‐regulatory proteins. Studies in the literature have involved the role of ANXA1 in the development and progression of malignant gliomas, especially GBM, by increasing the IL‐8 expression through NF‐κB (p65) activation, leading to immune escape in GBM (R. Chen, Xie, et al. <a href="#bmc70170-bib-0032" class="usa-link" aria-describedby="bmc70170-bib-0032">2022</a>). Other studies reported the role of ANXA2 in the pathogenesis of CNS tumors to promote tumor proliferation by upregulating several oncogenes, such as β‐catenin, cyclin D1, oncostatin M receptor, and c‐Myc (X. Li et al. <a href="#bmc70170-bib-0094" class="usa-link" aria-describedby="bmc70170-bib-0094">2021</a>). Hence, ANXA was assigned to act as an important biomarker of diagnosis and prognosis for a variety of cancer types. It was effectively selected as an FDA‐approved therapeutic target (The Human Protein Atlas <a href="#bmc70170-bib-0172" class="usa-link" aria-describedby="bmc70170-bib-0172">2024</a>, online available: <a href="https://www.proteinatlas.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.proteinatlas.org/</a>).</p>
<p>The family of Ca<sup>2+</sup>/calmodulin‐dependent protein kinase II (CAMK2) has been well described for its critical role in cancer development, metastasis, resistance, recurrence, and sustentation of glioma cells' stemness markers, as we have previously demonstrated in our published study on IDH‐mutant high‐grade gliomas (Louati et al. <a href="#bmc70170-bib-0106" class="usa-link" aria-describedby="bmc70170-bib-0106">2023</a>). Recently, CAMK2A has been involved in the progression of MNGs, attributed to the mutation of the NF2 gene (Lei et al. <a href="#bmc70170-bib-0092" class="usa-link" aria-describedby="bmc70170-bib-0092">2024</a>).</p>
<p>The member RAS oncogene family (RAB‐GTPases) are key regulators, involved in axonogenesis through regulation of vesicular membrane trafficking toward the axonal plasma membrane (The Human Protein Atlas <a href="#bmc70170-bib-0172" class="usa-link" aria-describedby="bmc70170-bib-0172">2024</a>, online available: <a href="https://www.proteinatlas.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.proteinatlas.org/</a>). They mainly regulate the trafficking of glucose transporters (GLUT) and the formation of lipid droplets during the metabolism of glucose and lipids by cancer cells; hence, the dysregulation of RABs has been unveiled in various diseases, including cancers (Jiang et al. <a href="#bmc70170-bib-0076" class="usa-link" aria-describedby="bmc70170-bib-0076">2022</a>; Jin et al. <a href="#bmc70170-bib-0077" class="usa-link" aria-describedby="bmc70170-bib-0077">2021</a>; Xu et al. <a href="#bmc70170-bib-0196" class="usa-link" aria-describedby="bmc70170-bib-0196">2024</a>).</p>
<p>The members of the transmembrane emp24 trafficking protein (TMED), also known as p24 proteins, are involved in protein vesicular trafficking and quality control in the ER and Golgi (The Human Protein Atlas <a href="#bmc70170-bib-0172" class="usa-link" aria-describedby="bmc70170-bib-0172">2024</a>, online available: <a href="https://www.proteinatlas.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.proteinatlas.org/</a>). They were reported to be implicated in the pathogenic processes of many human diseases, including carcinomas, by acting as an oncogene (Yang et al. <a href="#bmc70170-bib-0200" class="usa-link" aria-describedby="bmc70170-bib-0200">2022</a>; L. Zhou, Li, et al. <a href="#bmc70170-bib-0211" class="usa-link" aria-describedby="bmc70170-bib-0211">2023</a>). The TMED4 and TMED9 genes were reported to be highly expressed in low‐grade glioma and <a href="https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/glioblastoma" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GBM multiforme</a> tissues, negatively associated with the <a href="https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/overall-survival" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">overall surviva</a>l (Ullah et al. <a href="#bmc70170-bib-0178" class="usa-link" aria-describedby="bmc70170-bib-0178">2022</a>). The sorting nexin family member proteins (SNX) are also involved in intracellular trafficking. The overexpression of sorting nexin 9 (SNX9) was reported in cell invasion and metastasis from human mammary cancers (Bendris et al. <a href="#bmc70170-bib-0014" class="usa-link" aria-describedby="bmc70170-bib-0014">2016</a>; Xu et al. <a href="#bmc70170-bib-0195" class="usa-link" aria-describedby="bmc70170-bib-0195">2023</a>). The SNX6 was shown to interact with Cullin3, an E3 ubiquitin ligase responsible for the programmed death ligand 1 (PD‐L1) ubiquitination and subsequent degradation, which is a critical process for the ability of cancer cells to evade the host immune system (Ghosh et al. <a href="#bmc70170-bib-0056" class="usa-link" aria-describedby="bmc70170-bib-0056">2021</a>). The SNX21 is used as a prognostic marker in GBM multiforme (The Human Protein Atlas <a href="#bmc70170-bib-0172" class="usa-link" aria-describedby="bmc70170-bib-0172">2024</a>, online available: <a href="https://www.proteinatlas.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.proteinatlas.org/</a>).</p>
<p>The vacuolar protein sorting (VPS) genes play a crucial role in vesicle‐mediated protein trafficking from the Golgi stack through the trans‐Golgi network that are implicated in various cancers, including brain tumors (The Human Protein Atlas <a href="#bmc70170-bib-0172" class="usa-link" aria-describedby="bmc70170-bib-0172">2024</a>, online available: <a href="https://www.proteinatlas.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.proteinatlas.org/</a>). For example, in GBM, VPS4B was reported to maintain the integrity of the nuclear envelope during stress (Wu et al. <a href="#bmc70170-bib-0192" class="usa-link" aria-describedby="bmc70170-bib-0192">2024</a>). It was also evidenced to be involved in cell division and mitosis through ensuring the maintenance of centrosome and spindle assembly (Liu et al. <a href="#bmc70170-bib-0100" class="usa-link" aria-describedby="bmc70170-bib-0100">2013</a>). The mutation of this gene has been evidenced in cancer development and progression (Huang et al. <a href="#bmc70170-bib-0069" class="usa-link" aria-describedby="bmc70170-bib-0069">2023</a>).</p>
<p>The chaperone proteins assist in the proper folding of specific target proteins by the use of an ATPase activity modulated by co‐chaperones. Among these proteins, the HSPs are implicated in a wide variety of cellular processes, including protection of the proteome from stress, folding and transport of newly synthesized polypeptides, activation of proteolysis of misfolded proteins, and the formation and dissociation of protein complexes. Hence, they play a pivotal role in the protein quality control system, ensuring the correct folding of proteins, the re‐folding of misfolded proteins, and controlling the targeting of proteins for subsequent degradation (He et al. <a href="#bmc70170-bib-0065" class="usa-link" aria-describedby="bmc70170-bib-0065">2024</a>). HSPs with antiapoptotic properties were detected at higher levels in many human cancers associated with poor survival and response to therapy (Alexiou et al. <a href="#bmc70170-bib-0005" class="usa-link" aria-describedby="bmc70170-bib-0005">2014</a>; Babi et al. <a href="#bmc70170-bib-0007" class="usa-link" aria-describedby="bmc70170-bib-0007">2022</a>). FKBP proteins, particularly FKBP51, acting as co‐chaperones for Hsp90, play a multifaceted role in MNGs by influencing steroid hormone receptor activity such as the progesterone receptor (PR), which is often expressed in MNGs. They also interact with signaling pathways involved in cell growth and survival like NF‐κB and PI3K/Akt, contributing to the abnormal phenotypes observed in MNGs (Agam et al. <a href="#bmc70170-bib-0001" class="usa-link" aria-describedby="bmc70170-bib-0001">2024</a>).</p>
<p>The EIFs and EEFs involved in mRNA translation and protein biosynthesis play a significant role in tumor development and progression. Specifically, the EIF4F complex composed of EIF4A, EIF4E, and EIF4G was shown to be a crucial component for sustaining the growth of MNG cells (Oblinger et al. <a href="#bmc70170-bib-0137" class="usa-link" aria-describedby="bmc70170-bib-0137">2017</a>; Xue et al. <a href="#bmc70170-bib-0198" class="usa-link" aria-describedby="bmc70170-bib-0198">2021</a>). Strikingly, high expression levels of EEF proteins are associated with malignant forms and high‐grade MNGs to support their rapid growth (Cristiano <a href="#bmc70170-bib-0039" class="usa-link" aria-describedby="bmc70170-bib-0039">2021</a>).</p>
<p>Ribosome modifications drive tumor progression and metastatic development by remodeling tumor cell translational events. In this context, the mitochondrial ribosomal protein large/small subunits (RPL/RPS) were overexpressed and implicated in the onset and progression of melanoma brain tumors (Bowley et al. <a href="#bmc70170-bib-0022" class="usa-link" aria-describedby="bmc70170-bib-0022">2022</a>). A recent study conducted by Ebright et al. (<a href="#bmc70170-bib-0042" class="usa-link" aria-describedby="bmc70170-bib-0042">2020</a>) has also revealed elevated expression of RPL15 in breast cancer circulating tumor cells, which had triggered massive metastatic spread and induced the translation of other ribosomal subunit proteins. The mitochondrial ribosomal protein‐L (MRPL) genes have been reported to be implicated in many cellular processes, such as cell proliferation, apoptosis, and cell cycle (H. Zhang, Li, et al. <a href="#bmc70170-bib-0207" class="usa-link" aria-describedby="bmc70170-bib-0207">2022</a>). Although their dysfunction has been allied to diseases, including cancer, neurodegenerative, and metabolic disorders (Bacon et al. <a href="#bmc70170-bib-0009" class="usa-link" aria-describedby="bmc70170-bib-0009">2024</a>), they are not commonly reported to be mutated in MNGs. Among the identified MRPL genes in our case study of MNGs, MRPL13 was recently shown to be overexpressed in breast cancer, which could be a novel biomarker for predicting diagnosis and therapy response (Ye and Zhang <a href="#bmc70170-bib-0201" class="usa-link" aria-describedby="bmc70170-bib-0201">2021</a>).</p>
<p>Many other differently expressed proteins in MNG brain tumors have been identified to be involved in neurogenesis, including DNA repair, DNA‐binding, transcription regulation, mRNA processing/mRNA splicing, and cell differentiation (as described in Table <a href="#bmc70170-tbl-0002" class="usa-link">2</a>), which are all crucial steps for tumor growth and invasion.</p>
<p>Among the key identified proteins, lamins (LMNA and LMNB) are intermediate filament proteins, which provide a framework for the nuclear envelope, bridging the nuclear envelope and chromatin, thereby playing a pivotal role in nuclear assembly, chromatin organization, nuclear membrane, and telomere dynamics (The Human Protein Atlas <a href="#bmc70170-bib-0172" class="usa-link" aria-describedby="bmc70170-bib-0172">2024</a>, online available: <a href="https://www.proteinatlas.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.proteinatlas.org/</a>). The damage‐specific DNA‐binding proteins (DDB) are involved in DNA repair through the ubiquitination of histones to facilitate their removal from the nucleosome (The Human Protein Atlas <a href="#bmc70170-bib-0172" class="usa-link" aria-describedby="bmc70170-bib-0172">2024</a>, online available: <a href="https://www.proteinatlas.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.proteinatlas.org/</a>). These proteins were reported to be involved in the occurrence and development of cancer by affecting nucleotide excision, repair, and cell apoptosis (Bao et al. <a href="#bmc70170-bib-0012" class="usa-link" aria-describedby="bmc70170-bib-0012">2022</a>).</p>
<p>The histone superfamily proteins are basic nuclear proteins that are responsible for the nucleosome structure. They play a predominant role in transcription regulation, DNA repair, DNA replication, and chromosomal stability (The Human Protein Atlas <a href="#bmc70170-bib-0172" class="usa-link" aria-describedby="bmc70170-bib-0172">2024</a>, online available: <a href="https://www.proteinatlas.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.proteinatlas.org/</a>). It was reported that epigenetic modifications beyond DNA methylation, including the level of histones, are involved in the aggressiveness of MNGs (Katz et al. <a href="#bmc70170-bib-0082" class="usa-link" aria-describedby="bmc70170-bib-0082">2018</a>). Indeed, a recent study has revealed that the loss of trimethylation from lysine 27 on histone 3 (H3K27me3) has been implicated in worse prognoses for patients with MNGs (Cello et al. <a href="#bmc70170-bib-0031" class="usa-link" aria-describedby="bmc70170-bib-0031">2023</a>). In addition, altered DNA methylation, microRNA expression, histone, and chromatin modifications were frequently reported in MNGs (Murnyák et al. <a href="#bmc70170-bib-0127" class="usa-link" aria-describedby="bmc70170-bib-0127">2015</a>).</p>
<p>The SERPIN superfamily of proteins is highly expressed in glioma brain tumors, as we have demonstrated in our previously published study (Godinez et al. <a href="#bmc70170-bib-0060" class="usa-link" aria-describedby="bmc70170-bib-0060">2022</a>; Louati et al. <a href="#bmc70170-bib-0106" class="usa-link" aria-describedby="bmc70170-bib-0106">2023</a>). They are involved in calcium homeostasis and play a crucial role in mediating neurite outgrowth, axonal development, as well as maintaining normal synaptic plasticity through their inhibitory effects on tissue plasminogen activator (tPA) in the CNS to prevent its interaction with NMDA receptor‐mediated calcium influx (Nicole et al. <a href="#bmc70170-bib-0134" class="usa-link" aria-describedby="bmc70170-bib-0134">2001</a>). The elevated expression of SERPIN superfamily proteins was associated with low survival and increased recurrence rates (Chuang et al. <a href="#bmc70170-bib-0037" class="usa-link" aria-describedby="bmc70170-bib-0037">2021</a>).</p>
<p>The High mobility group of proteins (HMGA and HMGB) act as DNA chaperones involved in transcription regulation, DNA organization, DNA binding, cell differentiation, and tumor cell migration (The Human Protein Atlas <a href="#bmc70170-bib-0172" class="usa-link" aria-describedby="bmc70170-bib-0172">2024</a>, online available: <a href="https://www.proteinatlas.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.proteinatlas.org/</a>).</p>
<p>The spliceosome is a complex molecular machine responsible for RNA splicing as a crucial process for gene expression. Hence, aberrant RNA splicing driven by dysregulation of spliceosome contributes to tumor development and progression, associated with MNGs phenotypes and used as a predictor for tumor recurrence and overall survival (Bielli et al. <a href="#bmc70170-bib-0016" class="usa-link" aria-describedby="bmc70170-bib-0016">2019</a>; Leclair et al. <a href="#bmc70170-bib-0088" class="usa-link" aria-describedby="bmc70170-bib-0088">2024</a>).</p>
<p>Among the key identified proteins involved in mRNA processing/mRNA splicing, the uridyl‐rich snRNPs (U snRNPs), mainly the subunit G as an indispensable component in the biogenesis of spliceosomes, were reported to be involved in the tumorigenesis of different types of cancers (Mabonga and Kappo <a href="#bmc70170-bib-0112" class="usa-link" aria-describedby="bmc70170-bib-0112">2019</a>). Similarly, other subunits, namely, SNRPB and SNRPN, were reported for their oncogenic role in human tumors (Ji et al. <a href="#bmc70170-bib-0073" class="usa-link" aria-describedby="bmc70170-bib-0073">2020</a>; Wu et al. <a href="#bmc70170-bib-0191" class="usa-link" aria-describedby="bmc70170-bib-0191">2022</a>).</p>
<p>Additionally, the hnRNPs also represent a large family of RNA‐binding proteins that are associated with pre‐mRNAs in the nucleus and contribute to multiple aspects of nucleic acid metabolism, including alternative splicing, mRNA stabilization, transcriptional, and translational regulation. Hence, their dysregulation can contribute to cancer cell proliferation, metastasis, and drug resistance (Siculella et al. <a href="#bmc70170-bib-0156" class="usa-link" aria-describedby="bmc70170-bib-0156">2022</a>; The Human Protein Atlas <a href="#bmc70170-bib-0172" class="usa-link" aria-describedby="bmc70170-bib-0172">2024</a>, online available: <a href="https://www.proteinatlas.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.proteinatlas.org/</a>).</p>
<p>Among the other identified RNA‐binding proteins, LSM have been evidenced to be implicated in the tumorigenesis and metastasis of several cancer types (Q. Liu, Lian, et al. <a href="#bmc70170-bib-0104" class="usa-link" aria-describedby="bmc70170-bib-0104">2023</a>). In addition, dysregulation of the superfamily of the signal recognition particle (SRP) proteins involved in protein translocation to the ER or plasma membrane is allied to various diseases, including cancer, by affecting protein biogenesis, leading to cell dysfunction (Kellogg et al. <a href="#bmc70170-bib-0083" class="usa-link" aria-describedby="bmc70170-bib-0083">2022</a>). Moreover, the family members of serine and arginine‐rich splicing factor (SRSF) play an essential role in altered splicing dynamics associated with cancer progression (Sharma et al. <a href="#bmc70170-bib-0154" class="usa-link" aria-describedby="bmc70170-bib-0154">2024</a>). The snRPs and the poly(A)‐binding protein cytoplasmic (PABPs) proteins may also act as RNA‐binding proteins involved in posttranscriptional regulation of gene expression in tumors (The Human Protein Atlas <a href="#bmc70170-bib-0172" class="usa-link" aria-describedby="bmc70170-bib-0172">2024</a>, online available: <a href="https://www.proteinatlas.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.proteinatlas.org/</a>).</p>
<p>Cytokinesis includes regulation of the cell cycle, cell shape, actin‐binding and actin‐capping activities, which are all essential processes for invasive tumor growth and proliferation. Among the key identified proteins involved in this process, myosins (MYO) are actin‐based motor molecules with ATPase activity (The Human Protein Atlas <a href="#bmc70170-bib-0172" class="usa-link" aria-describedby="bmc70170-bib-0172">2024</a>, online available: <a href="https://www.proteinatlas.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.proteinatlas.org/</a>). Tubulins (TUBB) are the major constituent of microtubules, performing as regulators with binding activities, and reported as a robust biomarker with satisfying abilities in cancer diagnosis and prognosis (Zhu et al. <a href="#bmc70170-bib-0212" class="usa-link" aria-describedby="bmc70170-bib-0212">2024</a>; The Human Protein Atlas <a href="#bmc70170-bib-0172" class="usa-link" aria-describedby="bmc70170-bib-0172">2024</a>, online available: <a href="https://www.proteinatlas.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.proteinatlas.org/</a>). The SEPTIN family of GTPases is required for normal organization of the actin cytoskeleton and is involved in cytokinesis (The Human Protein Atlas <a href="#bmc70170-bib-0172" class="usa-link" aria-describedby="bmc70170-bib-0172">2024</a>, online available: <a href="https://www.proteinatlas.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.proteinatlas.org/</a>). The collapsin response mediator protein (CRMP1) protein participates in cytokinesis and is involved in invasive growth and cell migration (The Human Protein Atlas <a href="#bmc70170-bib-0172" class="usa-link" aria-describedby="bmc70170-bib-0172">2024</a>, online available: <a href="https://www.proteinatlas.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.proteinatlas.org/</a>).</p>
<p>The Rho GTPases (RHOA and RHOB) are a subfamily of the Ras small signaling G proteins, which play essential roles in a number of biological processes, especially in the regulation of cell morphology, survival, proliferation, and adhesion. Hence, they are key regulators of cytoskeleton reorganization and cell polarity. These biological processes are crucial for tumor development and metastases (Liu et al. <a href="#bmc70170-bib-0105" class="usa-link" aria-describedby="bmc70170-bib-0105">2024</a>; Q. Lu et al. <a href="#bmc70170-bib-0109" class="usa-link" aria-describedby="bmc70170-bib-0109">2009</a>). The micro GTPases affect a wide range of critical processes, including gene expression, signal transduction, cell morphology, vesicle trafficking, and nuclear trafficking. The GTPase domain of RHOBTB3 is divergent from other Ras‐like superfamily members and displays ATPase activity. It is involved in cullin‐3 (CUL3) dependent protein ubiquitination, retrograde transport from endosomes to the Golgi apparatus, regulation of the cell cycle, and modulating the adaptive response to hypoxia (National Center for Biotechnology Information <a href="#bmc70170-bib-0129" class="usa-link" aria-describedby="bmc70170-bib-0129">2025</a>). Hence, Rho GTPases are involved in cancer progression and dissemination, showing altered activities in many types of primary brain tumors (Crosas‐Molist et al. <a href="#bmc70170-bib-0040" class="usa-link" aria-describedby="bmc70170-bib-0040">2021</a>). Protein kinases (PAK) are critical effectors that link Rho GTPases to cytoskeleton reorganization and nuclear signaling (The Human Protein Atlas <a href="#bmc70170-bib-0172" class="usa-link" aria-describedby="bmc70170-bib-0172">2024</a>, online available: <a href="https://www.proteinatlas.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.proteinatlas.org/</a>).</p>
<p>The cell adhesion molecules play a critical role in MNG development by mediating cell‐to‐cell and cell‐to‐extracellular matrix interactions. Their expression was shown to be correlated with tumor grade, subtypes, and location. The most investigated proteins are E‐cadherin, catenins (CTNNA), integrins (ITGA, ITGB), laminins (LAMB1), and CD44 (Arsene et al. <a href="#bmc70170-bib-0006" class="usa-link" aria-describedby="bmc70170-bib-0006">2014</a>; Figarella‐Branger et al. <a href="#bmc70170-bib-0049" class="usa-link" aria-describedby="bmc70170-bib-0049">1997</a>; F. Liu, Wu, et al. <a href="#bmc70170-bib-0102" class="usa-link" aria-describedby="bmc70170-bib-0102">2023</a>).</p>
<p>The family of guanine nucleotide‐binding proteins (GNA proteins) acts as modulators or transducers in various transmembrane signaling systems controlled by G protein‐coupled receptors (GPCRs) (The Human Protein Atlas <a href="#bmc70170-bib-0172" class="usa-link" aria-describedby="bmc70170-bib-0172">2024</a>, online available: <a href="https://www.proteinatlas.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.proteinatlas.org/</a>). Hence, their mutations have been allied to dysregulation of these pathways, potentially contributing to tumor development and progression. Specifically, GNAS are recently discovered to be mutated in a subset of MNGs, with effects on tumor behavior and potential therapeutic targets (Hong et al. <a href="#bmc70170-bib-0067" class="usa-link" aria-describedby="bmc70170-bib-0067">2021</a>). The adapter proteins (YWHA) are implicated in the regulation of a large spectrum of both general and specialized signaling pathways, which may potentially contribute to tumor development and progression (The Human Protein Atlas <a href="#bmc70170-bib-0172" class="usa-link" aria-describedby="bmc70170-bib-0172">2024</a>, online available: <a href="https://www.proteinatlas.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.proteinatlas.org/</a>; J. Lee et al. <a href="#bmc70170-bib-0217" class="usa-link" aria-describedby="bmc70170-bib-0217">2023</a>). Indeed, some studies have shown that specific YWHA isoforms, like YWHAZ, are overexpressed in MNGs (Freitag et al. <a href="#bmc70170-bib-0050" class="usa-link" aria-describedby="bmc70170-bib-0050">2017</a>).</p>
<p>The MAPK and PI3K/Akt/mTOR pathways are the most dysregulated signaling pathways in brain tumors, including MNGs. Activation of the PI3K/Akt signaling was reported to contribute to the aggressive behavior of malignant MNGs, whereas the MAPK signaling activation is involved in both proliferation and apoptosis of malignant MNGs <strong>(</strong>Mawrin et al. <a href="#bmc70170-bib-0117" class="usa-link" aria-describedby="bmc70170-bib-0117">2005</a>). The ß‐catenin (CTNNB) is a multifunctional protein from the E‐cadherin family, involved in the <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/wnt-signaling" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Wnt signal transduction pathway</a> after translocation to the nucleus to form a β‐catenin/TCF transcription activation complex. It promotes angiogenesis by stimulating the expression of proangiogenic factors like VEGF and MMPs (Olsen et al. <a href="#bmc70170-bib-0140" class="usa-link" aria-describedby="bmc70170-bib-0140">2017</a>). It was reported as an obvious biomarker for tumor proliferation and progression, namely, in MNGs (Ibrahim et al. <a href="#bmc70170-bib-0070" class="usa-link" aria-describedby="bmc70170-bib-0070">2021</a>; Nager et al. <a href="#bmc70170-bib-0128" class="usa-link" aria-describedby="bmc70170-bib-0128">2012</a>). Its high‐level expression was significantly associated with transitional and meningiotheliomatous MNGs, low tumor grade, low recurrence rate, and low incidence of brain invasion (Ahmed et al. <a href="#bmc70170-bib-0002" class="usa-link" aria-describedby="bmc70170-bib-0002">2017</a>; Ibrahim et al. <a href="#bmc70170-bib-0070" class="usa-link" aria-describedby="bmc70170-bib-0070">2021</a>).</p>
<p>LAMTOR protein is involved in regulating the mTORC1 pathway, which is often dysregulated in cancer, promoting cell proliferation and survival (Gamallat et al. <a href="#bmc70170-bib-0054" class="usa-link" aria-describedby="bmc70170-bib-0054">2024</a>). Its activity was revealed to be enhanced by the activation of the transmembrane protein TMEM9 (S. Zhang, Lee, et al. <a href="#bmc70170-bib-0208" class="usa-link" aria-describedby="bmc70170-bib-0208">2022</a>). The protein kinases (PAK) are involved in intracellular signaling pathways downstream of integrins and receptor‐type kinases, playing a pivotal role in cytoskeleton dynamics, cell adhesion, migration, proliferation, mitosis, and vesicle‐mediated transport processes. They can directly phosphorylate BAD (BCL2‐associated agonist of cell death) and protect cells against apoptosis (The Human Protein Atlas <a href="#bmc70170-bib-0172" class="usa-link" aria-describedby="bmc70170-bib-0172">2024</a>, online available: <a href="https://www.proteinatlas.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.proteinatlas.org/</a>). The proteasome subunit beta (PSMB) has an ATP‐dependent proteolytic activity (The Human Protein Atlas <a href="#bmc70170-bib-0172" class="usa-link" aria-describedby="bmc70170-bib-0172">2024</a>, online available: <a href="https://www.proteinatlas.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.proteinatlas.org/</a>) that has recently been proved to be implicated in the proliferation and invasion of glioma cells (He et al. <a href="#bmc70170-bib-0065" class="usa-link" aria-describedby="bmc70170-bib-0065">2024</a>) through modulating ERK1/2 and PI3K/Akt signaling pathways (Yang et al. <a href="#bmc70170-bib-0199" class="usa-link" aria-describedby="bmc70170-bib-0199">2018</a>).</p>
<p>Thioredoxin (TXN) protein participates in various redox reactions. It contributes to the response to intracellular nitric oxide and regulates several physiological and biochemical functions, such as growth, apoptosis, and cellular defense (the Human Protein Atlas <a href="#bmc70170-bib-0172" class="usa-link" aria-describedby="bmc70170-bib-0172">2024</a>, online available: <a href="https://www.proteinatlas.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.proteinatlas.org/</a>). The TXN system was reported to be highly expressed in the lower pathological grade of MNGs and also involved in the malignant progression of MNGs (Cai et al. <a href="#bmc70170-bib-0027" class="usa-link" aria-describedby="bmc70170-bib-0027">2017</a>; Esen et al. <a href="#bmc70170-bib-0045" class="usa-link" aria-describedby="bmc70170-bib-0045">2015</a>). The family of Na<sup>+</sup>/K<sup>+</sup>‐ATPase transporting (NKA) is an integral membrane protein responsible for establishing and maintaining the electrochemical gradients of Na<sup>+</sup> and K<sup>+</sup> ions across the plasma membrane. It has been proposed as a signal transducer involved in various pathobiological processes, including tumorigenesis (the Human Protein Atlas <a href="#bmc70170-bib-0172" class="usa-link" aria-describedby="bmc70170-bib-0172">2024</a>, online available: <a href="https://www.proteinatlas.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.proteinatlas.org/</a>; S. Lu et al. <a href="#bmc70170-bib-0110" class="usa-link" aria-describedby="bmc70170-bib-0110">2021</a>).</p>
<p>Finally, tumor cells evade immune response to promote their growth by several mechanisms, among which is alteration in the major histocompatibility complex (MHC) expression. Studies have shown that MNGs can express MHC class I and class II molecules (Caffo et al. <a href="#bmc70170-bib-0026" class="usa-link" aria-describedby="bmc70170-bib-0026">2005</a>; Taylor and Balko <a href="#bmc70170-bib-0170" class="usa-link" aria-describedby="bmc70170-bib-0170">2022</a>).</p>
<p>Neutrophils are also implicated in several mechanisms of cancer progression such as promoting angiogenesis, matrix remodeling, immunosuppression, and cancer metastasis; hence, they could be adapted as potential cancer biomarkers of disease status (Mollinedo <a href="#bmc70170-bib-0123" class="usa-link" aria-describedby="bmc70170-bib-0123">2019</a>; Wu et al. <a href="#bmc70170-bib-0190" class="usa-link" aria-describedby="bmc70170-bib-0190">2020</a>). The CD superfamily genes are involved in negative regulation of cytokine production and monocyte activation (The Human Protein Atlas <a href="#bmc70170-bib-0172" class="usa-link" aria-describedby="bmc70170-bib-0172">2024</a>, online available: <a href="https://www.proteinatlas.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.proteinatlas.org/</a>). A study by Kanno et al. revealed that the overexpression of CD163 prevents apoptosis through the production of granulocyte colony‐stimulating factor in MNGs (Kanno et al. <a href="#bmc70170-bib-0080" class="usa-link" aria-describedby="bmc70170-bib-0080">2013</a>).</p>
<p>Overall, all these described biological functions involved by the key identified hub genes in both types of brain tumors comply well with our bioinformatics analysis. The better understanding of these molecular mechanisms is crucial for the development of more effective targeted cancer immunotherapies circumventing these evasion tactics.</p></section><section id="bmc70170-sec-0022"><h3 class="pmc_sec_title">4.6. The Usefulness of the High‐Throughput‐MS Application Over the IHC Technique</h3>
<p>By our adaptive strategy based on the “Bottom‐up” proteomic‐based approach with high‐resolution tandem MS, we have gained significant advantages over IHC staining in the analysis of human brain tumors, namely, saving time, cost, and resources. Moreover, we succeeded in the identification and characterization of several proteins at high sensitivity, accuracy, and in a very straightforward and timely manner, which is not readily available from the IHC technique. In addition, by proteome‐wide profiling and mapping, we deciphered the relative abundance of proteins related to each type of tumor, known as an expression pattern, which further enhances our understanding of tumor heterogeneity, suggesting that gene expression may be either differentially regulated across cell types or specifically dysregulated in cancer biology, as demonstrated in the clustered heatmap shown in Figure <a href="#bmc70170-fig-0010" class="usa-link">10</a>.</p>
<figure class="fig xbox font-sm" id="bmc70170-fig-0010"><h4 class="obj_head">FIGURE 10.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/045d/12326238/5676dbf72cf1/BMC-39-e70170-g004.jpg" loading="lazy" id="jats-graphic-19" height="724" width="709" alt="FIGURE 10"></p>
<div class="p text-right font-secondary"><a href="figure/bmc70170-fig-0010/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>A hierarchical clustered heatmap of the relative abundance of proteins between the two groups of brain tumors, Grade IV astrocytomas and meningiomas (MNGs); referred to as the expression patterns. The green blocks represent the overexpressed proteins, whereas the blue blocks represent proteins with the lowest expression level. Colored bars indicate the expression levels.</p></figcaption></figure><p>Hence, the MS technique has improved issues related to traditional methods based on antibodies because these approaches are low‐throughput, biased against hypermodified proteins, semiquantitative, time‐consuming, and lacking of sensitivity and accuracy in detecting low concentrations of proteins and in discriminating between certain tumor subtypes, giving usually subjective interpretation and discrepancies in results (Ghosh et al. <a href="#bmc70170-bib-0055" class="usa-link" aria-describedby="bmc70170-bib-0055">2014</a>; Jiang et al. <a href="#bmc70170-bib-0075" class="usa-link" aria-describedby="bmc70170-bib-0075">2021</a>; Sakamoto et al. <a href="#bmc70170-bib-0152" class="usa-link" aria-describedby="bmc70170-bib-0152">2017</a>; Thomas et al. <a href="#bmc70170-bib-0174" class="usa-link" aria-describedby="bmc70170-bib-0174">2019</a>).</p>
<p>Strikingly, our findings enabled the discovery of key hub genes specific to each type of brain cancer, emphasizing their dual potential role for being both obvious diagnostic biomarkers and pivotal predictors for tumor progression and prognosis.</p>
<p>Notably, they could also be untangled for their role as tumor suppressors and oncogenes as well as potential targets for epigenetic cancer therapies. By way of illustration, following the clustered heatmap presented in Figure <a href="#bmc70170-fig-0010" class="usa-link">10</a>, the most relevant genes dealing with metastatic and invasive forms of cancer with poor prognosis are NES, VIM (Nowicki et al. <a href="#bmc70170-bib-0136" class="usa-link" aria-describedby="bmc70170-bib-0136">2019</a>; Sugawara et al. <a href="#bmc70170-bib-0165" class="usa-link" aria-describedby="bmc70170-bib-0165">2002</a>; Sun et al. <a href="#bmc70170-bib-0166" class="usa-link" aria-describedby="bmc70170-bib-0166">2011</a>; Szymańska‐Chabowska et al. <a href="#bmc70170-bib-0169" class="usa-link" aria-describedby="bmc70170-bib-0169">2021</a>), some isoforms of Ca<sup>2+</sup> proteins (S100A and S100B, ANXA1 and ANXA2, CAMK2A) (Camby et al. <a href="#bmc70170-bib-0028" class="usa-link" aria-describedby="bmc70170-bib-0028">2000</a>; He and Li <a href="#bmc70170-bib-0064" class="usa-link" aria-describedby="bmc70170-bib-0064">2021</a>; Lei et al. <a href="#bmc70170-bib-0092" class="usa-link" aria-describedby="bmc70170-bib-0092">2024</a>; X. Li et al. <a href="#bmc70170-bib-0094" class="usa-link" aria-describedby="bmc70170-bib-0094">2021</a>; Polisetty et al. <a href="#bmc70170-bib-0146" class="usa-link" aria-describedby="bmc70170-bib-0146">2012</a>; H. Wang, Mao, et al. <a href="#bmc70170-bib-0185" class="usa-link" aria-describedby="bmc70170-bib-0185">2022</a>), SERPINA1 (Liu et al. <a href="#bmc70170-bib-0101" class="usa-link" aria-describedby="bmc70170-bib-0101">2022</a>), TUBB2B (J. Li et al. <a href="#bmc70170-bib-0095" class="usa-link" aria-describedby="bmc70170-bib-0095">2024</a>), LAMB1 (H. Lee et al. <a href="#bmc70170-bib-0090" class="usa-link" aria-describedby="bmc70170-bib-0090">2021</a>), EEF2 (Cristiano <a href="#bmc70170-bib-0039" class="usa-link" aria-describedby="bmc70170-bib-0039">2021</a>; Zhang et al. <a href="#bmc70170-bib-0205" class="usa-link" aria-describedby="bmc70170-bib-0205">2011</a>), SNRPG (Mabonga and Kappo <a href="#bmc70170-bib-0112" class="usa-link" aria-describedby="bmc70170-bib-0112">2019</a>), CD44 (Inoue et al. <a href="#bmc70170-bib-0071" class="usa-link" aria-describedby="bmc70170-bib-0071">2023</a>; Mooney et al. <a href="#bmc70170-bib-0124" class="usa-link" aria-describedby="bmc70170-bib-0124">2016</a>), and CD163 (Kanno et al. <a href="#bmc70170-bib-0080" class="usa-link" aria-describedby="bmc70170-bib-0080">2013</a>).</p>
<p>The accuracy and sensitivity of our analyses of brain tumors versus the IHC technique depend on the high‐throughput MS technology and the latest advances in the performance of database research engines, which represent our case study in adopting the Q‐Exactive hybrid quadrupole‐Orbitrap tandem mass spectrometer as well as the MaxQuant software. The selected mass spectrometer has played a prominent role in proteomics and PTMs analysis due to its high resolution and accurate MS data. In addition, it provides new levels of speed and resolution for every scan while maintaining high spectral quality for sensitive detection and confident quantitation of peptides (Thermo Scientific <a href="#bmc70170-bib-0173" class="usa-link" aria-describedby="bmc70170-bib-0173">2017</a>, Product Specification, Available on‐line: <a href="https://assets.thermofisher.com/TFSAssets/CMD/Specification-Sheets/PS-64048-LC-MS-Q-Exactive-HF-Orbitrap-PS64048-EN.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://assets.thermofisher.com/TFSAssets/CMD/Specification‐Sheets/PS‐64048‐LC‐MS‐Q‐Exactive‐HF‐Orbitrap‐PS64048‐EN.pdf</a>). The MaxQuant software is a famous platform for LC–MS/MS shotgun proteomics that achieves peptide mass accuracies with high sequencing coverage, thanks to its advanced nonlinear recalibration algorithms (Prianichnikov et al. <a href="#bmc70170-bib-0148" class="usa-link" aria-describedby="bmc70170-bib-0148">2020</a>).</p>
<p>Overall, genoproteomics has become a critical part of cancer research that integrates multiomics data benefiting from the recent advances related to the MS–high‐throughput technique, powerful algorithms in protein database search, and <a href="https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/bioinformatics" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">bioinformatics</a> tools. These advances have allowed the reliable detection of prognostic biomarkers involved in the progression and invasion of brain cancer, as well as a better understanding of the main warped mechanisms involved in tumorigenesis, which helps to counteract the limits and pitfalls of traditional diagnostic methods and the lack of specific antibodies in numerous hospital and clinical laboratories.</p></section></section><section id="bmc70170-sec-0023"><h2 class="pmc_sec_title">5. Conclusion</h2>
<p>The present study highlights the advantages of the application of the MS–high‐throughput technology in medical analyses thanks to its high reproducibility, sensitivity, and efficiency by providing accurate and precise measurements leading to the improvement of the quality of healthcare performance in the hospital management system through overseeing employees, funds, and resources, including human errors (Thomas et al. <a href="#bmc70170-bib-0175" class="usa-link" aria-describedby="bmc70170-bib-0175">2022</a>). Besides, it has promoted issues and caveats of traditional diagnostic methods and the lack of specific antibodies in numerous hospitals and clinical laboratories. Consequently, the current health problems in the medium hospital, where the majority of patients' claims nowadays could be addressed.</p>
<p>The state of the art, dealing with proteomics, comprises a set of tools for the large‐scale study of gene expression at the protein level, which provides comprehensive insights into the dynamics of cellular processes, modifications, and interactions. Thus, genoproteomics has emerged as an important component of cancer research that incorporates multiomics data processing, benefiting from the recent improvements in the MS–high‐throughput technology, sophisticated protein database search algorithms, and bioinformatics tools.</p>
<p>In this regard, we succeeded in our study by proteome‐wide profiling and mapping using a shotgun proteomic–based approach with high‐resolution tandem MS, the discovery of the key hub genes specific to each type of brain tumor, emphasizing their dual potential role for being both obvious diagnostic biomarkers and pivotal predictors for tumor progression and prognosis. Notably, from these genes, we have unveiled the major aberrant mechanisms underpinning tumorigenesis, which are mitochondrial metabolism, drug transporters, calcium influx, protein transport and trafficking, protein folding and biosynthesis, angiogenesis, neurogenesis, cytokinesis, cell adhesion, signal transduction, downstream signaling pathways related to cancer growth and progression, hemostasis, electron transport, and adaptive immunity response.</p>
<p>Accordingly, our findings from the reliable identification of prognostic biomarkers involved in tumorigenesis present two major assets: First, they mitigate our understanding of tumor physiopathology as well as the degree of invasiveness and metastatic potential across diverse tissue types. Second, they pave the way for better diagnosis and optimization of treatment guidelines to support the development of personalized therapies targeting specific biomarkers, while effectively minimizing adverse effects and circumventing cancer evasion tactics (Herrmann et al. <a href="#bmc70170-bib-0066" class="usa-link" aria-describedby="bmc70170-bib-0066">2001</a>; Procópio‐Azevedo et al. <a href="#bmc70170-bib-0149" class="usa-link" aria-describedby="bmc70170-bib-0149">2023</a>).</p></section><section id="bmc70170-sec-0030"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>
<strong>Kaouthar Louati:</strong> conceptualization, investigation, writing original draft, methodology, formal analysis, data curation, writing – review and editing. <strong>Fatma Kolsi, Mahdi Borni:</strong> investigation, resources. <strong>Manel Mellouli, Rim Kallel, Leila Sellami Hakim, Tahya Sellami Boudawara:</strong> validation. <strong>Amina Maalej, Sirine Choura:</strong> formal analysis, software. <strong>Rania Zribi:</strong> writing – review and editing. <strong>Sami Sayadi:</strong> resources. <strong>Hanen Louati, Mohamed Chamkha:</strong> resources, project administration. <strong>Mohamed Zaher Boudawara:</strong> supervision. <strong>Zouheir Khemakhem:</strong> project administration, visualization. <strong>Kaouthar Zribi, Fathi Safta:</strong> supervision.</p></section><section id="bmc70170-sec-0027"><h2 class="pmc_sec_title">Ethics Statement</h2>
<p>The procedure carried out in this work was in accordance with the Declaration of Helsinki. It was approved by our Ethics Committee in the HABIB BOURGUIBA university hospital, Sfax, Tunisia, where this study was conducted. The study was approved under the number CPP SUD‐0443/2022.</p></section><section id="bmc70170-sec-0028"><h2 class="pmc_sec_title">Consent</h2>
<p>The participants gave their consent to take part in this research. A written informed consent was obtained from each patient before undergoing any neurosurgery for the possible risk of paralysis or mortality. An additional informed consent was obtained from all individual participants, whose personal information is included in this study.</p></section><section id="bmc70170-sec-0029"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>The authors declare no conflicts of interest.</p></section><section id="sec28"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="bmc70170-supitem-0001"><div class="caption p">
<p>
<strong>Data S1.</strong> Methodology of immunohistochemical staining.</p>
<p>
<strong>Figure S1.</strong> Venn diagram representation of the differently expressed genes in the analyzed human brain tumor tissues.</p>
<p>
<strong>Figure S2.</strong> Pathway enrichment analysis by METASCAPE of the differently expressed proteins in Grade IV astrocytoma brain tumor tissues.</p>
<p>
<strong>Figure S3.</strong> Pathway enrichment analysis by METASCAPE of the differently expressed proteins in meningioma brain tumor tissues.</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12326238/bin/BMC-39-e70170-s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">BMC-39-e70170-s001.pdf</a><sup> (615.5KB, pdf) </sup>
</div></div></section></section><section id="bmc70170-sec-0024" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>Our study was supported by the Ministry of Higher Education and the Ministry of Health, Tunisia. Our deepest and most sincere gratitude and thanks go to (1) our representative authorities of the medical Ethics committee: Dr. Khalil Nouri and Dr. Zouheir Bahloul; (2) the head of the Pathological Anatomy department and Cytology Laboratory in Habib Bourguiba medium hospital, and her team due to their support in the histopathological diagnosis; (3) neurosurgeons: all our neurosurgical doctors who have performed successful surgeries by taking into consideration their patients' safety and all the team in the neurosurgery department for their help; (4) Mrs. Sirine Choura, Amina Maalej, and Pr. Mohamed Chamkha for their technical assistance and help by providing the necessary materials for stem‐like cells culture in the Biotechnology center, Sfax, Tunisia; (5) Mrs. Rania Zribi, for proofreading English in this article; (6) the pharmaceutical team of Habib Bourguiba medium hospital for providing the necessary surgical materials; and (7) Dr. Lively J, and Ren S., for performing us facility analysis (Proteomics, USA). My special thanks are extended to Mrs. C. Coveny and Dr. D. Boocock at the University of Nottingham, UK, for supporting my knowledge in cancer research and proteomic‐based MS/ analysis. Open Access funding enabled and organized by CNUDST.</p></section><section id="notes1"><p>


Louati, K.
, Kolsi F., Mellouli M., et al. 2025. “Application of the Mass Spectrometry–High‐Throughput Technique Over the Immunohistochemical Analysis for Human Brain Tumor Diagnosis and Prognosis: Insights Into Biomarkers' Identification for the Case Study of Grade IV Astrocytomas and Meningiomas.” Biomedical Chromatography
39, no. 9: e70170. 10.1002/bmc.70170.

</p>
<section id="bmc70170-ntgp-0001" class="fn-group"><div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="bmc70170-note-0001"><p>
<strong>Funding:</strong> Our study was supported by the Ministry of Higher Education and the Ministry of Health. We have not received any other specific grant from funding agencies in public, commercial, or not‐for‐profit sectors.</p></div>
<div class="fn p" id="bmc70170-note-0002"><p>All authors have approved the final article.</p></div>
</div></section></section><section id="bmc70170-sec-0026"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>Data that support the findings of this study, including peptide sequencing and protein identification, are available at the ProteomeXchange Consortium via the MassIVE partner repository (for shotgun proteomics data) at: <a href="https://massive.ucsd.edu/ProteoSAFe/QueryPXD?id=PXD054822" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://massive.ucsd.edu/ProteoSAFe/QueryPXD?id=PXD054822</a>. With the dataset identifier: Username: MSV000095574_reviewer. Password: REVIEWER105. The data are not publicly available due to privacy or ethical restrictions.</p></section><section id="bmc70170-bibl-0001" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="bmc70170-bibl-0001_sec2"><ol class="ref-list font-sm">
<li id="bmc70170-bib-0001">
<cite>

Agam, G.
, Atawna B., Damri O., and Azab A. N.. 2024. “The Role of FKBPs in Complex Disorders: Neuropsychiatric Diseases, Cancer, and Type 2 Diabetes Mellitus.” Cells
13, no. 10: 801. 10.3390/cells13100801.
</cite> [<a href="https://doi.org/10.3390/cells13100801" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11119362/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38786025/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cells&amp;title=The%20Role%20of%20FKBPs%20in%20Complex%20Disorders:%20Neuropsychiatric%20Diseases,%20Cancer,%20and%20Type%202%20Diabetes%20Mellitus&amp;author=G.%20Agam&amp;author=B.%20Atawna&amp;author=O.%20Damri&amp;author=A.%20N.%20Azab&amp;volume=13&amp;issue=10&amp;publication_year=2024&amp;pages=801&amp;pmid=38786025&amp;doi=10.3390/cells13100801&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0216">
<cite>

Agulló, C.
, Puig N., 
T. Contreras
, et al. 2024. “Mass Spectrometry as Alternative Method to Identify and Monitor Non‐Secretory Progressive Disease in Patients with Multiple Myeloma.” Biomedicines
12, no. 6: 1153. 10.3390/biomedicines12061153.
</cite> [<a href="https://doi.org/10.3390/biomedicines12061153" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11200560/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38927360/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomedicines&amp;title=Mass%20Spectrometry%20as%20Alternative%20Method%20to%20Identify%20and%20Monitor%20Non%E2%80%90Secretory%20Progressive%20Disease%20in%20Patients%20with%20Multiple%20Myeloma&amp;author=C.%20Agull%C3%B3&amp;author=N.%20Puig&amp;author=T%20Contreras&amp;volume=12&amp;issue=6&amp;publication_year=2024&amp;pages=1153&amp;pmid=38927360&amp;doi=10.3390/biomedicines12061153&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0002">
<cite>

Ahmed, R. A.
, Shebl A. M., and Habashy H. O.. 2017. “Expression Levels of β‐Catenin and Galectin‐3 in Meningioma and Their Effect on Brain Invasion and Recurrence: A Tissue Microarray Study.” Cancer Biology &amp; Medicine
14, no. 3: 319–326. 10.20892/j.issn.2095-3941.2017.0024.
</cite> [<a href="https://doi.org/10.20892/j.issn.2095-3941.2017.0024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5570608/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28884048/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Biology%20&amp;%20Medicine&amp;title=Expression%20Levels%20of%20%CE%B2%E2%80%90Catenin%20and%20Galectin%E2%80%903%20in%20Meningioma%20and%20Their%20Effect%20on%20Brain%20Invasion%20and%20Recurrence:%20A%20Tissue%20Microarray%20Study&amp;author=R.%20A.%20Ahmed&amp;author=A.%20M.%20Shebl&amp;author=H.%20O.%20Habashy&amp;volume=14&amp;issue=3&amp;publication_year=2017&amp;pages=319-326&amp;pmid=28884048&amp;doi=10.20892/j.issn.2095-3941.2017.0024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0003">
<cite>

Åkesson, J.
, Hojjati S., Hellberg S., et al. 2023. “Proteomics Reveal Biomarkers for Diagnosis, Disease Activity and Long‐Term Disability Outcomes in Multiple Sclerosis.” Nature Communications
14, no. 1: 6903. 10.1038/s41467-023-42682-9.</cite> [<a href="https://doi.org/10.1038/s41467-023-42682-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10616092/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37903821/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Communications&amp;title=Proteomics%20Reveal%20Biomarkers%20for%20Diagnosis,%20Disease%20Activity%20and%20Long%E2%80%90Term%20Disability%20Outcomes%20in%20Multiple%20Sclerosis&amp;author=J.%20%C3%85kesson&amp;author=S.%20Hojjati&amp;author=S.%20Hellberg&amp;volume=14&amp;issue=1&amp;publication_year=2023&amp;pages=6903&amp;pmid=37903821&amp;doi=10.1038/s41467-023-42682-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0004">
<cite>

Alamir, H.
, Alomari M., Salwati A. A. A., et al. 2018. “In Situ Characterization of Stem Cells‐Like Biomarkers in Meningiomas.” Cancer Cell International
18, no. 1: 77. 10.1186/s12935-018-0571-6.
</cite> [<a href="https://doi.org/10.1186/s12935-018-0571-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5970464/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29849507/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Cell%20International&amp;title=In%20Situ%20Characterization%20of%20Stem%20Cells%E2%80%90Like%20Biomarkers%20in%20Meningiomas&amp;author=H.%20Alamir&amp;author=M.%20Alomari&amp;author=A.%20A.%20A.%20Salwati&amp;volume=18&amp;issue=1&amp;publication_year=2018&amp;pages=77&amp;pmid=29849507&amp;doi=10.1186/s12935-018-0571-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0005">
<cite>

Alexiou, G.
, Karamoutsios A., Lallas G., et al. 2014. “Expression of Heat Shock Proteins in Brain Tumors.” Turkish Neurosurgery
24, no. 5: 745–749. 10.5137/1019-5149.jtn.9852-13.0.
</cite> [<a href="https://doi.org/10.5137/1019-5149.jtn.9852-13.0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25269047/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Turkish%20Neurosurgery&amp;title=Expression%20of%20Heat%20Shock%20Proteins%20in%20Brain%20Tumors&amp;author=G.%20Alexiou&amp;author=A.%20Karamoutsios&amp;author=G.%20Lallas&amp;volume=24&amp;issue=5&amp;publication_year=2014&amp;pages=745-749&amp;pmid=25269047&amp;doi=10.5137/1019-5149.jtn.9852-13.0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0006">
<cite>

Arsene, D.
, Comănescu M., and Ardeleanu C.. 2014. “Adhesion Cell Molecules as Potential Markers of Aggressiveness in Meningiomas.” Romanian Journal of Morphology and Embryology
55, no. 2 Suppl: 585–589.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/25178329/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Romanian%20Journal%20of%20Morphology%20and%20Embryology&amp;title=Adhesion%20Cell%20Molecules%20as%20Potential%20Markers%20of%20Aggressiveness%20in%20Meningiomas&amp;author=D.%20Arsene&amp;author=M.%20Com%C4%83nescu&amp;author=C.%20Ardeleanu&amp;volume=55&amp;issue=2%20Suppl&amp;publication_year=2014&amp;pages=585-589&amp;pmid=25178329&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0007">
<cite>

Babi, A.
, Menlibayeva K., Bex T., Doskaliev A., Akshulakov S., and Shevtsov M.. 2022. “Targeting Heat Shock Proteins in Malignant Brain Tumors: From Basic Research to Clinical Trials.” Cancers
14, no. 21: 5435. 10.3390/cancers14215435.
</cite> [<a href="https://doi.org/10.3390/cancers14215435" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9659111/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36358853/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers&amp;title=Targeting%20Heat%20Shock%20Proteins%20in%20Malignant%20Brain%20Tumors:%20From%20Basic%20Research%20to%20Clinical%20Trials&amp;author=A.%20Babi&amp;author=K.%20Menlibayeva&amp;author=T.%20Bex&amp;author=A.%20Doskaliev&amp;author=S.%20Akshulakov&amp;volume=14&amp;issue=21&amp;publication_year=2022&amp;pages=5435&amp;pmid=36358853&amp;doi=10.3390/cancers14215435&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0008">
<cite>

Backer‐Grøndahl, T.
, Moen B. H., Arnli M. B., Torseth K., and Torp S. H.. 2014. “Immunohistochemical Characterization of Brain‐Invasive Meningiomas.” International Journal of Clinical and Experimental Pathology
7, no. 10: 7206–7219. <a href="https://pubmed.ncbi.nlm.nih.gov/25400818" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/25400818</a>.
</cite> [<a href="/articles/PMC4230100/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25400818/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Clinical%20and%20Experimental%20Pathology&amp;title=Immunohistochemical%20Characterization%20of%20Brain%E2%80%90Invasive%20Meningiomas&amp;author=T.%20Backer%E2%80%90Gr%C3%B8ndahl&amp;author=B.%20H.%20Moen&amp;author=M.%20B.%20Arnli&amp;author=K.%20Torseth&amp;author=S.%20H.%20Torp&amp;volume=7&amp;issue=10&amp;publication_year=2014&amp;pages=7206-7219&amp;pmid=25400818&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0009">
<cite>

Bacon, J. M.
, Jones J. L., Liu G., Dickinson J. L., and Raspin K.. 2024. “Mitochondrial Ribosomal Proteins in Metastasis and Their Potential Use as Prognostic and Therapeutic Targets.” Cancer Metastasis Reviews
43: 1119–1135. 10.1007/s10555-024-10216-4.
</cite> [<a href="https://doi.org/10.1007/s10555-024-10216-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11554709/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39354291/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Metastasis%20Reviews&amp;title=Mitochondrial%20Ribosomal%20Proteins%20in%20Metastasis%20and%20Their%20Potential%20Use%20as%20Prognostic%20and%20Therapeutic%20Targets&amp;author=J.%20M.%20Bacon&amp;author=J.%20L.%20Jones&amp;author=G.%20Liu&amp;author=J.%20L.%20Dickinson&amp;author=K.%20Raspin&amp;volume=43&amp;publication_year=2024&amp;pages=1119-1135&amp;pmid=39354291&amp;doi=10.1007/s10555-024-10216-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0010">
<cite>

Baghel, U. S.
, Singh A., Singh D., and Sinha M.. 2017. “Application of Mass Spectroscopy in Pharmaceutical and Biomedical Analysis.” In Spectroscopic Analyses—Developments and Applications. InTech eBooks. 10.5772/intechopen.70655.</cite> [<a href="https://doi.org/10.5772/intechopen.70655" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?title=Spectroscopic%20Analyses%E2%80%94Developments%20and%20Applications&amp;author=U.%20S.%20Baghel&amp;author=A.%20Singh&amp;author=D.%20Singh&amp;author=M.%20Sinha&amp;publication_year=2017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0011">
<cite>

Baltira, C.
, Aronica E., Elmquist W. F., et al. 2024. “The Impact of ATP‐Binding Cassette Transporters in the Diseased Brain: Context Matters.” Cell Reports Medicine
5, no. 6: 101609. 10.1016/j.xcrm.2024.101609.
</cite> [<a href="https://doi.org/10.1016/j.xcrm.2024.101609" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11228798/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38897176/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Reports%20Medicine&amp;title=The%20Impact%20of%20ATP%E2%80%90Binding%20Cassette%20Transporters%20in%20the%20Diseased%20Brain:%20Context%20Matters&amp;author=C.%20Baltira&amp;author=E.%20Aronica&amp;author=W.%20F.%20Elmquist&amp;volume=5&amp;issue=6&amp;publication_year=2024&amp;pages=101609&amp;pmid=38897176&amp;doi=10.1016/j.xcrm.2024.101609&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0012">
<cite>

Bao, N.
, Han J., and Zhou H.. 2022. “A Protein With Broad Functions: Damage‐Specific DNA‐Binding Protein 2.” Molecular Biology Reports
49, no. 12: 12181–12192. 10.1007/s11033-022-07963-4.
</cite> [<a href="https://doi.org/10.1007/s11033-022-07963-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9712371/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36190612/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Biology%20Reports&amp;title=A%20Protein%20With%20Broad%20Functions:%20Damage%E2%80%90Specific%20DNA%E2%80%90Binding%20Protein%202&amp;author=N.%20Bao&amp;author=J.%20Han&amp;author=H.%20Zhou&amp;volume=49&amp;issue=12&amp;publication_year=2022&amp;pages=12181-12192&amp;pmid=36190612&amp;doi=10.1007/s11033-022-07963-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0013">
<cite>

Benaud, C.
, Gentil B. J., Assard N., et al. 2003. “AHNAK Interaction With the Annexin 2/S100A10 Complex Regulates Cell Membrane Cytoarchitecture.” Journal of Cell Biology
164, no. 1: 133–144. 10.1083/jcb.200307098.
</cite> [<a href="https://doi.org/10.1083/jcb.200307098" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2171952/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14699089/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Cell%20Biology&amp;title=AHNAK%20Interaction%20With%20the%20Annexin%202/S100A10%20Complex%20Regulates%20Cell%20Membrane%20Cytoarchitecture&amp;author=C.%20Benaud&amp;author=B.%20J.%20Gentil&amp;author=N.%20Assard&amp;volume=164&amp;issue=1&amp;publication_year=2003&amp;pages=133-144&amp;pmid=14699089&amp;doi=10.1083/jcb.200307098&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0014">
<cite>

Bendris, N.
, Stearns C. J. S., Reis C. R., et al. 2016. “Sorting Nexin 9 Negatively Regulates Invadopodia Formation and Function in Cancer Cells.” Journal of Cell Science
129, no. 14: 2804–2816. 10.1242/jcs.188045.
</cite> [<a href="https://doi.org/10.1242/jcs.188045" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4958298/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27278018/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Cell%20Science&amp;title=Sorting%20Nexin%209%20Negatively%20Regulates%20Invadopodia%20Formation%20and%20Function%20in%20Cancer%20Cells&amp;author=N.%20Bendris&amp;author=C.%20J.%20S.%20Stearns&amp;author=C.%20R.%20Reis&amp;volume=129&amp;issue=14&amp;publication_year=2016&amp;pages=2804-2816&amp;pmid=27278018&amp;doi=10.1242/jcs.188045&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0015">
<cite>

Bhatia, P.
, Bernier M., Sanghvi M., et al. 2012. “Breast Cancer Resistance Protein (BCRP/ABCG2) Localises to the Nucleus in Glioblastoma Multiforme Cells.” Xenobiotica
42, no. 8: 748–755. 10.3109/00498254.2012.662726.
</cite> [<a href="https://doi.org/10.3109/00498254.2012.662726" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3374059/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22401348/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Xenobiotica&amp;title=Breast%20Cancer%20Resistance%20Protein%20(BCRP/ABCG2)%20Localises%20to%20the%20Nucleus%20in%20Glioblastoma%20Multiforme%20Cells&amp;author=P.%20Bhatia&amp;author=M.%20Bernier&amp;author=M.%20Sanghvi&amp;volume=42&amp;issue=8&amp;publication_year=2012&amp;pages=748-755&amp;pmid=22401348&amp;doi=10.3109/00498254.2012.662726&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0016">
<cite>

Bielli, P.
, Pagliarini V., Pieraccioli M., Caggiano C., and Sette C.. 2019. “Splicing Dysregulation as Oncogenic Driver and Passenger Factor in Brain Tumors.” Cells
9, no. 1: 10. 10.3390/cells9010010.
</cite> [<a href="https://doi.org/10.3390/cells9010010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7016899/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31861467/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cells&amp;title=Splicing%20Dysregulation%20as%20Oncogenic%20Driver%20and%20Passenger%20Factor%20in%20Brain%20Tumors&amp;author=P.%20Bielli&amp;author=V.%20Pagliarini&amp;author=M.%20Pieraccioli&amp;author=C.%20Caggiano&amp;author=C.%20Sette&amp;volume=9&amp;issue=1&amp;publication_year=2019&amp;pages=10&amp;pmid=31861467&amp;doi=10.3390/cells9010010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0017">
<cite>

Bindea, G.
, Mlecnik B., Hackl H., et al. 2009. “ClueGO: A Cytoscape Plug‐In to Decipher Functionally Grouped Gene Ontology and Pathway Annotation Networks.” Bioinformatics
25, no. 8: 1091–1093. 10.1093/bioinformatics/btp101.
</cite> [<a href="https://doi.org/10.1093/bioinformatics/btp101" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2666812/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19237447/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=ClueGO:%20A%20Cytoscape%20Plug%E2%80%90In%20to%20Decipher%20Functionally%20Grouped%20Gene%20Ontology%20and%20Pathway%20Annotation%20Networks&amp;author=G.%20Bindea&amp;author=B.%20Mlecnik&amp;author=H.%20Hackl&amp;volume=25&amp;issue=8&amp;publication_year=2009&amp;pages=1091-1093&amp;pmid=19237447&amp;doi=10.1093/bioinformatics/btp101&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0018">
<cite>

Bindea, G.
, Galon J., and Mlecnik B.. 2013. “CluePedia Cytoscape Plugin: Pathway Insights Using Integrated Experimental and In Silico Data.” Bioinformatics
29, no. 5: 661–663. 10.1093/bioinformatics/btt019.
</cite> [<a href="https://doi.org/10.1093/bioinformatics/btt019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3582273/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23325622/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=CluePedia%20Cytoscape%20Plugin:%20Pathway%20Insights%20Using%20Integrated%20Experimental%20and%20In%20Silico%20Data&amp;author=G.%20Bindea&amp;author=J.%20Galon&amp;author=B.%20Mlecnik&amp;volume=29&amp;issue=5&amp;publication_year=2013&amp;pages=661-663&amp;pmid=23325622&amp;doi=10.1093/bioinformatics/btt019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0019">
<cite>

Birhanu, A. G.

2023. “Mass Spectrometry‐Based Proteomics as an Emerging Tool in Clinical Laboratories.” Clinical Proteomics
20, no. 1: 32. 10.1186/s12014-023-09424-x.
</cite> [<a href="https://doi.org/10.1186/s12014-023-09424-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10464495/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37633929/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Proteomics&amp;title=Mass%20Spectrometry%E2%80%90Based%20Proteomics%20as%20an%20Emerging%20Tool%20in%20Clinical%20Laboratories&amp;author=A.%20G.%20Birhanu&amp;volume=20&amp;issue=1&amp;publication_year=2023&amp;pages=32&amp;pmid=37633929&amp;doi=10.1186/s12014-023-09424-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0020">
<cite>

Bouamrani, A.
, Ramus C., Gay E., et al. 2010. “Increased Phosphorylation of Vimentin in Noninfiltrative Meningiomas.” PLoS ONE
5, no. 2: e9238. 10.1371/journal.pone.0009238.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0009238" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2821924/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20169076/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20ONE&amp;title=Increased%20Phosphorylation%20of%20Vimentin%20in%20Noninfiltrative%20Meningiomas&amp;author=A.%20Bouamrani&amp;author=C.%20Ramus&amp;author=E.%20Gay&amp;volume=5&amp;issue=2&amp;publication_year=2010&amp;pages=e9238&amp;pmid=20169076&amp;doi=10.1371/journal.pone.0009238&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0021">
<cite>

Boulagnon‐Rombi, C.
, Fleury C., Fichel C., Lefour S., Bressenot A. M., and Gauchotte G.. 2017. “Immunohistochemical Approach to the Differential Diagnosis of Meningiomas and Their Mimics.” Journal of Neuropathology &amp; Experimental Neurology
76, no. 4: 289–298. 10.1093/jnen/nlx008.
</cite> [<a href="https://doi.org/10.1093/jnen/nlx008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28340171/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neuropathology%20&amp;%20Experimental%20Neurology&amp;title=Immunohistochemical%20Approach%20to%20the%20Differential%20Diagnosis%20of%20Meningiomas%20and%20Their%20Mimics&amp;author=C.%20Boulagnon%E2%80%90Rombi&amp;author=C.%20Fleury&amp;author=C.%20Fichel&amp;author=S.%20Lefour&amp;author=A.%20M.%20Bressenot&amp;volume=76&amp;issue=4&amp;publication_year=2017&amp;pages=289-298&amp;pmid=28340171&amp;doi=10.1093/jnen/nlx008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0022">
<cite>

Bowley, T. Y.
, Lagutina I. V., Francis C., et al. 2022. “The RPL/RPS Gene Signature of Melanoma CTCs Associates With Brain Metastasis.” Cancer Research Communications
2, no. 11: 1436–1448. 10.1158/2767-9764.crc-22-0337.</cite> [<a href="https://doi.org/10.1158/2767-9764.crc-22-0337" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9668078/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36407834/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Research%20Communications&amp;title=The%20RPL/RPS%20Gene%20Signature%20of%20Melanoma%20CTCs%20Associates%20With%20Brain%20Metastasis&amp;author=T.%20Y.%20Bowley&amp;author=I.%20V.%20Lagutina&amp;author=C.%20Francis&amp;volume=2&amp;issue=11&amp;publication_year=2022&amp;pages=1436-1448&amp;pmid=36407834&amp;doi=10.1158/2767-9764.crc-22-0337&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0023">
<cite>

Brehar, F. M.
, Arsene D., Brinduse L. A., and Gorgan M. R.. 2014. “Immunohistochemical Analysis of GFAP‐δ and Nestin in Cerebral Astrocytomas.” Brain Tumor Pathology
32, no. 2: 90–98. 10.1007/s10014-014-0199-8.
</cite> [<a href="https://doi.org/10.1007/s10014-014-0199-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25178519/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Tumor%20Pathology&amp;title=Immunohistochemical%20Analysis%20of%20GFAP%E2%80%90%CE%B4%20and%20Nestin%20in%20Cerebral%20Astrocytomas&amp;author=F.%20M.%20Brehar&amp;author=D.%20Arsene&amp;author=L.%20A.%20Brinduse&amp;author=M.%20R.%20Gorgan&amp;volume=32&amp;issue=2&amp;publication_year=2014&amp;pages=90-98&amp;pmid=25178519&amp;doi=10.1007/s10014-014-0199-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0024">
<cite>

Breuss, M. W.
, Leca I., Gstrein T., Hansen A. H., and Keays D. A.. 2017. “Tubulins and Brain Development—The Origins of Functional Specification.” Molecular and Cellular Neuroscience
84: 58–67. 10.1016/j.mcn.2017.03.002.
</cite> [<a href="https://doi.org/10.1016/j.mcn.2017.03.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28347630/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20and%20Cellular%20Neuroscience&amp;title=Tubulins%20and%20Brain%20Development%E2%80%94The%20Origins%20of%20Functional%20Specification&amp;author=M.%20W.%20Breuss&amp;author=I.%20Leca&amp;author=T.%20Gstrein&amp;author=A.%20H.%20Hansen&amp;author=D.%20A.%20Keays&amp;volume=84&amp;publication_year=2017&amp;pages=58-67&amp;pmid=28347630&amp;doi=10.1016/j.mcn.2017.03.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0025">
<cite>

Buerki, R. A.
, Horbinski C. M., Kruser T., Horowitz P. M., James C. D., and Lukas R. V.. 2018. “An Overview of Meningiomas.” Future Oncology
14, no. 21: 2161–2177. 10.2217/fon-2018-0006.
</cite> [<a href="https://doi.org/10.2217/fon-2018-0006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6123887/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30084265/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Future%20Oncology&amp;title=An%20Overview%20of%20Meningiomas&amp;author=R.%20A.%20Buerki&amp;author=C.%20M.%20Horbinski&amp;author=T.%20Kruser&amp;author=P.%20M.%20Horowitz&amp;author=C.%20D.%20James&amp;volume=14&amp;issue=21&amp;publication_year=2018&amp;pages=2161-2177&amp;pmid=30084265&amp;doi=10.2217/fon-2018-0006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0026">
<cite>

Caffo, M.
, Caruso G., Germanò A., Galatioto S., Meli F., and Tomasello F.. 2005. “CD68 and CR3/43 Immunohistochemical Expression in Secretory Meningiomas.” Neurosurgery
57, no. 3: 551–557. 10.1227/01.neu.0000170440.32720.77.
</cite> [<a href="https://doi.org/10.1227/01.neu.0000170440.32720.77" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16145535/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurosurgery&amp;title=CD68%20and%20CR3/43%20Immunohistochemical%20Expression%20in%20Secretory%20Meningiomas&amp;author=M.%20Caffo&amp;author=G.%20Caruso&amp;author=A.%20German%C3%B2&amp;author=S.%20Galatioto&amp;author=F.%20Meli&amp;volume=57&amp;issue=3&amp;publication_year=2005&amp;pages=551-557&amp;pmid=16145535&amp;doi=10.1227/01.neu.0000170440.32720.77&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0027">
<cite>

Cai, Z.
, Zhang C., Zou Y., et al. 2017. “Tissue Thioredoxin‐Interacting Protein Expression Predicted Recurrence in Patients With Meningiomas.” International Journal of Clinical Oncology
22, no. 4: 660–666. 10.1007/s10147-017-1103-4.
</cite> [<a href="https://doi.org/10.1007/s10147-017-1103-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28243945/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Clinical%20Oncology&amp;title=Tissue%20Thioredoxin%E2%80%90Interacting%20Protein%20Expression%20Predicted%20Recurrence%20in%20Patients%20With%20Meningiomas&amp;author=Z.%20Cai&amp;author=C.%20Zhang&amp;author=Y.%20Zou&amp;volume=22&amp;issue=4&amp;publication_year=2017&amp;pages=660-666&amp;pmid=28243945&amp;doi=10.1007/s10147-017-1103-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0028">
<cite>

Camby, I.
, LeFranc F., Titeca G., et al. 2000. “Differential Expression of S100 Calcium‐Binding Proteins Characterizes Distinct Clinical Entities in Both WHO Grade II and III Astrocytic Tumours.” Neuropathology and Applied Neurobiology
26, no. 1: 76–90. 10.1046/j.1365-2990.2000.00223.x.
</cite> [<a href="https://doi.org/10.1046/j.1365-2990.2000.00223.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10736069/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropathology%20and%20Applied%20Neurobiology&amp;title=Differential%20Expression%20of%20S100%20Calcium%E2%80%90Binding%20Proteins%20Characterizes%20Distinct%20Clinical%20Entities%20in%20Both%20WHO%20Grade%20II%20and%20III%20Astrocytic%20Tumours&amp;author=I.%20Camby&amp;author=F.%20LeFranc&amp;author=G.%20Titeca&amp;volume=26&amp;issue=1&amp;publication_year=2000&amp;pages=76-90&amp;pmid=10736069&amp;doi=10.1046/j.1365-2990.2000.00223.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0029">
<cite>

Carrillo‐Rodriguez, P.
, Selheim F., and Hernandez‐Valladares M.. 2023. “Mass Spectrometry‐Based Proteomics Workflows in Cancer Research: The Relevance of Choosing the Right Steps.” Cancers
15, no. 2: 555. 10.3390/cancers15020555.
</cite> [<a href="https://doi.org/10.3390/cancers15020555" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9856946/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36672506/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers&amp;title=Mass%20Spectrometry%E2%80%90Based%20Proteomics%20Workflows%20in%20Cancer%20Research:%20The%20Relevance%20of%20Choosing%20the%20Right%20Steps&amp;author=P.%20Carrillo%E2%80%90Rodriguez&amp;author=F.%20Selheim&amp;author=M.%20Hernandez%E2%80%90Valladares&amp;volume=15&amp;issue=2&amp;publication_year=2023&amp;pages=555&amp;pmid=36672506&amp;doi=10.3390/cancers15020555&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0030">
<cite>

Cassidy, L.
, Kaulich P. T., Maaß S., Bartel J., Becher D., and Tholey A.. 2021. “Bottom‐Up and Top‐Down Proteomic Approaches for the Identification, Characterization, and Quantification of the Low Molecular Weight Proteome With Focus on Short Open Reading Frame‐Encoded Peptides.” Proteomics
21, no. 23–24: e2100008. 10.1002/pmic.202100008.
</cite> [<a href="https://doi.org/10.1002/pmic.202100008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34145981/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proteomics&amp;title=Bottom%E2%80%90Up%20and%20Top%E2%80%90Down%20Proteomic%20Approaches%20for%20the%20Identification,%20Characterization,%20and%20Quantification%20of%20the%20Low%20Molecular%20Weight%20Proteome%20With%20Focus%20on%20Short%20Open%20Reading%20Frame%E2%80%90Encoded%20Peptides&amp;author=L.%20Cassidy&amp;author=P.%20T.%20Kaulich&amp;author=S.%20Maa%C3%9F&amp;author=J.%20Bartel&amp;author=D.%20Becher&amp;volume=21&amp;issue=23%E2%80%9324&amp;publication_year=2021&amp;pages=e2100008&amp;pmid=34145981&amp;doi=10.1002/pmic.202100008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0031">
<cite>

Cello, G.
, Patel R. V., McMahon J. T., Santagata S., and Bi W. L.. 2023. “Impact of H3K27 Trimethylation Loss in Meningiomas: A Meta‐Analysis.” Acta Neuropathologica Communications
11, no. 1: 122. 10.1186/s40478-023-01615-9.
</cite> [<a href="https://doi.org/10.1186/s40478-023-01615-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10369842/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37491289/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Neuropathologica%20Communications&amp;title=Impact%20of%20H3K27%20Trimethylation%20Loss%20in%20Meningiomas:%20A%20Meta%E2%80%90Analysis&amp;author=G.%20Cello&amp;author=R.%20V.%20Patel&amp;author=J.%20T.%20McMahon&amp;author=S.%20Santagata&amp;author=W.%20L.%20Bi&amp;volume=11&amp;issue=1&amp;publication_year=2023&amp;pages=122&amp;pmid=37491289&amp;doi=10.1186/s40478-023-01615-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0032">
<cite>

Chen, R.
, Chen C., Han N., et al. 2022. “Annexin‐1 Is an Oncogene in Glioblastoma and Causes Tumour Immune Escape Through the Indirect Upregulation of Interleukin‐8.” Journal of Cellular and Molecular Medicine
26, no. 15: 4343–4356. 10.1111/jcmm.17458.
</cite> [<a href="https://doi.org/10.1111/jcmm.17458" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9344830/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35770335/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Cellular%20and%20Molecular%20Medicine&amp;title=Annexin%E2%80%901%20Is%20an%20Oncogene%20in%20Glioblastoma%20and%20Causes%20Tumour%20Immune%20Escape%20Through%20the%20Indirect%20Upregulation%20of%20Interleukin%E2%80%908&amp;author=R.%20Chen&amp;author=C.%20Chen&amp;author=N.%20Han&amp;volume=26&amp;issue=15&amp;publication_year=2022&amp;pages=4343-4356&amp;pmid=35770335&amp;doi=10.1111/jcmm.17458&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0033">
<cite>

Chen, Y.
, Xie Y., Li L., Wang Z., and Yang L.. 2022. “Advances in Mass Spectrometry Imaging for Toxicological Analysis and Safety Evaluation of Pharmaceuticals.” Mass Spectrometry Reviews
42, no. 5: 2207–2233. 10.1002/mas.21807.
</cite> [<a href="https://doi.org/10.1002/mas.21807" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36146929/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mass%20Spectrometry%20Reviews&amp;title=Advances%20in%20Mass%20Spectrometry%20Imaging%20for%20Toxicological%20Analysis%20and%20Safety%20Evaluation%20of%20Pharmaceuticals&amp;author=Y.%20Chen&amp;author=Y.%20Xie&amp;author=L.%20Li&amp;author=Z.%20Wang&amp;author=L.%20Yang&amp;volume=42&amp;issue=5&amp;publication_year=2022&amp;pages=2207-2233&amp;pmid=36146929&amp;doi=10.1002/mas.21807&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0034">
<cite>

Cherry, A.
, and Stella N.. 2014. “G Protein‐Coupled Receptors as Oncogenic Signals in Glioma: Emerging Therapeutic Avenues.” Neuroscience
278: 222–236. 10.1016/j.neuroscience.2014.08.015.
</cite> [<a href="https://doi.org/10.1016/j.neuroscience.2014.08.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4180709/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25158675/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuroscience&amp;title=G%20Protein%E2%80%90Coupled%20Receptors%20as%20Oncogenic%20Signals%20in%20Glioma:%20Emerging%20Therapeutic%20Avenues&amp;author=A.%20Cherry&amp;author=N.%20Stella&amp;volume=278&amp;publication_year=2014&amp;pages=222-236&amp;pmid=25158675&amp;doi=10.1016/j.neuroscience.2014.08.015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0035">
<cite>

Cho, W. C.

2017. “Mass Spectrometry‐Based Proteomics in Cancer Research.” Expert Review of Proteomics
14, no. 9: 725–727. 10.1080/14789450.2017.1365604.
</cite> [<a href="https://doi.org/10.1080/14789450.2017.1365604" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28783987/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Review%20of%20Proteomics&amp;title=Mass%20Spectrometry%E2%80%90Based%20Proteomics%20in%20Cancer%20Research&amp;author=W.%20C.%20Cho&amp;volume=14&amp;issue=9&amp;publication_year=2017&amp;pages=725-727&amp;pmid=28783987&amp;doi=10.1080/14789450.2017.1365604&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0036">
<cite>

Chu, J.
, Cargnello M., Topisirovic I., and Pelletier J.. 2016. “Translation Initiation Factors: Reprogramming Protein Synthesis in Cancer.” Trends in Cell Biology
26, no. 12: 918–933. 10.1016/j.tcb.2016.06.005.
</cite> [<a href="https://doi.org/10.1016/j.tcb.2016.06.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27426745/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20in%20Cell%20Biology&amp;title=Translation%20Initiation%20Factors:%20Reprogramming%20Protein%20Synthesis%20in%20Cancer&amp;author=J.%20Chu&amp;author=M.%20Cargnello&amp;author=I.%20Topisirovic&amp;author=J.%20Pelletier&amp;volume=26&amp;issue=12&amp;publication_year=2016&amp;pages=918-933&amp;pmid=27426745&amp;doi=10.1016/j.tcb.2016.06.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0037">
<cite>

Chuang, H.
, Hsia K., Liao J., Yeh C., Kuo W., and Yang Y.. 2021. “SERPINE2 Overexpression Is Associated With Poor Prognosis of Urothelial Carcinoma.” Diagnostics
11, no. 10: 1928. 10.3390/diagnostics11101928.
</cite> [<a href="https://doi.org/10.3390/diagnostics11101928" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8535068/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34679626/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diagnostics&amp;title=SERPINE2%20Overexpression%20Is%20Associated%20With%20Poor%20Prognosis%20of%20Urothelial%20Carcinoma&amp;author=H.%20Chuang&amp;author=K.%20Hsia&amp;author=J.%20Liao&amp;author=C.%20Yeh&amp;author=W.%20Kuo&amp;volume=11&amp;issue=10&amp;publication_year=2021&amp;pages=1928&amp;pmid=34679626&amp;doi=10.3390/diagnostics11101928&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0038">
<cite>

Ciocan‐Cartita, C. A.
, Jurj A., Buse M., et al. 2019. “The Relevance of Mass Spectrometry Analysis for Personalized Medicine Through Its Successful Application in Cancer “Omics”.” International Journal of Molecular Sciences
20, no. 10: 2576. 10.3390/ijms20102576.
</cite> [<a href="https://doi.org/10.3390/ijms20102576" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6567119/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31130665/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Molecular%20Sciences&amp;title=The%20Relevance%20of%20Mass%20Spectrometry%20Analysis%20for%20Personalized%20Medicine%20Through%20Its%20Successful%20Application%20in%20Cancer%20%E2%80%9COmics%E2%80%9D&amp;author=C.%20A.%20Ciocan%E2%80%90Cartita&amp;author=A.%20Jurj&amp;author=M.%20Buse&amp;volume=20&amp;issue=10&amp;publication_year=2019&amp;pages=2576&amp;pmid=31130665&amp;doi=10.3390/ijms20102576&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0039">
<cite>

Cristiano, L.

2021. “The Pseudogenes of Eukaryotic Translation Elongation Factors (EEFs): Role in Cancer and Other Human Diseases.” Genes and Diseases
9, no. 4: 941–958. 10.1016/j.gendis.2021.03.009.
</cite> [<a href="https://doi.org/10.1016/j.gendis.2021.03.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9170609/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35685457/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genes%20and%20Diseases&amp;title=The%20Pseudogenes%20of%20Eukaryotic%20Translation%20Elongation%20Factors%20(EEFs):%20Role%20in%20Cancer%20and%20Other%20Human%20Diseases&amp;author=L.%20Cristiano&amp;volume=9&amp;issue=4&amp;publication_year=2021&amp;pages=941-958&amp;pmid=35685457&amp;doi=10.1016/j.gendis.2021.03.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0040">
<cite>

Crosas‐Molist, E.
, Samain R., Kohlhammer L., et al. 2021. “Rho GTPase Signaling in Cancer Progression and Dissemination.” Physiological Reviews
102, no. 1: 455–510. 10.1152/physrev.00045.2020.
</cite> [<a href="https://doi.org/10.1152/physrev.00045.2020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34541899/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Physiological%20Reviews&amp;title=Rho%20GTPase%20Signaling%20in%20Cancer%20Progression%20and%20Dissemination&amp;author=E.%20Crosas%E2%80%90Molist&amp;author=R.%20Samain&amp;author=L.%20Kohlhammer&amp;volume=102&amp;issue=1&amp;publication_year=2021&amp;pages=455-510&amp;pmid=34541899&amp;doi=10.1152/physrev.00045.2020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0041">
<cite>

Diao, J.
, Xia T., Zhao H., Liu J., Li B., and Zhang Z.. 2015. “Overexpression of HLA‐DR Is Associated With Prognosis of Glioma Patients.” International Journal of Clinical and Experimental Pathology
8, no. 5: 5485–5490.
</cite> [<a href="/articles/PMC4503125/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26191254/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Clinical%20and%20Experimental%20Pathology&amp;title=Overexpression%20of%20HLA%E2%80%90DR%20Is%20Associated%20With%20Prognosis%20of%20Glioma%20Patients&amp;author=J.%20Diao&amp;author=T.%20Xia&amp;author=H.%20Zhao&amp;author=J.%20Liu&amp;author=B.%20Li&amp;volume=8&amp;issue=5&amp;publication_year=2015&amp;pages=5485-5490&amp;pmid=26191254&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0042">
<cite>

Ebright, R. Y.
, Lee S., Wittner B. S., et al. 2020. “Deregulation of Ribosomal Protein Expression and Translation Promotes Breast Cancer Metastasis.” Science
367, no. 6485: 1468–1473. 10.1126/science.aay0939.
</cite> [<a href="https://doi.org/10.1126/science.aay0939" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7307008/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32029688/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Deregulation%20of%20Ribosomal%20Protein%20Expression%20and%20Translation%20Promotes%20Breast%20Cancer%20Metastasis&amp;author=R.%20Y.%20Ebright&amp;author=S.%20Lee&amp;author=B.%20S.%20Wittner&amp;volume=367&amp;issue=6485&amp;publication_year=2020&amp;pages=1468-1473&amp;pmid=32029688&amp;doi=10.1126/science.aay0939&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0043">
<cite>

Ehteram, H.
, Aslanbeigi F., Khorasani E. G., Tolouee M., and Kashani H. H.. 2022. “Expression and Prognostic Significance of Stem Cell Marker CD133 in Survival Rate of Patients With Colon Cancer.” Oncology and Therapy
10, no. 2: 451–461. 10.1007/s40487-022-00205-4.
</cite> [<a href="https://doi.org/10.1007/s40487-022-00205-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9681962/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35980560/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncology%20and%20Therapy&amp;title=Expression%20and%20Prognostic%20Significance%20of%20Stem%20Cell%20Marker%20CD133%20in%20Survival%20Rate%20of%20Patients%20With%20Colon%20Cancer&amp;author=H.%20Ehteram&amp;author=F.%20Aslanbeigi&amp;author=E.%20G.%20Khorasani&amp;author=M.%20Tolouee&amp;author=H.%20H.%20Kashani&amp;volume=10&amp;issue=2&amp;publication_year=2022&amp;pages=451-461&amp;pmid=35980560&amp;doi=10.1007/s40487-022-00205-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0044">
<cite>

Ensign, S. P. F.
, Mathews I. T., Symons M. H., Berens M. E., and Tran N. L.. 2013. “Implications of RHO GTPASE Signaling in Glioma Cell Invasion and Tumor Progression.” Frontiers in Oncology
3: 241. 10.3389/fonc.2013.00241.
</cite> [<a href="https://doi.org/10.3389/fonc.2013.00241" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3790103/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24109588/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Oncology&amp;title=Implications%20of%20RHO%20GTPASE%20Signaling%20in%20Glioma%20Cell%20Invasion%20and%20Tumor%20Progression&amp;author=S.%20P.%20F.%20Ensign&amp;author=I.%20T.%20Mathews&amp;author=M.%20H.%20Symons&amp;author=M.%20E.%20Berens&amp;author=N.%20L.%20Tran&amp;volume=3&amp;publication_year=2013&amp;pages=241&amp;pmid=24109588&amp;doi=10.3389/fonc.2013.00241&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0045">
<cite>

Esen, H.
, Feyzioglu B., Erdi F., Keskin F., Kaya B., and Demir L. S.. 2015. “High Thioredoxin Reductase 1 Expression in Meningiomas Undergoing Malignant Progression.” Brain Tumor Pathology
32, no. 3: 195–201. 10.1007/s10014-015-0212-x.
</cite> [<a href="https://doi.org/10.1007/s10014-015-0212-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25592259/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Tumor%20Pathology&amp;title=High%20Thioredoxin%20Reductase%201%20Expression%20in%20Meningiomas%20Undergoing%20Malignant%20Progression&amp;author=H.%20Esen&amp;author=B.%20Feyzioglu&amp;author=F.%20Erdi&amp;author=F.%20Keskin&amp;author=B.%20Kaya&amp;volume=32&amp;issue=3&amp;publication_year=2015&amp;pages=195-201&amp;pmid=25592259&amp;doi=10.1007/s10014-015-0212-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0046">
<cite>

Fan, X.
, Liang J., Wu Z., Shan X., Qiao H., and Jiang T.. 2017. “Expression of HLA‐DR Genes in Gliomas: Correlation With Clinicopathological Features and Prognosis.” Chinese Neurosurgical Journal
3, no. 1: 27. 10.1186/s41016-017-0090-7.</cite> [<a href="https://doi.org/10.1186/s41016-017-0090-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chinese%20Neurosurgical%20Journal&amp;title=Expression%20of%20HLA%E2%80%90DR%20Genes%20in%20Gliomas:%20Correlation%20With%20Clinicopathological%20Features%20and%20Prognosis&amp;author=X.%20Fan&amp;author=J.%20Liang&amp;author=Z.%20Wu&amp;author=X.%20Shan&amp;author=H.%20Qiao&amp;volume=3&amp;issue=1&amp;publication_year=2017&amp;pages=27&amp;doi=10.1186/s41016-017-0090-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0047">
<cite>

Fan, M.
, Hu J., Xu X., et al. 2024. “Mass Spectrometry‐Based Multi‐Omics Analysis Reveals Distinct Molecular Features in Early and Advanced Stages of Hepatocellular Carcinoma.” Heliyon
10, no. 19: e38182. 10.1016/j.heliyon.2024.e38182.
</cite> [<a href="https://doi.org/10.1016/j.heliyon.2024.e38182" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11456867/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39381095/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Heliyon&amp;title=Mass%20Spectrometry%E2%80%90Based%20Multi%E2%80%90Omics%20Analysis%20Reveals%20Distinct%20Molecular%20Features%20in%20Early%20and%20Advanced%20Stages%20of%20Hepatocellular%20Carcinoma&amp;author=M.%20Fan&amp;author=J.%20Hu&amp;author=X.%20Xu&amp;volume=10&amp;issue=19&amp;publication_year=2024&amp;pages=e38182&amp;pmid=39381095&amp;doi=10.1016/j.heliyon.2024.e38182&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0048">
<cite>

Favaro, R.
, Appolloni I., Pellegatta S., et al. 2014. “SOX2 Is Required to Maintain Cancer Stem Cells in a Mouse Model of High‐Grade Oligodendroglioma.” Cancer Research
74, no. 6: 1833–1844. 10.1158/0008-5472.can-13-1942.
</cite> [<a href="https://doi.org/10.1158/0008-5472.can-13-1942" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24599129/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Research&amp;title=SOX2%20Is%20Required%20to%20Maintain%20Cancer%20Stem%20Cells%20in%20a%20Mouse%20Model%20of%20High%E2%80%90Grade%20Oligodendroglioma&amp;author=R.%20Favaro&amp;author=I.%20Appolloni&amp;author=S.%20Pellegatta&amp;volume=74&amp;issue=6&amp;publication_year=2014&amp;pages=1833-1844&amp;pmid=24599129&amp;doi=10.1158/0008-5472.can-13-1942&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0049">
<cite>

Figarella‐Branger, D.
, Roche P. H., Daniel L., Dufour H., Bianco N., and Pellissier J. F.. 1997. “Cell‐Adhesion Molecules in Human Meningiomas: Correlation With Clinical and Morphological Data.” Neuropathol Appl Neurobiol
23, no. 2: 113–122.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/9160896/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuropathol%20Appl%20Neurobiol&amp;title=Cell%E2%80%90Adhesion%20Molecules%20in%20Human%20Meningiomas:%20Correlation%20With%20Clinical%20and%20Morphological%20Data&amp;author=D.%20Figarella%E2%80%90Branger&amp;author=P.%20H.%20Roche&amp;author=L.%20Daniel&amp;author=H.%20Dufour&amp;author=N.%20Bianco&amp;volume=23&amp;issue=2&amp;publication_year=1997&amp;pages=113-122&amp;pmid=9160896&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0050">
<cite>

Freitag, D.
, Koch A., McLean A. L., Kalff R., and Walter J.. 2017. “Validation of Reference Genes for Expression Studies in Human Meningiomas Under Different Experimental Settings.” Molecular Neurobiology
55, no. 7: 5787–5797. 10.1007/s12035-017-0800-3.
</cite> [<a href="https://doi.org/10.1007/s12035-017-0800-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29079997/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Neurobiology&amp;title=Validation%20of%20Reference%20Genes%20for%20Expression%20Studies%20in%20Human%20Meningiomas%20Under%20Different%20Experimental%20Settings&amp;author=D.%20Freitag&amp;author=A.%20Koch&amp;author=A.%20L.%20McLean&amp;author=R.%20Kalff&amp;author=J.%20Walter&amp;volume=55&amp;issue=7&amp;publication_year=2017&amp;pages=5787-5797&amp;pmid=29079997&amp;doi=10.1007/s12035-017-0800-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0051">
<cite>

Friedman, H. S.
, Kerby T., and Calvert H.. 2000. “Temozolomide and Treatment of Malignant Glioma.” Clinical Cancer Research
6, no. 7: 2585–2597. <a href="https://pubmed.ncbi.nlm.nih.gov/10914698" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/10914698</a>.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/10914698/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Cancer%20Research&amp;title=Temozolomide%20and%20Treatment%20of%20Malignant%20Glioma&amp;author=H.%20S.%20Friedman&amp;author=T.%20Kerby&amp;author=H.%20Calvert&amp;volume=6&amp;issue=7&amp;publication_year=2000&amp;pages=2585-2597&amp;pmid=10914698&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0052">
<cite>

Fung, A. W.
, Sugumar V., Ren A. H., and Kulasingam V.. 2019. “Emerging Role of Clinical Mass Spectrometry in Pathology.” Journal of Clinical Pathology
73, no. 2: 61–69. 10.1136/jclinpath-2019-206269.
</cite> [<a href="https://doi.org/10.1136/jclinpath-2019-206269" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31690564/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Pathology&amp;title=Emerging%20Role%20of%20Clinical%20Mass%20Spectrometry%20in%20Pathology&amp;author=A.%20W.%20Fung&amp;author=V.%20Sugumar&amp;author=A.%20H.%20Ren&amp;author=V.%20Kulasingam&amp;volume=73&amp;issue=2&amp;publication_year=2019&amp;pages=61-69&amp;pmid=31690564&amp;doi=10.1136/jclinpath-2019-206269&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0053">
<cite>

Galani, V.
, Alexiou G., Miliaras G., et al. 2015. “Expression of Stem Cell Marker Nestin and MicroRNA‐21 in Meningiomas.” Turkish Neurosurgery
25: 574–577. 10.5137/1019-5149.jtn.10800-14.2.
</cite> [<a href="https://doi.org/10.5137/1019-5149.jtn.10800-14.2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26242334/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Turkish%20Neurosurgery&amp;title=Expression%20of%20Stem%20Cell%20Marker%20Nestin%20and%20MicroRNA%E2%80%9021%20in%20Meningiomas&amp;author=V.%20Galani&amp;author=G.%20Alexiou&amp;author=G.%20Miliaras&amp;volume=25&amp;publication_year=2015&amp;pages=574-577&amp;pmid=26242334&amp;doi=10.5137/1019-5149.jtn.10800-14.2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0054">
<cite>

Gamallat, Y.
, Alwazan H., Turko R., et al. 2024. “Elevated LAMTOR4 Expression Is Associated With Lethal Prostate Cancer and Its Knockdown Decreases Cell Proliferation, Invasion, and Migration In Vitro.” International Journal of Molecular Sciences
25, no. 15: 8100. 10.3390/ijms25158100.
</cite> [<a href="https://doi.org/10.3390/ijms25158100" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11312415/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39125671/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Molecular%20Sciences&amp;title=Elevated%20LAMTOR4%20Expression%20Is%20Associated%20With%20Lethal%20Prostate%20Cancer%20and%20Its%20Knockdown%20Decreases%20Cell%20Proliferation,%20Invasion,%20and%20Migration%20In%C2%A0Vitro&amp;author=Y.%20Gamallat&amp;author=H.%20Alwazan&amp;author=R.%20Turko&amp;volume=25&amp;issue=15&amp;publication_year=2024&amp;pages=8100&amp;pmid=39125671&amp;doi=10.3390/ijms25158100&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0055">
<cite>

Ghosh, R.
, Gilda J. E., and Gomes A. V.. 2014. “The Necessity of and Strategies for Improving Confidence in the Accuracy of Western Blots.” Expert Review of Proteomics
11, no. 5: 549–560. 10.1586/14789450.2014.939635.
</cite> [<a href="https://doi.org/10.1586/14789450.2014.939635" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4791038/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25059473/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Review%20of%20Proteomics&amp;title=The%20Necessity%20of%20and%20Strategies%20for%20Improving%20Confidence%20in%20the%20Accuracy%20of%20Western%20Blots&amp;author=R.%20Ghosh&amp;author=J.%20E.%20Gilda&amp;author=A.%20V.%20Gomes&amp;volume=11&amp;issue=5&amp;publication_year=2014&amp;pages=549-560&amp;pmid=25059473&amp;doi=10.1586/14789450.2014.939635&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0056">
<cite>

Ghosh, C.
, Xing Y., Li S., et al. 2021. “Sorting Nexin 6 Interacts With Cullin3 and Regulates Programmed Death Ligand 1 Expression.” FEBS Letters
595, no. 20: 2558–2569. 10.1002/1873-3468.14191.
</cite> [<a href="https://doi.org/10.1002/1873-3468.14191" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8545913/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34510437/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FEBS%20Letters&amp;title=Sorting%20Nexin%206%20Interacts%20With%20Cullin3%20and%20Regulates%20Programmed%20Death%20Ligand%201%20Expression&amp;author=C.%20Ghosh&amp;author=Y.%20Xing&amp;author=S.%20Li&amp;volume=595&amp;issue=20&amp;publication_year=2021&amp;pages=2558-2569&amp;pmid=34510437&amp;doi=10.1002/1873-3468.14191&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0057">
<cite>

Giambra, M.
, Di Cristofori A., Raimondo F., et al. 2024. “Vacuolar Proton‐Translocating ATPAsE May Take Part in the Drug Resistance Phenotype of Glioma Stem Cells.” International Journal of Molecular Sciences
25, no. 5: 2743. 10.3390/ijms25052743.
</cite> [<a href="https://doi.org/10.3390/ijms25052743" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10932054/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38473989/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Molecular%20Sciences&amp;title=Vacuolar%20Proton%E2%80%90Translocating%20ATPAsE%20May%20Take%20Part%20in%20the%20Drug%20Resistance%20Phenotype%20of%20Glioma%20Stem%20Cells&amp;author=M.%20Giambra&amp;author=A.%20Di%20Cristofori&amp;author=F.%20Raimondo&amp;volume=25&amp;issue=5&amp;publication_year=2024&amp;pages=2743&amp;pmid=38473989&amp;doi=10.3390/ijms25052743&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0058">
<cite>

Girolamo, F.
, Lante I., Muraca M., and Putignani L.. 2013. “The Role of Mass Spectrometry in the “Omics” Era.” Current Organic Chemistry
17, no. 23: 2891–2905. 10.2174/1385272817888131118162725.
</cite> [<a href="https://doi.org/10.2174/1385272817888131118162725" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3873040/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24376367/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Organic%20Chemistry&amp;title=The%20Role%20of%20Mass%20Spectrometry%20in%20the%20%E2%80%9COmics%E2%80%9D%20Era&amp;author=F.%20Girolamo&amp;author=I.%20Lante&amp;author=M.%20Muraca&amp;author=L.%20Putignani&amp;volume=17&amp;issue=23&amp;publication_year=2013&amp;pages=2891-2905&amp;pmid=24376367&amp;doi=10.2174/1385272817888131118162725&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0059">
<cite>

Givant‐Horwitz, V.
, Davidson B., and Reich R.. 2004. “Laminin‐Induced Signaling in Tumor Cells.” Cancer Research
64, no. 10: 3572–3579. 10.1158/0008-5472.can-03-3424.
</cite> [<a href="https://doi.org/10.1158/0008-5472.can-03-3424" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15150114/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Research&amp;title=Laminin%E2%80%90Induced%20Signaling%20in%20Tumor%20Cells&amp;author=V.%20Givant%E2%80%90Horwitz&amp;author=B.%20Davidson&amp;author=R.%20Reich&amp;volume=64&amp;issue=10&amp;publication_year=2004&amp;pages=3572-3579&amp;pmid=15150114&amp;doi=10.1158/0008-5472.can-03-3424&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0060">
<cite>

Godinez, A.
, Rajput R., Chitranshi N., et al. 2022. “Neuroserpin, a Crucial Regulator for Axogenesis, Synaptic Modelling and Cell–Cell Interactions in the Pathophysiology of Neurological Disease.” Cellular and Molecular Life Sciences
79, no. 3: 172. 10.1007/s00018-022-04185-6.
</cite> [<a href="https://doi.org/10.1007/s00018-022-04185-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8897380/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35244780/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cellular%20and%20Molecular%20Life%20Sciences&amp;title=Neuroserpin,%20a%20Crucial%20Regulator%20for%20Axogenesis,%20Synaptic%20Modelling%20and%20Cell%E2%80%93Cell%20Interactions%20in%20the%20Pathophysiology%20of%20Neurological%20Disease&amp;author=A.%20Godinez&amp;author=R.%20Rajput&amp;author=N.%20Chitranshi&amp;volume=79&amp;issue=3&amp;publication_year=2022&amp;pages=172&amp;pmid=35244780&amp;doi=10.1007/s00018-022-04185-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0061">
<cite>

Han, C. H.
, and Batchelor T. T.. 2017. “Isocitrate Dehydrogenase Mutation as a Therapeutic Target in Gliomas.” Chinese Clinical Oncology
6, no. 3: 33–33. 10.21037/cco.2017.06.11.
</cite> [<a href="https://doi.org/10.21037/cco.2017.06.11" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28705010/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chinese%20Clinical%20Oncology&amp;title=Isocitrate%20Dehydrogenase%20Mutation%20as%20a%20Therapeutic%20Target%20in%20Gliomas&amp;author=C.%20H.%20Han&amp;author=T.%20T.%20Batchelor&amp;volume=6&amp;issue=3&amp;publication_year=2017&amp;pages=33-33&amp;pmid=28705010&amp;doi=10.21037/cco.2017.06.11&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0062">
<cite>

Han, S.
, Liu Y., Cai S. J., et al. 2020. “IDH Mutation in Glioma: Molecular Mechanisms and Potential Therapeutic Targets.” British Journal of Cancer
122, no. 11: 1580–1589. 10.1038/s41416-020-0814-x.
</cite> [<a href="https://doi.org/10.1038/s41416-020-0814-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7250901/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32291392/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Cancer&amp;title=IDH%20Mutation%20in%20Glioma:%20Molecular%20Mechanisms%20and%20Potential%20Therapeutic%20Targets&amp;author=S.%20Han&amp;author=Y.%20Liu&amp;author=S.%20J.%20Cai&amp;volume=122&amp;issue=11&amp;publication_year=2020&amp;pages=1580-1589&amp;pmid=32291392&amp;doi=10.1038/s41416-020-0814-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0063">
<cite>

Hao, C.
, Duan H., Li H., et al. 2018. “Knockdown of MRPL42 Suppresses Glioma Cell Proliferation by Inducing Cell Cycle Arrest and Apoptosis.” Bioscience Reports
38, no. 2: BSR20171456. 10.1042/bsr20171456.
</cite> [<a href="https://doi.org/10.1042/bsr20171456" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5920136/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29531015/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Bioscience%20Reports&amp;title=Knockdown%20of%20MRPL42%20Suppresses%20Glioma%20Cell%20Proliferation%20by%20Inducing%20Cell%20Cycle%20Arrest%20and%20Apoptosis&amp;author=C.%20Hao&amp;author=H.%20Duan&amp;author=H.%20Li&amp;volume=38&amp;issue=2&amp;publication_year=2018&amp;pages=BSR20171456&amp;pmid=29531015&amp;doi=10.1042/bsr20171456&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0064">
<cite>

He, Q.
, and Li Z.. 2021. “The Dysregulated Expression and Functional Effect of CaMK2 in Cancer.” Cancer Cell International
21, no. 1: 326. 10.1186/s12935-021-02030-7.
</cite> [<a href="https://doi.org/10.1186/s12935-021-02030-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8243487/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34193145/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Cell%20International&amp;title=The%20Dysregulated%20Expression%20and%20Functional%20Effect%20of%20CaMK2%20in%20Cancer&amp;author=Q.%20He&amp;author=Z.%20Li&amp;volume=21&amp;issue=1&amp;publication_year=2021&amp;pages=326&amp;pmid=34193145&amp;doi=10.1186/s12935-021-02030-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0065">
<cite>

He, W.
, Zhang Z., Tan Z., et al. 2024. “PSMB2 Plays An Oncogenic Role in Glioma and Correlates to the Immune Microenvironment.” Scientific Reports
14, no. 1: 5861. 10.1038/s41598-024-56493-5.
</cite> [<a href="https://doi.org/10.1038/s41598-024-56493-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10928079/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38467767/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scientific%20Reports&amp;title=PSMB2%20Plays%20An%20Oncogenic%20Role%20in%20Glioma%20and%20Correlates%20to%20the%20Immune%20Microenvironment&amp;author=W.%20He&amp;author=Z.%20Zhang&amp;author=Z.%20Tan&amp;volume=14&amp;issue=1&amp;publication_year=2024&amp;pages=5861&amp;pmid=38467767&amp;doi=10.1038/s41598-024-56493-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0066">
<cite>

Herrmann, P. C.
, Liotta L. A., and Petricoin E. F.. 2001. “Cancer Proteomics: The State of the Art.” Disease Markers
17, no. 2: 49–57. 10.1155/2001/327047.
</cite> [<a href="https://doi.org/10.1155/2001/327047" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3851073/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11673651/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Disease%20Markers&amp;title=Cancer%20Proteomics:%20The%20State%20of%20the%20Art&amp;author=P.%20C.%20Herrmann&amp;author=L.%20A.%20Liotta&amp;author=E.%20F.%20Petricoin&amp;volume=17&amp;issue=2&amp;publication_year=2001&amp;pages=49-57&amp;pmid=11673651&amp;doi=10.1155/2001/327047&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0067">
<cite>

Hong, W.
, Shan C., Ye M., et al. 2021. “Case Report: Identification of a Novel GNAS Mutation and 1p/22q Co‐Deletion in a Patient With Multiple Recurrent Meningiomas Sensitive to Sunitinib.” Frontiers in Oncology
11: 737523. 10.3389/fonc.2021.737523.
</cite> [<a href="https://doi.org/10.3389/fonc.2021.737523" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8554081/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34722286/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Oncology&amp;title=Case%20Report:%20Identification%20of%20a%20Novel%20GNAS%20Mutation%20and%201p/22q%20Co%E2%80%90Deletion%20in%20a%20Patient%20With%20Multiple%20Recurrent%20Meningiomas%20Sensitive%20to%20Sunitinib&amp;author=W.%20Hong&amp;author=C.%20Shan&amp;author=M.%20Ye&amp;volume=11&amp;publication_year=2021&amp;pages=737523&amp;pmid=34722286&amp;doi=10.3389/fonc.2021.737523&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0068">
<cite>

Hristova, J.
, and Svinarov D.. 2022. “Enhancing Precision Medicine Through Clinical Mass Spectrometry Platform.” Biotechnology &amp; Biotechnological Equipment
36, no. 1: 107–117. 10.1080/13102818.2022.2053342.</cite> [<a href="https://doi.org/10.1080/13102818.2022.2053342" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biotechnology%20&amp;%20Biotechnological%20Equipment&amp;title=Enhancing%20Precision%20Medicine%20Through%20Clinical%20Mass%20Spectrometry%20Platform&amp;author=J.%20Hristova&amp;author=D.%20Svinarov&amp;volume=36&amp;issue=1&amp;publication_year=2022&amp;pages=107-117&amp;doi=10.1080/13102818.2022.2053342&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0069">
<cite>

Huang, L. J.
, Zhan S. T., Pan Y. Q., Bao W., and Yang Y.. 2023. “The Role of Vps4 in Cancer Development.” Frontiers in Oncology
13: 1203359. 10.3389/fonc.2023.1203359.
</cite> [<a href="https://doi.org/10.3389/fonc.2023.1203359" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10315677/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37404768/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Oncology&amp;title=The%20Role%20of%20Vps4%20in%20Cancer%20Development&amp;author=L.%20J.%20Huang&amp;author=S.%20T.%20Zhan&amp;author=Y.%20Q.%20Pan&amp;author=W.%20Bao&amp;author=Y.%20Yang&amp;volume=13&amp;publication_year=2023&amp;pages=1203359&amp;pmid=37404768&amp;doi=10.3389/fonc.2023.1203359&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0070">
<cite>

Ibrahim, R. A.
, Shash L. S., and Elgohary S. A.. 2021. “FOXM1 and β‐Catenin in Meningiomas.” Egyptian Journal of Pathology
41, no. 2: 137–145. 10.4103/egjp.egjp_44_21.</cite> [<a href="https://doi.org/10.4103/egjp.egjp_44_21" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Egyptian%20Journal%20of%20Pathology&amp;title=FOXM1%20and%20%CE%B2%E2%80%90Catenin%20in%20Meningiomas&amp;author=R.%20A.%20Ibrahim&amp;author=L.%20S.%20Shash&amp;author=S.%20A.%20Elgohary&amp;volume=41&amp;issue=2&amp;publication_year=2021&amp;pages=137-145&amp;doi=10.4103/egjp.egjp_44_21&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0071">
<cite>

Inoue, A.
, Ohnishi T., Nishikawa M., et al. 2023. “A Narrative Review on CD44's Role in Glioblastoma Invasion, Proliferation, and Tumor Recurrence.” Cancers
15, no. 19: 4898. 10.3390/cancers15194898.
</cite> [<a href="https://doi.org/10.3390/cancers15194898" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10572085/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37835592/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers&amp;title=A%20Narrative%20Review%20on%20CD44's%20Role%20in%20Glioblastoma%20Invasion,%20Proliferation,%20and%20Tumor%20Recurrence&amp;author=A.%20Inoue&amp;author=T.%20Ohnishi&amp;author=M.%20Nishikawa&amp;volume=15&amp;issue=19&amp;publication_year=2023&amp;pages=4898&amp;pmid=37835592&amp;doi=10.3390/cancers15194898&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0072">
<cite>

Izdebska, M.
, Zielińska W., Grzanka D., and Gagat M.. 2018. “The Role of Actin Dynamics and Actin‐Binding Proteins Expression in Epithelial‐To‐Mesenchymal Transition and Its Association With Cancer Progression and Evaluation of Possible Therapeutic Targets.” BioMed Research International
2018: 1–13. 10.1155/2018/4578373.</cite> [<a href="https://doi.org/10.1155/2018/4578373" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5822767/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29581975/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BioMed%20Research%20International&amp;title=The%20Role%20of%20Actin%20Dynamics%20and%20Actin%E2%80%90Binding%20Proteins%20Expression%20in%20Epithelial%E2%80%90To%E2%80%90Mesenchymal%20Transition%20and%20Its%20Association%20With%20Cancer%20Progression%20and%20Evaluation%20of%20Possible%20Therapeutic%20Targets&amp;author=M.%20Izdebska&amp;author=W.%20Zieli%C5%84ska&amp;author=D.%20Grzanka&amp;author=M.%20Gagat&amp;volume=2018&amp;publication_year=2018&amp;pages=1-13&amp;pmid=29581975&amp;doi=10.1155/2018/4578373&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0073">
<cite>

Ji, M.
, Ren L., Lv Y., et al. 2020. “Small Nuclear Ribonucleoprotein Polypeptide N Accelerates Malignant Progression and Poor Prognosis in Colorectal Cancer Transcriptionally Regulated by E2F8.” Frontiers in Oncology
10: 561287. 10.3389/fonc.2020.561287.
</cite> [<a href="https://doi.org/10.3389/fonc.2020.561287" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7669248/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33224876/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Oncology&amp;title=Small%20Nuclear%20Ribonucleoprotein%20Polypeptide%20N%20Accelerates%20Malignant%20Progression%20and%20Poor%20Prognosis%20in%20Colorectal%20Cancer%20Transcriptionally%20Regulated%20by%20E2F8&amp;author=M.%20Ji&amp;author=L.%20Ren&amp;author=Y.%20Lv&amp;volume=10&amp;publication_year=2020&amp;pages=561287&amp;pmid=33224876&amp;doi=10.3389/fonc.2020.561287&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0074">
<cite>

Jia, Y.
, Wang N., Zhang Y., Xue D., Lou H., and Liu X.. 2020. “Alteration in the Function and Expression of SLC and ABC Transporters in the Neurovascular Unit in Alzheimer's Disease and the Clinical Significance.” Aging and Disease
11, no. 2: 390–404. 10.14336/ad.2019.0519.
</cite> [<a href="https://doi.org/10.14336/ad.2019.0519" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7069460/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32257549/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Aging%20and%20Disease&amp;title=Alteration%20in%20the%20Function%20and%20Expression%20of%20SLC%20and%20ABC%20Transporters%20in%20the%20Neurovascular%20Unit%20in%20Alzheimer's%20Disease%20and%20the%20Clinical%20Significance&amp;author=Y.%20Jia&amp;author=N.%20Wang&amp;author=Y.%20Zhang&amp;author=D.%20Xue&amp;author=H.%20Lou&amp;volume=11&amp;issue=2&amp;publication_year=2020&amp;pages=390-404&amp;pmid=32257549&amp;doi=10.14336/ad.2019.0519&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0075">
<cite>

Jiang, X.
, Wu M., Albo J., and Rao Q.. 2021. “Non‐Specific Binding and Cross‐Reaction of ELISA: A Case Study of Porcine Hemoglobin Detection.” Food
10, no. 8: 1708. 10.3390/foods10081708.</cite> [<a href="https://doi.org/10.3390/foods10081708" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8394222/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34441486/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Food&amp;title=Non%E2%80%90Specific%20Binding%20and%20Cross%E2%80%90Reaction%20of%20ELISA:%20A%20Case%20Study%20of%20Porcine%20Hemoglobin%20Detection&amp;author=X.%20Jiang&amp;author=M.%20Wu&amp;author=J.%20Albo&amp;author=Q.%20Rao&amp;volume=10&amp;issue=8&amp;publication_year=2021&amp;pages=1708&amp;pmid=34441486&amp;doi=10.3390/foods10081708&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0076">
<cite>

Jiang, X.
, Yang L., Gao Q., et al. 2022. “The Role of RAB GTPASEs and Its Potential in Predicting Immunotherapy Response and Prognosis in Colorectal Cancer.” Frontiers in Genetics
13: 828373. 10.3389/fgene.2022.828373.
</cite> [<a href="https://doi.org/10.3389/fgene.2022.828373" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8833848/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35154286/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Genetics&amp;title=The%20Role%20of%20RAB%20GTPASEs%20and%20Its%20Potential%20in%20Predicting%20Immunotherapy%20Response%20and%20Prognosis%20in%20Colorectal%20Cancer&amp;author=X.%20Jiang&amp;author=L.%20Yang&amp;author=Q.%20Gao&amp;volume=13&amp;publication_year=2022&amp;pages=828373&amp;pmid=35154286&amp;doi=10.3389/fgene.2022.828373&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0077">
<cite>

Jin, H.
, Tang Y., Yang L., et al. 2021. “RAB GTPases: Central Coordinators of Membrane Trafficking in Cancer.” Frontiers in Cell and Developmental Biology
9: 648384. 10.3389/fcell.2021.648384.
</cite> [<a href="https://doi.org/10.3389/fcell.2021.648384" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8204108/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34141705/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Cell%20and%20Developmental%20Biology&amp;title=RAB%20GTPases:%20Central%20Coordinators%20of%20Membrane%20Trafficking%20in%20Cancer&amp;author=H.%20Jin&amp;author=Y.%20Tang&amp;author=L.%20Yang&amp;volume=9&amp;publication_year=2021&amp;pages=648384&amp;pmid=34141705&amp;doi=10.3389/fcell.2021.648384&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0078">
<cite>

Joo, K. M.
, Kim J., Jin J., et al. 2013. “Patient‐Specific Orthotopic Glioblastoma Xenograft Models Recapitulate the Histopathology and Biology of Human Glioblastomas In Situ.” Cell Reports
3, no. 1: 260–273. 10.1016/j.celrep.2012.12.013.
</cite> [<a href="https://doi.org/10.1016/j.celrep.2012.12.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23333277/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Reports&amp;title=Patient%E2%80%90Specific%20Orthotopic%20Glioblastoma%20Xenograft%20Models%20Recapitulate%20the%20Histopathology%20and%20Biology%20of%20Human%20Glioblastomas%20In%C2%A0Situ&amp;author=K.%20M.%20Joo&amp;author=J.%20Kim&amp;author=J.%20Jin&amp;volume=3&amp;issue=1&amp;publication_year=2013&amp;pages=260-273&amp;pmid=23333277&amp;doi=10.1016/j.celrep.2012.12.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0079">
<cite>

Jung, N.
, Kwon H., and Jung H.. 2017. “Downregulation of Mitochondrial UQCRB Inhibits Cancer Stem Cell‐Like Properties in Glioblastoma.” International Journal of Oncology
52, no. 1: 241–251. 10.3892/ijo.2017.4191.
</cite> [<a href="https://doi.org/10.3892/ijo.2017.4191" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29115404/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Oncology&amp;title=Downregulation%20of%20Mitochondrial%20UQCRB%20Inhibits%20Cancer%20Stem%20Cell%E2%80%90Like%20Properties%20in%20Glioblastoma&amp;author=N.%20Jung&amp;author=H.%20Kwon&amp;author=H.%20Jung&amp;volume=52&amp;issue=1&amp;publication_year=2017&amp;pages=241-251&amp;pmid=29115404&amp;doi=10.3892/ijo.2017.4191&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0080">
<cite>

Kanno, H.
, Nishihara H., Wang L., et al. 2013. “Expression of CD163 Prevents Apoptosis Through the Production of Granulocyte Colony‐Stimulating Factor in Meningioma.” Neuro‐Oncology
15, no. 7: 853–864. 10.1093/neuonc/not028.
</cite> [<a href="https://doi.org/10.1093/neuonc/not028" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3688010/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23539121/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuro%E2%80%90Oncology&amp;title=Expression%20of%20CD163%20Prevents%20Apoptosis%20Through%20the%20Production%20of%20Granulocyte%20Colony%E2%80%90Stimulating%20Factor%20in%20Meningioma&amp;author=H.%20Kanno&amp;author=H.%20Nishihara&amp;author=L.%20Wang&amp;volume=15&amp;issue=7&amp;publication_year=2013&amp;pages=853-864&amp;pmid=23539121&amp;doi=10.1093/neuonc/not028&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0081">
<cite>

Karantza, V.

2010. “Keratins in Health and Cancer: More Than Mere Epithelial Cell Markers.” Oncogene
30, no. 2: 127–138. 10.1038/onc.2010.456.
</cite> [<a href="https://doi.org/10.1038/onc.2010.456" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3155291/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20890307/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Keratins%20in%20Health%20and%20Cancer:%20More%20Than%20Mere%20Epithelial%20Cell%20Markers&amp;author=V.%20Karantza&amp;volume=30&amp;issue=2&amp;publication_year=2010&amp;pages=127-138&amp;pmid=20890307&amp;doi=10.1038/onc.2010.456&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0082">
<cite>

Katz, L. M.
, Hielscher T., Liechty B., et al. 2018. “Loss of Histone H3K27me3 Identifies a Subset of Meningiomas With Increased Risk of Recurrence.” Acta Neuropathologica
135, no. 6: 955–963. 10.1007/s00401-018-1844-9.
</cite> [<a href="https://doi.org/10.1007/s00401-018-1844-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29627952/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Neuropathologica&amp;title=Loss%20of%20Histone%20H3K27me3%20Identifies%20a%20Subset%20of%20Meningiomas%20With%20Increased%20Risk%20of%20Recurrence&amp;author=L.%20M.%20Katz&amp;author=T.%20Hielscher&amp;author=B.%20Liechty&amp;volume=135&amp;issue=6&amp;publication_year=2018&amp;pages=955-963&amp;pmid=29627952&amp;doi=10.1007/s00401-018-1844-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0083">
<cite>

Kellogg, M. K.
, Tikhonova E. B., and Karamyshev A. L.. 2022. “Signal Recognition Particle in Human Diseases.” Frontiers in Genetics
13: 898083. 10.3389/fgene.2022.898083.
</cite> [<a href="https://doi.org/10.3389/fgene.2022.898083" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9214365/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35754847/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Genetics&amp;title=Signal%20Recognition%20Particle%20in%20Human%20Diseases&amp;author=M.%20K.%20Kellogg&amp;author=E.%20B.%20Tikhonova&amp;author=A.%20L.%20Karamyshev&amp;volume=13&amp;publication_year=2022&amp;pages=898083&amp;pmid=35754847&amp;doi=10.3389/fgene.2022.898083&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0084">
<cite>

Kim, Y. Z.

2014. “Altered Histone Modifications in Gliomas.” Brain Tumor Research and Treatment
2, no. 1: 7. 10.14791/btrt.2014.2.1.7.
</cite> [<a href="https://doi.org/10.14791/btrt.2014.2.1.7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4049557/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24926467/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Tumor%20Research%20and%20Treatment&amp;title=Altered%20Histone%20Modifications%20in%20Gliomas&amp;author=Y.%20Z.%20Kim&amp;volume=2&amp;issue=1&amp;publication_year=2014&amp;pages=7&amp;pmid=24926467&amp;doi=10.14791/btrt.2014.2.1.7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0085">
<cite>

Klotz, S.
, Matula C., Pones M., et al. 2018. “Clinical Neuropathology Image 6‐2018: Metastasis of Breast Carcinoma to Meningioma.” Clinical Neuropathology
37, no. 6: 252–253. 10.5414/np301150.
</cite> [<a href="https://doi.org/10.5414/np301150" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6350239/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30343679/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Neuropathology&amp;title=Clinical%20Neuropathology%20Image%206%E2%80%902018:%20Metastasis%20of%20Breast%20Carcinoma%20to%20Meningioma&amp;author=S.%20Klotz&amp;author=C.%20Matula&amp;author=M.%20Pones&amp;volume=37&amp;issue=6&amp;publication_year=2018&amp;pages=252-253&amp;pmid=30343679&amp;doi=10.5414/np301150&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0086">
<cite>

Krishna, K. V.
, Dubey S. K., Singhvi G., Gupta G., and Kesharwani P.. 2020. “MAPK Pathway: Potential Role in Glioblastoma Multiforme.” Interdisciplinary Neurosurgery
23: 100901. 10.1016/j.inat.2020.100901.</cite> [<a href="https://doi.org/10.1016/j.inat.2020.100901" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Interdisciplinary%20Neurosurgery&amp;title=MAPK%20Pathway:%20Potential%20Role%20in%20Glioblastoma%20Multiforme&amp;author=K.%20V.%20Krishna&amp;author=S.%20K.%20Dubey&amp;author=G.%20Singhvi&amp;author=G.%20Gupta&amp;author=P.%20Kesharwani&amp;volume=23&amp;publication_year=2020&amp;pages=100901&amp;doi=10.1016/j.inat.2020.100901&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0087">
<cite>

Kwon, Y. W.
, Jo H., Bae S., et al. 2021. “Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery.” Frontiers in Medicine
8: 747333. 10.3389/fmed.2021.747333.
</cite> [<a href="https://doi.org/10.3389/fmed.2021.747333" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8492935/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34631760/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Medicine&amp;title=Application%20of%20Proteomics%20in%20Cancer:%20Recent%20Trends%20and%20Approaches%20for%20Biomarkers%20Discovery&amp;author=Y.%20W.%20Kwon&amp;author=H.%20Jo&amp;author=S.%20Bae&amp;volume=8&amp;publication_year=2021&amp;pages=747333&amp;pmid=34631760&amp;doi=10.3389/fmed.2021.747333&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0088">
<cite>

Leclair, N. K.
, Choudury A., Chen W. C., et al. 2024. “RNA Splicing as a Biomarker and Phenotypic Driver of Meningioma DNA‐Methylation Groups.” Neuro‐Oncology
26, no. 12: 2222–2236. 10.1093/neuonc/noae150.
</cite> [<a href="https://doi.org/10.1093/neuonc/noae150" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11630566/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39093629/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuro%E2%80%90Oncology&amp;title=RNA%20Splicing%20as%20a%20Biomarker%20and%20Phenotypic%20Driver%20of%20Meningioma%20DNA%E2%80%90Methylation%20Groups&amp;author=N.%20K.%20Leclair&amp;author=A.%20Choudury&amp;author=W.%20C.%20Chen&amp;volume=26&amp;issue=12&amp;publication_year=2024&amp;pages=2222-2236&amp;pmid=39093629&amp;doi=10.1093/neuonc/noae150&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0089">
<cite>

Lee, J.
, Solomon D. A., and Tihan T.. 2017. “Erratum to: The Role of Histone Modifications and Telomere Alterations in the Pathogenesis of Diffuse Gliomas in Adults and Children.” Journal of Neuro‐Oncology
132, no. 1: 13. 10.1007/s11060-017-2376-1.
</cite> [<a href="https://doi.org/10.1007/s11060-017-2376-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28176031/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neuro%E2%80%90Oncology&amp;title=Erratum%20to:%20The%20Role%20of%20Histone%20Modifications%20and%20Telomere%20Alterations%20in%20the%20Pathogenesis%20of%20Diffuse%20Gliomas%20in%20Adults%20and%20Children&amp;author=J.%20Lee&amp;author=D.%20A.%20Solomon&amp;author=T.%20Tihan&amp;volume=132&amp;issue=1&amp;publication_year=2017&amp;pages=13&amp;pmid=28176031&amp;doi=10.1007/s11060-017-2376-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0090">
<cite>

Lee, H.
, Kim W., Kang H., et al. 2021. “Upregulation of LAMB1 via ERK/C‐JUN Axis Promotes Gastric Cancer Growth and Motility.” International Journal of Molecular Sciences
22, no. 2: 626. 10.3390/ijms22020626.
</cite> [<a href="https://doi.org/10.3390/ijms22020626" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7826975/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33435161/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Molecular%20Sciences&amp;title=Upregulation%20of%20LAMB1%20via%20ERK/C%E2%80%90JUN%20Axis%20Promotes%20Gastric%20Cancer%20Growth%20and%20Motility&amp;author=H.%20Lee&amp;author=W.%20Kim&amp;author=H.%20Kang&amp;volume=22&amp;issue=2&amp;publication_year=2021&amp;pages=626&amp;pmid=33435161&amp;doi=10.3390/ijms22020626&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0217">
<cite>

Lee, J. X. T.
, Tan W. R., Low Z. S., et al. 2023. “YWHAG Deficiency Disrupts the EMT‐Associated Network to Induce Oxidative Cell Death and Prevent Metastasis.” Advanced Science (Weinheim, Baden‐Württemberg, Germany)
10, no. 31: e2301714. 10.1002/advs.202301714.
</cite> [<a href="https://doi.org/10.1002/advs.202301714" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10625110/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37759388/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Advanced%20Science%20(Weinheim,%20Baden%E2%80%90W%C3%BCrttemberg,%20Germany)&amp;title=YWHAG%20Deficiency%20Disrupts%20the%20EMT%E2%80%90Associated%20Network%20to%20Induce%20Oxidative%20Cell%20Death%20and%20Prevent%20Metastasis&amp;author=J.%20X.%20T.%20Lee&amp;author=W.%20R.%20Tan&amp;author=Z.%20S.%20Low&amp;volume=10&amp;issue=31&amp;publication_year=2023&amp;pages=e2301714&amp;pmid=37759388&amp;doi=10.1002/advs.202301714&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0092">
<cite>

Lei, Z.
, Cai H., and Yan Q.. 2024. “NF2 Can Mediate the Expression of CAMK2A in a Tissue Specific Manner.” Scientific Reports
14, no. 1: 31992. 10.1038/s41598-024-83553-7.
</cite> [<a href="https://doi.org/10.1038/s41598-024-83553-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11685432/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39738767/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scientific%20Reports&amp;title=NF2%20Can%20Mediate%20the%20Expression%20of%20CAMK2A%20in%20a%20Tissue%20Specific%20Manner&amp;author=Z.%20Lei&amp;author=H.%20Cai&amp;author=Q.%20Yan&amp;volume=14&amp;issue=1&amp;publication_year=2024&amp;pages=31992&amp;pmid=39738767&amp;doi=10.1038/s41598-024-83553-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0093">
<cite>

Li, L.
, Feng R., Xu Q., et al. 2017. “Expression of the β3 Subunit of Na+/K+‐ATPase Is Increased in Gastric Cancer and Regulates Gastric Cancer Cell Progression and Prognosis via the PI3/AKT Pathway.” Oncotarget
8, no. 48: 84285–84299. 10.18632/oncotarget.20894.
</cite> [<a href="https://doi.org/10.18632/oncotarget.20894" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5663595/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29137423/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Expression%20of%20the%20%CE%B23%20Subunit%20of%20Na+/K+%E2%80%90ATPase%20Is%20Increased%20in%20Gastric%20Cancer%20and%20Regulates%20Gastric%20Cancer%20Cell%20Progression%20and%20Prognosis%20via%20the%20PI3/AKT%20Pathway&amp;author=L.%20Li&amp;author=R.%20Feng&amp;author=Q.%20Xu&amp;volume=8&amp;issue=48&amp;publication_year=2017&amp;pages=84285-84299&amp;pmid=29137423&amp;doi=10.18632/oncotarget.20894&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0094">
<cite>

Li, X.
, Nie S., Lv Z., et al. 2021. “Overexpression of Annexin A2 Promotes Proliferation by Forming a Glypican 1/c‐Myc Positive Feedback Loop: Prognostic Significance in Human Glioma.” Cell Death and Disease
12, no. 3: 261. 10.1038/s41419-021-03547-5.
</cite> [<a href="https://doi.org/10.1038/s41419-021-03547-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7954792/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33712571/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20and%20Disease&amp;title=Overexpression%20of%20Annexin%20A2%20Promotes%20Proliferation%20by%20Forming%20a%20Glypican%201/c%E2%80%90Myc%20Positive%20Feedback%20Loop:%20Prognostic%20Significance%20in%20Human%20Glioma&amp;author=X.%20Li&amp;author=S.%20Nie&amp;author=Z.%20Lv&amp;volume=12&amp;issue=3&amp;publication_year=2021&amp;pages=261&amp;pmid=33712571&amp;doi=10.1038/s41419-021-03547-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0095">
<cite>

Li, J.
, Zhou Z., Zhang J., et al. 2024. “TUBB2B Regulates Epithelial‐Mesenchymal Transition via Interaction With Vimentin to Promote Glioma Migration and Invasion.” Cancer Cell International
24, no. 1: 423. 10.1186/s12935-024-03618-5.
</cite> [<a href="https://doi.org/10.1186/s12935-024-03618-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11662515/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39707368/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Cell%20International&amp;title=TUBB2B%20Regulates%20Epithelial%E2%80%90Mesenchymal%20Transition%20via%20Interaction%20With%20Vimentin%20to%20Promote%20Glioma%20Migration%20and%20Invasion&amp;author=J.%20Li&amp;author=Z.%20Zhou&amp;author=J.%20Zhang&amp;volume=24&amp;issue=1&amp;publication_year=2024&amp;pages=423&amp;pmid=39707368&amp;doi=10.1186/s12935-024-03618-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0096">
<cite>

Li, Z.
, Wang X., Li Q., Wang X., and Ding X.. 2025. “Association of Mitochondrial Ribosomal Protein S33 Expression With Poor Prognosis in Glioma.” Cancer Plus
0, no. 0: 4987. 10.36922/cp.4987.</cite> [<a href="https://doi.org/10.36922/cp.4987" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Plus&amp;title=Association%20of%20Mitochondrial%20Ribosomal%20Protein%20S33%20Expression%20With%20Poor%20Prognosis%20in%20Glioma&amp;author=Z.%20Li&amp;author=X.%20Wang&amp;author=Q.%20Li&amp;author=X.%20Wang&amp;author=X.%20Ding&amp;volume=0&amp;issue=0&amp;publication_year=2025&amp;pages=4987&amp;doi=10.36922/cp.4987&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0097">
<cite>

Lim, Y. S.
, Kim M. K., Park B. J., Kim T. S., and Lim Y. J.. 2013. “Long Term Clinical Outcomes of Malignant Meningiomas.” Brain Tumor Research and Treatment
1, no. 2: 85. 10.14791/btrt.2013.1.2.85.
</cite> [<a href="https://doi.org/10.14791/btrt.2013.1.2.85" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4027110/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24904897/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Tumor%20Research%20and%20Treatment&amp;title=Long%20Term%20Clinical%20Outcomes%20of%20Malignant%20Meningiomas&amp;author=Y.%20S.%20Lim&amp;author=M.%20K.%20Kim&amp;author=B.%20J.%20Park&amp;author=T.%20S.%20Kim&amp;author=Y.%20J.%20Lim&amp;volume=1&amp;issue=2&amp;publication_year=2013&amp;pages=85&amp;pmid=24904897&amp;doi=10.14791/btrt.2013.1.2.85&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0098">
<cite>

Lin, S.
, and Garcia B. A.. 2012. “Examining Histone Posttranslational Modification Patterns by High‐Resolution Mass Spectrometry.” Methods in Enzymology
512: 3–28. 10.1016/b978-0-12-391940-3.00001-9.
</cite> [<a href="https://doi.org/10.1016/b978-0-12-391940-3.00001-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4116684/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22910200/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Methods%20in%20Enzymology&amp;title=Examining%20Histone%20Posttranslational%20Modification%20Patterns%20by%20High%E2%80%90Resolution%20Mass%20Spectrometry&amp;author=S.%20Lin&amp;author=B.%20A.%20Garcia&amp;volume=512&amp;publication_year=2012&amp;pages=3-28&amp;pmid=22910200&amp;doi=10.1016/b978-0-12-391940-3.00001-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0099">
<cite>

Liu, Y.
, Sturgis C. D., Bunker M., et al. 2004. “Expression of Cytokeratin by Malignant Meningiomas: Diagnostic Pitfall of Cytokeratin to Separate Malignant Meningiomas From Metastatic Carcinoma.” Modern Pathology
17, no. 9: 1129–1133. 10.1038/modpathol.3800162.
</cite> [<a href="https://doi.org/10.1038/modpathol.3800162" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15133478/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Modern%20Pathology&amp;title=Expression%20of%20Cytokeratin%20by%20Malignant%20Meningiomas:%20Diagnostic%20Pitfall%20of%20Cytokeratin%20to%20Separate%20Malignant%20Meningiomas%20From%20Metastatic%20Carcinoma&amp;author=Y.%20Liu&amp;author=C.%20D.%20Sturgis&amp;author=M.%20Bunker&amp;volume=17&amp;issue=9&amp;publication_year=2004&amp;pages=1129-1133&amp;pmid=15133478&amp;doi=10.1038/modpathol.3800162&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0100">
<cite>

Liu, Y.
, Lv L., Xue Q., et al. 2013. “Vacuolar Protein Sorting 4B, an ATPase Protein Positively Regulates the Progression of NSCLC via Promoting Cell Division.” Molecular and Cellular Biochemistry
381, no. 1–2: 163–171. 10.1007/s11010-013-1699-2.
</cite> [<a href="https://doi.org/10.1007/s11010-013-1699-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23737133/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20and%20Cellular%20Biochemistry&amp;title=Vacuolar%20Protein%20Sorting%204B,%20an%20ATPase%20Protein%20Positively%20Regulates%20the%20Progression%20of%20NSCLC%20via%20Promoting%20Cell%20Division&amp;author=Y.%20Liu&amp;author=L.%20Lv&amp;author=Q.%20Xue&amp;volume=381&amp;issue=1%E2%80%932&amp;publication_year=2013&amp;pages=163-171&amp;pmid=23737133&amp;doi=10.1007/s11010-013-1699-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0101">
<cite>

Liu, W.
, Du M., Wan H., et al. 2022. “Serpin Family A Member 1 Is an Oncogene in Glioma and Its Translation Is Enhanced by NAD(P)H Quinone Dehydrogenase 1 Through RNA‐Binding Activity.” Open Medicine
17, no. 1: 1645–1654. 10.1515/med-2022-0572.
</cite> [<a href="https://doi.org/10.1515/med-2022-0572" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9587530/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36349191/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Open%20Medicine&amp;title=Serpin%20Family%20A%20Member%201%20Is%20an%20Oncogene%20in%20Glioma%20and%20Its%20Translation%20Is%20Enhanced%20by%20NAD(P)H%20Quinone%20Dehydrogenase%201%20Through%20RNA%E2%80%90Binding%20Activity&amp;author=W.%20Liu&amp;author=M.%20Du&amp;author=H.%20Wan&amp;volume=17&amp;issue=1&amp;publication_year=2022&amp;pages=1645-1654&amp;pmid=36349191&amp;doi=10.1515/med-2022-0572&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0102">
<cite>

Liu, F.
, Wu Q., Dong Z., and Liu K.. 2023. “Integrins in Cancer: Emerging Mechanisms and Therapeutic Opportunities.” Pharmacology &amp; Therapeutics
247: 108458. 10.1016/j.pharmthera.2023.108458.
</cite> [<a href="https://doi.org/10.1016/j.pharmthera.2023.108458" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37245545/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacology%20&amp;%20Therapeutics&amp;title=Integrins%20in%20Cancer:%20Emerging%20Mechanisms%20and%20Therapeutic%20Opportunities&amp;author=F.%20Liu&amp;author=Q.%20Wu&amp;author=Z.%20Dong&amp;author=K.%20Liu&amp;volume=247&amp;publication_year=2023&amp;pages=108458&amp;pmid=37245545&amp;doi=10.1016/j.pharmthera.2023.108458&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0103">
<cite>

Liu, L.
, Chen C., Liu P., et al. 2023. “MYH10 Combines With MYH9 to Recruit USP45 by Deubiquitinating Snail and Promotes Serous Ovarian Cancer Carcinogenesis, Progression, and Cisplatin Resistance.” Advanced Science
10, no. 14: e2203423. 10.1002/advs.202203423.
</cite> [<a href="https://doi.org/10.1002/advs.202203423" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10190571/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36929633/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Advanced%20Science&amp;title=MYH10%20Combines%20With%20MYH9%20to%20Recruit%20USP45%20by%20Deubiquitinating%20Snail%20and%20Promotes%20Serous%20Ovarian%20Cancer%20Carcinogenesis,%20Progression,%20and%20Cisplatin%20Resistance&amp;author=L.%20Liu&amp;author=C.%20Chen&amp;author=P.%20Liu&amp;volume=10&amp;issue=14&amp;publication_year=2023&amp;pages=e2203423&amp;pmid=36929633&amp;doi=10.1002/advs.202203423&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40714850/" class="text-red">Retracted</a>]</li>
<li id="bmc70170-bib-0104">
<cite>

Liu, Q.
, Lian Q., Song Y., Yang S., Jia C., and Fang J.. 2023. “Identification of LSM Family Members as Potential Chemoresistance Predictive and Therapeutic Biomarkers for Gastric Cancer.” Frontiers in Oncology
13: 1119945. 10.3389/fonc.2023.1119945.
</cite> [<a href="https://doi.org/10.3389/fonc.2023.1119945" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10064066/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37007092/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Oncology&amp;title=Identification%20of%20LSM%20Family%20Members%20as%20Potential%20Chemoresistance%20Predictive%20and%20Therapeutic%20Biomarkers%20for%20Gastric%20Cancer&amp;author=Q.%20Liu&amp;author=Q.%20Lian&amp;author=Y.%20Song&amp;author=S.%20Yang&amp;author=C.%20Jia&amp;volume=13&amp;publication_year=2023&amp;pages=1119945&amp;pmid=37007092&amp;doi=10.3389/fonc.2023.1119945&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0105">
<cite>

Liu, C.
, Chen S., Zhang Y., et al. 2024. “Mechanisms of RHO GTPASes in Regulating Tumor Proliferation, Migration and Invasion.” Cytokine &amp; Growth Factor Reviews
80: 168–174. 10.1016/j.cytogfr.2024.09.002.
</cite> [<a href="https://doi.org/10.1016/j.cytogfr.2024.09.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39317522/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cytokine%20&amp;%20Growth%20Factor%20Reviews&amp;title=Mechanisms%20of%20RHO%20GTPASes%20in%20Regulating%20Tumor%20Proliferation,%20Migration%20and%20Invasion&amp;author=C.%20Liu&amp;author=S.%20Chen&amp;author=Y.%20Zhang&amp;volume=80&amp;publication_year=2024&amp;pages=168-174&amp;pmid=39317522&amp;doi=10.1016/j.cytogfr.2024.09.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0106">
<cite>

Louati, K.
, Maalej A., Kolsi F., et al. 2023. “Differential Proteome Profiling Analysis Under Pesticide Stress by the Use of a Nano‐UHPLC‐MS/MS Untargeted Proteomic‐Based Approach on a 3D‐Developed Neurospheroid Model: Identification of Protein Interactions, Prognostic Biomarkers, and Potential Therapeutic Targets in Human IDH Mutant High‐Grade Gliomas.” Journal of Proteome Research
22, no. 11: 3534–3558. 10.1021/acs.jproteome.3c00395.
</cite> [<a href="https://doi.org/10.1021/acs.jproteome.3c00395" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10629271/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37651309/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Proteome%20Research&amp;title=Differential%20Proteome%20Profiling%20Analysis%20Under%20Pesticide%20Stress%20by%20the%20Use%20of%20a%20Nano%E2%80%90UHPLC%E2%80%90MS/MS%20Untargeted%20Proteomic%E2%80%90Based%20Approach%20on%20a%203D%E2%80%90Developed%20Neurospheroid%20Model:%20Identification%20of%20Protein%20Interactions,%20Prognostic%20Biomarkers,%20and%20Potential%20Therapeutic%20Targets%20in%20Human%20IDH%20Mutant%20High%E2%80%90Grade%20Gliomas&amp;author=K.%20Louati&amp;author=A.%20Maalej&amp;author=F.%20Kolsi&amp;volume=22&amp;issue=11&amp;publication_year=2023&amp;pages=3534-3558&amp;pmid=37651309&amp;doi=10.1021/acs.jproteome.3c00395&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0107">
<cite>

Louati, K.
, Maalej A., Kolsi F., et al. 2024. “A Shotgun Proteomic‐Based Approach With a Q‐Exactive Hybrid Quadrupole‐Orbitrap High‐Resolution Mass Spectrometer for the Assessment of Pesticide Mixture‐Induced Neurotoxicity on a 3D‐Developed Neurospheroid Model From Human Brain Meningiomas: Identification of Trityl‐Post‐Translational Modification.” Journal of Proteome Research
23: 5554–5576. 10.1021/acs.jproteome.4c00804.
</cite> [<a href="https://doi.org/10.1021/acs.jproteome.4c00804" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11629387/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39556108/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Proteome%20Research&amp;title=A%20Shotgun%20Proteomic%E2%80%90Based%20Approach%20With%20a%20Q%E2%80%90Exactive%20Hybrid%20Quadrupole%E2%80%90Orbitrap%20High%E2%80%90Resolution%20Mass%20Spectrometer%20for%20the%20Assessment%20of%20Pesticide%20Mixture%E2%80%90Induced%20Neurotoxicity%20on%20a%203D%E2%80%90Developed%20Neurospheroid%20Model%20From%20Human%20Brain%20Meningiomas:%20Identification%20of%20Trityl%E2%80%90Post%E2%80%90Translational%20Modification&amp;author=K.%20Louati&amp;author=A.%20Maalej&amp;author=F.%20Kolsi&amp;volume=23&amp;publication_year=2024&amp;pages=5554-5576&amp;pmid=39556108&amp;doi=10.1021/acs.jproteome.4c00804&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0108">
<cite>

Louis, D. N.
, Perry A., Wesseling P., et al. 2021. “The 2021 WHO Classification of Tumors of the Central Nervous System: A Summary.” Neuro‐Oncology
23, no. 8: 1231–1251. 10.1093/neuonc/noab106.
</cite> [<a href="https://doi.org/10.1093/neuonc/noab106" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8328013/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34185076/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuro%E2%80%90Oncology&amp;title=The%202021%20WHO%20Classification%20of%20Tumors%20of%20the%20Central%20Nervous%20System:%20A%20Summary&amp;author=D.%20N.%20Louis&amp;author=A.%20Perry&amp;author=P.%20Wesseling&amp;volume=23&amp;issue=8&amp;publication_year=2021&amp;pages=1231-1251&amp;pmid=34185076&amp;doi=10.1093/neuonc/noab106&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0109">
<cite>

Lu, Q.
, Longo F., Zhou H., Massa S., and Chen Y.. 2009. “Signaling Through RHO GTPASE Pathway as Viable Drug Target.” Current Medicinal Chemistry
16, no. 11: 1355–1365. 10.2174/092986709787846569.
</cite> [<a href="https://doi.org/10.2174/092986709787846569" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3829470/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19355891/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Medicinal%20Chemistry&amp;title=Signaling%20Through%20RHO%20GTPASE%20Pathway%20as%20Viable%20Drug%20Target&amp;author=Q.%20Lu&amp;author=F.%20Longo&amp;author=H.%20Zhou&amp;author=S.%20Massa&amp;author=Y.%20Chen&amp;volume=16&amp;issue=11&amp;publication_year=2009&amp;pages=1355-1365&amp;pmid=19355891&amp;doi=10.2174/092986709787846569&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0110">
<cite>

Lu, S.
, Cai S., Peng X., Cheng R., and Zhang Y.. 2021. “Integrative Transcriptomic, Proteomic and Functional Analysis Reveals ATP1B3 as a Diagnostic and Potential Therapeutic Target in Hepatocellular Carcinoma.” Frontiers in Immunology
12: 636614. 10.3389/fimmu.2021.636614.
</cite> [<a href="https://doi.org/10.3389/fimmu.2021.636614" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8050352/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33868261/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Immunology&amp;title=Integrative%20Transcriptomic,%20Proteomic%20and%20Functional%20Analysis%20Reveals%20ATP1B3%20as%20a%20Diagnostic%20and%20Potential%20Therapeutic%20Target%20in%20Hepatocellular%20Carcinoma&amp;author=S.%20Lu&amp;author=S.%20Cai&amp;author=X.%20Peng&amp;author=R.%20Cheng&amp;author=Y.%20Zhang&amp;volume=12&amp;publication_year=2021&amp;pages=636614&amp;pmid=33868261&amp;doi=10.3389/fimmu.2021.636614&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0111">
<cite>

Ma, K.
, Chen X., Liu W., et al. 2021. “ANXA2 Is Correlated With the Molecular Features and Clinical Prognosis of Glioma, and Acts as a Potential Marker of Immunosuppression.” Scientific Reports
11, no. 1: 20839. 10.1038/s41598-021-00366-8.
</cite> [<a href="https://doi.org/10.1038/s41598-021-00366-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8531374/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34675316/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scientific%20Reports&amp;title=ANXA2%20Is%20Correlated%20With%20the%20Molecular%20Features%20and%20Clinical%20Prognosis%20of%20Glioma,%20and%20Acts%20as%20a%20Potential%20Marker%20of%20Immunosuppression&amp;author=K.%20Ma&amp;author=X.%20Chen&amp;author=W.%20Liu&amp;volume=11&amp;issue=1&amp;publication_year=2021&amp;pages=20839&amp;pmid=34675316&amp;doi=10.1038/s41598-021-00366-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0112">
<cite>

Mabonga, L.
, and Kappo A. P.. 2019. “The Oncogenic Potential of Small Nuclear Ribonucleoprotein Polypeptide G: A Comprehensive and Perspective View.” American Journal of Translational Research
11, no. 11: 6702–6716. <a href="https://pubmed.ncbi.nlm.nih.gov/31814883" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/31814883</a>.
</cite> [<a href="/articles/PMC6895504/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31814883/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Translational%20Research&amp;title=The%20Oncogenic%20Potential%20of%20Small%20Nuclear%20Ribonucleoprotein%20Polypeptide%20G:%20A%20Comprehensive%20and%20Perspective%20View&amp;author=L.%20Mabonga&amp;author=A.%20P.%20Kappo&amp;volume=11&amp;issue=11&amp;publication_year=2019&amp;pages=6702-6716&amp;pmid=31814883&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0113">
<cite>

Madabhushi, V.
, Venkata R., Garikaparthi S., Kakarala S., and Duttaluru S.. 2015. “Role of Immunohistochemistry in Diagnosis of Brain Tumors: A Single Institutional Experience.” Journal of Dr NTR University of Health Sciences
4, no. 2: 103. 10.4103/2277-8632.154262.</cite> [<a href="https://doi.org/10.4103/2277-8632.154262" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Dr%20NTR%20University%20of%20Health%20Sciences&amp;title=Role%20of%20Immunohistochemistry%20in%20Diagnosis%20of%20Brain%20Tumors:%20A%20Single%20Institutional%20Experience&amp;author=V.%20Madabhushi&amp;author=R.%20Venkata&amp;author=S.%20Garikaparthi&amp;author=S.%20Kakarala&amp;author=S.%20Duttaluru&amp;volume=4&amp;issue=2&amp;publication_year=2015&amp;pages=103&amp;doi=10.4103/2277-8632.154262&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0114">
<cite>

Maekawa, M.
, and Mano N.. 2022. “Cutting‐Edge LC–MS/MS Applications in Clinical Mass Spectrometry: Focusing on Analysis of Drugs and Metabolites.” Biomedical Chromatography
36, no. 5: e5347. 10.1002/bmc.5347.
</cite> [<a href="https://doi.org/10.1002/bmc.5347" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35073598/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomedical%20Chromatography&amp;title=Cutting%E2%80%90Edge%20LC%E2%80%93MS/MS%20Applications%20in%20Clinical%20Mass%20Spectrometry:%20Focusing%20on%20Analysis%20of%20Drugs%20and%20Metabolites&amp;author=M.%20Maekawa&amp;author=N.%20Mano&amp;volume=36&amp;issue=5&amp;publication_year=2022&amp;pages=e5347&amp;pmid=35073598&amp;doi=10.1002/bmc.5347&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0115">
<cite>

Mandoj, C.
, Tomao L., and Conti L.. 2019. “Coagulation in Brain Tumors: Biological Basis and Clinical Implications.” Frontiers in Neurology
10: 181. 10.3389/fneur.2019.00181.
</cite> [<a href="https://doi.org/10.3389/fneur.2019.00181" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6436068/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30949114/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Neurology&amp;title=Coagulation%20in%20Brain%20Tumors:%20Biological%20Basis%20and%20Clinical%20Implications&amp;author=C.%20Mandoj&amp;author=L.%20Tomao&amp;author=L.%20Conti&amp;volume=10&amp;publication_year=2019&amp;pages=181&amp;pmid=30949114&amp;doi=10.3389/fneur.2019.00181&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0116">
<cite>

Mariani, M.
, Karki R., Spennato M., et al. 2015. “Class III β‐Tubulin in Normal and Cancer Tissues.” Gene
563, no. 2: 109–114. 10.1016/j.gene.2015.03.061.
</cite> [<a href="https://doi.org/10.1016/j.gene.2015.03.061" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6649683/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25839941/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gene&amp;title=Class%20III%20%CE%B2%E2%80%90Tubulin%20in%20Normal%20and%20Cancer%20Tissues&amp;author=M.%20Mariani&amp;author=R.%20Karki&amp;author=M.%20Spennato&amp;volume=563&amp;issue=2&amp;publication_year=2015&amp;pages=109-114&amp;pmid=25839941&amp;doi=10.1016/j.gene.2015.03.061&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0117">
<cite>

Mawrin, C.
, Sasse T., Kirches E., et al. 2005. “Different Activation of Mitogen‐Activated Protein Kinase and Akt Signaling Is Associated With Aggressive Phenotype of Human Meningiomas.” Clinical Cancer Research
11, no. 11: 4074–4082. 10.1158/1078-0432.ccr-04-2550.
</cite> [<a href="https://doi.org/10.1158/1078-0432.ccr-04-2550" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15930342/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Cancer%20Research&amp;title=Different%20Activation%20of%20Mitogen%E2%80%90Activated%20Protein%20Kinase%20and%20Akt%20Signaling%20Is%20Associated%20With%20Aggressive%20Phenotype%20of%20Human%20Meningiomas&amp;author=C.%20Mawrin&amp;author=T.%20Sasse&amp;author=E.%20Kirches&amp;volume=11&amp;issue=11&amp;publication_year=2005&amp;pages=4074-4082&amp;pmid=15930342&amp;doi=10.1158/1078-0432.ccr-04-2550&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0118">
<cite>

Mazzucchelli, L.

2002. “Protein S100A4: Too Long Overlooked by Pathologists?” American Journal of Pathology
160, no. 1: 7–13. 10.1016/s0002-9440(10)64342-8.
</cite> [<a href="https://doi.org/10.1016/s0002-9440(10)64342-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1867142/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11786392/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Pathology&amp;title=Protein%20S100A4:%20Too%20Long%20Overlooked%20by%20Pathologists?&amp;author=L.%20Mazzucchelli&amp;volume=160&amp;issue=1&amp;publication_year=2002&amp;pages=7-13&amp;pmid=11786392&amp;doi=10.1016/s0002-9440(10)64342-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0119">
<cite>

Mebratie, D. Y.
, and Dagnaw G. G.. 2024. “Review of Immunohistochemistry Techniques: Applications, Current Status, and Future Perspectives.” Seminars in Diagnostic Pathology
41, no. 3: 154–160. 10.1053/j.semdp.2024.05.001.
</cite> [<a href="https://doi.org/10.1053/j.semdp.2024.05.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38744555/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Seminars%20in%20Diagnostic%20Pathology&amp;title=Review%20of%20Immunohistochemistry%20Techniques:%20Applications,%20Current%20Status,%20and%20Future%20Perspectives&amp;author=D.%20Y.%20Mebratie&amp;author=G.%20G.%20Dagnaw&amp;volume=41&amp;issue=3&amp;publication_year=2024&amp;pages=154-160&amp;pmid=38744555&amp;doi=10.1053/j.semdp.2024.05.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0120">
<cite>

Melby, J. A.
, Roberts D. S., Larson E. J., et al. 2021. “Novel Strategies to Address the Challenges in Top‐Down Proteomics.” Journal of the American Society for Mass Spectrometry
32, no. 6: 1278–1294. 10.1021/jasms.1c00099.
</cite> [<a href="https://doi.org/10.1021/jasms.1c00099" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8310706/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33983025/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20American%20Society%20for%20Mass%20Spectrometry&amp;title=Novel%20Strategies%20to%20Address%20the%20Challenges%20in%20Top%E2%80%90Down%20Proteomics&amp;author=J.%20A.%20Melby&amp;author=D.%20S.%20Roberts&amp;author=E.%20J.%20Larson&amp;volume=32&amp;issue=6&amp;publication_year=2021&amp;pages=1278-1294&amp;pmid=33983025&amp;doi=10.1021/jasms.1c00099&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0121">
<cite>
METASCAPE
. 2019. A Gene Annotation &amp; Analysis Resource. Metascape Team. <a href="https://metascape.org/gp/index.html#/main/step1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://metascape.org/gp/index.html#/main/step1</a>.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=A%20Gene%20Annotation%20&amp;%20Analysis%20Resource&amp;publication_year=2019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0122">
<cite>

Mohammed, A.
, Hamdan A., and Homoud A.. 2019. “Histopathological Profile of Brain Tumors: A 12‐Year Retrospective Study From Madinah, Saudi Arabia.” Asian Journal of Neurosurgery
14, no. 04: 1106–1111. 10.4103/ajns.ajns_185_19.
</cite> [<a href="https://doi.org/10.4103/ajns.ajns_185_19" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6896618/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31903347/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Asian%20Journal%20of%20Neurosurgery&amp;title=Histopathological%20Profile%20of%20Brain%20Tumors:%20A%2012%E2%80%90Year%20Retrospective%20Study%20From%20Madinah,%20Saudi%20Arabia&amp;author=A.%20Mohammed&amp;author=A.%20Hamdan&amp;author=A.%20Homoud&amp;volume=14&amp;issue=04&amp;publication_year=2019&amp;pages=1106-1111&amp;pmid=31903347&amp;doi=10.4103/ajns.ajns_185_19&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0123">
<cite>

Mollinedo, F.

2019. “Neutrophil Degranulation, Plasticity, and Cancer Metastasis.” Trends in Immunology
40, no. 3: 228–242. 10.1016/j.it.2019.01.006.
</cite> [<a href="https://doi.org/10.1016/j.it.2019.01.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30777721/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Trends%20in%20Immunology&amp;title=Neutrophil%20Degranulation,%20Plasticity,%20and%20Cancer%20Metastasis&amp;author=F.%20Mollinedo&amp;volume=40&amp;issue=3&amp;publication_year=2019&amp;pages=228-242&amp;pmid=30777721&amp;doi=10.1016/j.it.2019.01.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0124">
<cite>

Mooney, K. L.
, Choy W., Sidhu S., et al. 2016. “The Role of CD<sub>44</sub> in Glioblastoma Multiforme.” Journal of Clinical Neuroscience
34: 1–5. 10.1016/j.jocn.2016.05.012.
</cite> [<a href="https://doi.org/10.1016/j.jocn.2016.05.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27578526/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Neuroscience&amp;title=The%20Role%20of%20CD44%20in%20Glioblastoma%20Multiforme&amp;author=K.%20L.%20Mooney&amp;author=W.%20Choy&amp;author=S.%20Sidhu&amp;volume=34&amp;publication_year=2016&amp;pages=1-5&amp;pmid=27578526&amp;doi=10.1016/j.jocn.2016.05.012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0125">
<cite>

Moriconi, C.
, Civita P., Neto C., Pilkington G. J., and Gumbleton M.. 2021. “Caveolin‐1, a Key Mediator Across Multiple Pathways in Glioblastoma and an Independent Negative Biomarker of Patient Survival.” Frontiers in Oncology
11: 701933. 10.3389/fonc.2021.701933.
</cite> [<a href="https://doi.org/10.3389/fonc.2021.701933" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8417742/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34490102/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Oncology&amp;title=Caveolin%E2%80%901,%20a%20Key%20Mediator%20Across%20Multiple%20Pathways%20in%20Glioblastoma%20and%20an%20Independent%20Negative%20Biomarker%20of%20Patient%20Survival&amp;author=C.%20Moriconi&amp;author=P.%20Civita&amp;author=C.%20Neto&amp;author=G.%20J.%20Pilkington&amp;author=M.%20Gumbleton&amp;volume=11&amp;publication_year=2021&amp;pages=701933&amp;pmid=34490102&amp;doi=10.3389/fonc.2021.701933&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0126">
<cite>

Mrid, R. B.
, Guendouzi S. E., Mineo M., and Fatimy R. E.. 2025. “The Emerging Roles of Aberrant Alternative Splicing in Glioma.” Cell Death Discovery
11, no. 1: 50. 10.1038/s41420-025-02323-0.
</cite> [<a href="https://doi.org/10.1038/s41420-025-02323-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11802826/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39915450/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Discovery&amp;title=The%20Emerging%20Roles%20of%20Aberrant%20Alternative%20Splicing%20in%20Glioma&amp;author=R.%20B.%20Mrid&amp;author=S.%20E.%20Guendouzi&amp;author=M.%20Mineo&amp;author=R.%20E.%20Fatimy&amp;volume=11&amp;issue=1&amp;publication_year=2025&amp;pages=50&amp;pmid=39915450&amp;doi=10.1038/s41420-025-02323-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0127">
<cite>

Murnyák, B.
, Bognár L., Klekner Á., and Hortobágyi T.. 2015. “Epigenetics of Meningiomas.” BioMed Research International
2015: 1–6. 10.1155/2015/532451.</cite> [<a href="https://doi.org/10.1155/2015/532451" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4458517/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26101774/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BioMed%20Research%20International&amp;title=Epigenetics%20of%20Meningiomas&amp;author=B.%20Murny%C3%A1k&amp;author=L.%20Bogn%C3%A1r&amp;author=%C3%81.%20Klekner&amp;author=T.%20Hortob%C3%A1gyi&amp;volume=2015&amp;publication_year=2015&amp;pages=1-6&amp;pmid=26101774&amp;doi=10.1155/2015/532451&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0128">
<cite>

Nager, M.
, Bhardwaj D., Cantí C., Medina L., Nogués P., and Herreros J.. 2012. “Β‐Catenin Signalling in Glioblastoma Multiforme and Glioma‐Initiating Cells.” Chemotherapy Research and Practice
2012: 1–7. 10.1155/2012/192362.</cite> [<a href="https://doi.org/10.1155/2012/192362" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3286890/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22400111/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chemotherapy%20Research%20and%20Practice&amp;title=%CE%92%E2%80%90Catenin%20Signalling%20in%20Glioblastoma%20Multiforme%20and%20Glioma%E2%80%90Initiating%20Cells&amp;author=M.%20Nager&amp;author=D.%20Bhardwaj&amp;author=C.%20Cant%C3%AD&amp;author=L.%20Medina&amp;author=P.%20Nogu%C3%A9s&amp;volume=2012&amp;publication_year=2012&amp;pages=1-7&amp;pmid=22400111&amp;doi=10.1155/2012/192362&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0129">
<cite>
National Center for Biotechnology Information
. 2025. PubChem Pathway Summary for Pathway R‐HSA‐9716542, Signaling by Rho GTPases, Miro GTPases and RHOBTB3, Source: Reactome. National Center for Biotechnology Information. Retrieved January 7, 2025, from <a href="https://pubchem.ncbi.nlm.nih.gov/pathway/Reactome:R-HSA-9716542" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pubchem.ncbi.nlm.nih.gov/pathway/Reactome:R‐HSA‐9716542</a>.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=PubChem%20Pathway%20Summary%20for%20Pathway%20R%E2%80%90HSA%E2%80%909716542,%20Signaling%20by%20Rho%20GTPases,%20Miro%20GTPases%20and%20RHOBTB3,%20Source:%20Reactome&amp;publication_year=2025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0130">
<cite>

Roberts, D. S.
, Loo J. A., Tsybin Y. O., et al. 2024. “Top‐Down Proteomics.” Nature Reviews Methods Primers
4, no. 1): 38. 10.1038/s43586-024-00318-2.</cite> [<a href="https://doi.org/10.1038/s43586-024-00318-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11242913/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39006170/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews%20Methods%20Primers&amp;title=Top%E2%80%90Down%20Proteomics&amp;author=D.%20S.%20Roberts&amp;author=J.%20A.%20Loo&amp;author=Y.%20O.%20Tsybin&amp;volume=4&amp;issue=1&amp;publication_year=2024&amp;pages=38&amp;pmid=39006170&amp;doi=10.1038/s43586-024-00318-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0131">
<cite>

Navone, S. E.
, Guarnaccia L., Locatelli M., et al. 2018. “Significance and Prognostic Value of the Coagulation Profile in Patients With Glioblastoma: Implications for Personalized Therapy.” World Neurosurgery
121: e621–e629. 10.1016/j.wneu.2018.09.177.
</cite> [<a href="https://doi.org/10.1016/j.wneu.2018.09.177" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30292037/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=World%20Neurosurgery&amp;title=Significance%20and%20Prognostic%20Value%20of%20the%20Coagulation%20Profile%20in%20Patients%20With%20Glioblastoma:%20Implications%20for%20Personalized%20Therapy&amp;author=S.%20E.%20Navone&amp;author=L.%20Guarnaccia&amp;author=M.%20Locatelli&amp;volume=121&amp;publication_year=2018&amp;pages=e621-e629&amp;pmid=30292037&amp;doi=10.1016/j.wneu.2018.09.177&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0132">
<cite>

Neradil, J.
, and Veselska R.. 2015. “Nestin as a Marker of Cancer Stem Cells.” Cancer Science
106, no. 7: 803–811. 10.1111/cas.12691.
</cite> [<a href="https://doi.org/10.1111/cas.12691" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4520630/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25940879/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Science&amp;title=Nestin%20as%20a%20Marker%20of%20Cancer%20Stem%20Cells&amp;author=J.%20Neradil&amp;author=R.%20Veselska&amp;volume=106&amp;issue=7&amp;publication_year=2015&amp;pages=803-811&amp;pmid=25940879&amp;doi=10.1111/cas.12691&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0133">
<cite>

Niclou, S. P.
, Fack F., and Rajcevic U.. 2010. “Glioma Proteomics: Status and Perspectives.” Journal of Proteomics
73, no. 10: 1823–1838. 10.1016/j.jprot.2010.03.007.
</cite> [<a href="https://doi.org/10.1016/j.jprot.2010.03.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20332038/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Proteomics&amp;title=Glioma%20Proteomics:%20Status%20and%20Perspectives&amp;author=S.%20P.%20Niclou&amp;author=F.%20Fack&amp;author=U.%20Rajcevic&amp;volume=73&amp;issue=10&amp;publication_year=2010&amp;pages=1823-1838&amp;pmid=20332038&amp;doi=10.1016/j.jprot.2010.03.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0134">
<cite>

Nicole, O.
, Docagne F., Ali C., et al. 2001. “The Proteolytic Activity of Tissue‐Plasminogen Activator Enhances NMDA Receptor‐Mediated Signaling.” Nature Medicine
7, no. 1: 59–64. 10.1038/83358.</cite> [<a href="https://doi.org/10.1038/83358" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11135617/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Medicine&amp;title=The%20Proteolytic%20Activity%20of%20Tissue%E2%80%90Plasminogen%20Activator%20Enhances%20NMDA%20Receptor%E2%80%90Mediated%20Signaling&amp;author=O.%20Nicole&amp;author=F.%20Docagne&amp;author=C.%20Ali&amp;volume=7&amp;issue=1&amp;publication_year=2001&amp;pages=59-64&amp;pmid=11135617&amp;doi=10.1038/83358&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0135">
<cite>

Noberini, R.
, Robusti G., and Bonaldi T.. 2021. “Mass Spectrometry‐Based Characterization of Histones in Clinical Samples: Applications, Progress, and Challenges.” FEBS Journal
289, no. 5: 1191–1213. 10.1111/febs.15707.
</cite> [<a href="https://doi.org/10.1111/febs.15707" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9291046/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33415821/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=FEBS%20Journal&amp;title=Mass%20Spectrometry%E2%80%90Based%20Characterization%20of%20Histones%20in%20Clinical%20Samples:%20Applications,%20Progress,%20and%20Challenges&amp;author=R.%20Noberini&amp;author=G.%20Robusti&amp;author=T.%20Bonaldi&amp;volume=289&amp;issue=5&amp;publication_year=2021&amp;pages=1191-1213&amp;pmid=33415821&amp;doi=10.1111/febs.15707&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0136">
<cite>

Nowicki, M. O.
, Hayes J. L., Chiocca E. A., and Lawler S. E.. 2019. “Proteomic Analysis Implicates Vimentin in Glioblastoma Cell Migration.” Cancers
11, no. 4: 466. 10.3390/cancers11040466.
</cite> [<a href="https://doi.org/10.3390/cancers11040466" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6521049/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30987208/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers&amp;title=Proteomic%20Analysis%20Implicates%20Vimentin%20in%20Glioblastoma%20Cell%20Migration&amp;author=M.%20O.%20Nowicki&amp;author=J.%20L.%20Hayes&amp;author=E.%20A.%20Chiocca&amp;author=S.%20E.%20Lawler&amp;volume=11&amp;issue=4&amp;publication_year=2019&amp;pages=466&amp;pmid=30987208&amp;doi=10.3390/cancers11040466&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0137">
<cite>

Oblinger, J. L.
, Burns S. S., Huang J., et al. 2017. “Overexpression of eIF4F Components in Meningiomas and Suppression of Meningioma Cell Growth by Inhibiting Translation Initiation.” Experimental Neurology
299: 299–307. 10.1016/j.expneurol.2017.06.015.
</cite> [<a href="https://doi.org/10.1016/j.expneurol.2017.06.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5723558/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28610844/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Experimental%20Neurology&amp;title=Overexpression%20of%20eIF4F%20Components%20in%20Meningiomas%20and%20Suppression%20of%20Meningioma%20Cell%20Growth%20by%20Inhibiting%20Translation%20Initiation&amp;author=J.%20L.%20Oblinger&amp;author=S.%20S.%20Burns&amp;author=J.%20Huang&amp;volume=299&amp;publication_year=2017&amp;pages=299-307&amp;pmid=28610844&amp;doi=10.1016/j.expneurol.2017.06.015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0138">
<cite>

Ocak, P. E.
, Ocak U., Tang J., and Zhang J. H.. 2019. “The Role of Caveolin‐1 in Tumors of the Brain—Functional and Clinical Implications.” Cellular Oncology
42, no. 4: 423–447. 10.1007/s13402-019-00447-x.
</cite> [<a href="https://doi.org/10.1007/s13402-019-00447-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30993541/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cellular%20Oncology&amp;title=The%20Role%20of%20Caveolin%E2%80%901%20in%20Tumors%20of%20the%20Brain%E2%80%94Functional%20and%20Clinical%20Implications&amp;author=P.%20E.%20Ocak&amp;author=U.%20Ocak&amp;author=J.%20Tang&amp;author=J.%20H.%20Zhang&amp;volume=42&amp;issue=4&amp;publication_year=2019&amp;pages=423-447&amp;pmid=30993541&amp;doi=10.1007/s13402-019-00447-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0139">
<cite>

Oldak, L.
, Chludzinska‐Kasperuk S., Milewska P., Grubczak K., Reszec J., and Gorodkiewicz E.. 2022. “Laminin‐5, Fibronectin, and Type IV Collagen as Potential Biomarkers of Brain Glioma Malignancy.” Biomedicine
10, no. 9: 2290. 10.3390/biomedicines10092290.</cite> [<a href="https://doi.org/10.3390/biomedicines10092290" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9496479/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36140391/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomedicine&amp;title=Laminin%E2%80%905,%20Fibronectin,%20and%20Type%20IV%20Collagen%20as%20Potential%20Biomarkers%20of%20Brain%20Glioma%20Malignancy&amp;author=L.%20Oldak&amp;author=S.%20Chludzinska%E2%80%90Kasperuk&amp;author=P.%20Milewska&amp;author=K.%20Grubczak&amp;author=J.%20Reszec&amp;volume=10&amp;issue=9&amp;publication_year=2022&amp;pages=2290&amp;pmid=36140391&amp;doi=10.3390/biomedicines10092290&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0140">
<cite>

Olsen, J. J.
, Pohl S. Ö., Deshmukh A., et al. 2017. “The Role of Wnt Signalling in Angiogenesis.” Clinical Biochemist Reviews
38, no. 3: 131–142.
</cite> [<a href="/articles/PMC5759160/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29332977/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Biochemist%20Reviews&amp;title=The%20Role%20of%20Wnt%20Signalling%20in%20Angiogenesis&amp;author=J.%20J.%20Olsen&amp;author=S.%20%C3%96.%20Pohl&amp;author=A.%20Deshmukh&amp;volume=38&amp;issue=3&amp;publication_year=2017&amp;pages=131-142&amp;pmid=29332977&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0141">
<cite>
PANTHER database (Version 19.0). 2025. Paul D Thomas. <a href="http://www.pantherdb.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.pantherdb.org</a>.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=PANTHER%20database%20(Version%2019.0)&amp;publication_year=2025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0142">
<cite>

Papavassiliou, K. A.
, and Papavassiliou A. G.. 2021. “Transcription Factors in Glioblastoma—Molecular Pathogenesis and Clinical Implications.” Biochimica et Biophysica Acta—Reviews on Cancer
1877, no. 1: 188667. 10.1016/j.bbcan.2021.188667.
</cite> [<a href="https://doi.org/10.1016/j.bbcan.2021.188667" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34894431/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochimica%20et%20Biophysica%20Acta%E2%80%94Reviews%20on%20Cancer&amp;title=Transcription%20Factors%20in%20Glioblastoma%E2%80%94Molecular%20Pathogenesis%20and%20Clinical%20Implications&amp;author=K.%20A.%20Papavassiliou&amp;author=A.%20G.%20Papavassiliou&amp;volume=1877&amp;issue=1&amp;publication_year=2021&amp;pages=188667&amp;pmid=34894431&amp;doi=10.1016/j.bbcan.2021.188667&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0143">
<cite>

Patarroyo, M.
, Tryggvason K., and Virtanen I.. 2002. “Laminin Isoforms in Tumor Invasion, Angiogenesis and Metastasis.” Seminars in Cancer Biology
12, no. 3: 197–207. 10.1016/s1044-579x(02)00023-8.
</cite> [<a href="https://doi.org/10.1016/s1044-579x(02)00023-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12083850/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Seminars%20in%20Cancer%20Biology&amp;title=Laminin%20Isoforms%20in%20Tumor%20Invasion,%20Angiogenesis%20and%20Metastasis&amp;author=M.%20Patarroyo&amp;author=K.%20Tryggvason&amp;author=I.%20Virtanen&amp;volume=12&amp;issue=3&amp;publication_year=2002&amp;pages=197-207&amp;pmid=12083850&amp;doi=10.1016/s1044-579x(02)00023-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0144">
<cite>

Pei, S.
, Wang X., Wang X., et al. 2021. “Aberrant Nuclear Lamina Contributes to the Malignancy of Human Gliomas.” Journal of Genetics and Genomics/Journal of Genetics and Genomics
49, no. 2: 132–144. 10.1016/j.jgg.2021.08.013.
</cite> [<a href="https://doi.org/10.1016/j.jgg.2021.08.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34530169/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Genetics%20and%20Genomics/Journal%20of%20Genetics%20and%20Genomics&amp;title=Aberrant%20Nuclear%20Lamina%20Contributes%20to%20the%20Malignancy%20of%20Human%20Gliomas&amp;author=S.%20Pei&amp;author=X.%20Wang&amp;author=X.%20Wang&amp;volume=49&amp;issue=2&amp;publication_year=2021&amp;pages=132-144&amp;pmid=34530169&amp;doi=10.1016/j.jgg.2021.08.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0145">
<cite>

Phon, B. W. S.
, Chelliah S. S., Osman D. E., Bhuvanendran S., Radhakrishnan A. K., and Kamarudin M. N. A.. 2025. “Revisiting ABC Transporters and Their Clinical Significance in Glioblastoma.” Pharmaceuticals
18, no. 1: 102. 10.3390/ph18010102.
</cite> [<a href="https://doi.org/10.3390/ph18010102" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11769420/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39861164/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceuticals&amp;title=Revisiting%20ABC%20Transporters%20and%20Their%20Clinical%20Significance%20in%20Glioblastoma&amp;author=B.%20W.%20S.%20Phon&amp;author=S.%20S.%20Chelliah&amp;author=D.%20E.%20Osman&amp;author=S.%20Bhuvanendran&amp;author=A.%20K.%20Radhakrishnan&amp;volume=18&amp;issue=1&amp;publication_year=2025&amp;pages=102&amp;pmid=39861164&amp;doi=10.3390/ph18010102&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0146">
<cite>

Polisetty, R. V.
, Gautam P., Sharma R., et al. 2012. “LC‐MS/MS Analysis of Differentially Expressed Glioblastoma Membrane Proteome Reveals Altered Calcium Signaling and Other Protein Groups of Regulatory Functions.” Molecular and Cellular Proteomics
11, no. 6: M111.013565. 10.1074/mcp.m111.013565.</cite> [<a href="https://doi.org/10.1074/mcp.m111.013565" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3433906/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22219345/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20and%20Cellular%20Proteomics&amp;title=LC%E2%80%90MS/MS%20Analysis%20of%20Differentially%20Expressed%20Glioblastoma%20Membrane%20Proteome%20Reveals%20Altered%20Calcium%20Signaling%20and%20Other%20Protein%20Groups%20of%20Regulatory%20Functions&amp;author=R.%20V.%20Polisetty&amp;author=P.%20Gautam&amp;author=R.%20Sharma&amp;volume=11&amp;issue=6&amp;publication_year=2012&amp;pages=M111.013565&amp;pmid=22219345&amp;doi=10.1074/mcp.m111.013565&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0147">
<cite>

Pooladi, M.
, Rezaei‐Tavirani M., Hashemi M., et al. 2014. “The Study of “Dihydropyrimidinase Related Proteins (DRPs)” expression Changes Influence in Malignant Astrocytoma Brain Tumor.” Iranian Journal of Cancer Prevention
7, no. 3: 130–136.
</cite> [<a href="/articles/PMC4171831/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25250163/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Iranian%20Journal%20of%20Cancer%20Prevention&amp;title=The%20Study%20of%20%E2%80%9CDihydropyrimidinase%20Related%20Proteins%20(DRPs)%E2%80%9D%20expression%20Changes%20Influence%20in%20Malignant%20Astrocytoma%20Brain%20Tumor&amp;author=M.%20Pooladi&amp;author=M.%20Rezaei%E2%80%90Tavirani&amp;author=M.%20Hashemi&amp;volume=7&amp;issue=3&amp;publication_year=2014&amp;pages=130-136&amp;pmid=25250163&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0148">
<cite>

Prianichnikov, N.
, Koch H., Koch S., et al. 2020. “MaxQuant Software for Ion Mobility Enhanced Shotgun Proteomics.” Molecular and Cellular Proteomics
19, no. 6: 1058–1069. 10.1074/mcp.tir119.001720.
</cite> [<a href="https://doi.org/10.1074/mcp.tir119.001720" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7261821/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32156793/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20and%20Cellular%20Proteomics&amp;title=MaxQuant%20Software%20for%20Ion%20Mobility%20Enhanced%20Shotgun%20Proteomics&amp;author=N.%20Prianichnikov&amp;author=H.%20Koch&amp;author=S.%20Koch&amp;volume=19&amp;issue=6&amp;publication_year=2020&amp;pages=1058-1069&amp;pmid=32156793&amp;doi=10.1074/mcp.tir119.001720&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0149">
<cite>

Procópio‐Azevedo, A. C.
, De Abreu Almeida M., Almeida‐Paes R., et al. 2023. “The State of the Art in Transcriptomics and Proteomics of Clinically Relevant <em>sporothrix</em> Species.” Journal of Fungi
9, no. 8: 790. 10.3390/jof9080790.
</cite> [<a href="https://doi.org/10.3390/jof9080790" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10455387/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37623561/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Fungi&amp;title=The%20State%20of%20the%20Art%20in%20Transcriptomics%20and%20Proteomics%20of%20Clinically%20Relevant%20sporothrix%20Species&amp;author=A.%20C.%20Proc%C3%B3pio%E2%80%90Azevedo&amp;author=M.%20De%20Abreu%20Almeida&amp;author=R.%20Almeida%E2%80%90Paes&amp;volume=9&amp;issue=8&amp;publication_year=2023&amp;pages=790&amp;pmid=37623561&amp;doi=10.3390/jof9080790&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0150">
<cite>

Reiswich, V.
, Schmidt C. E., Lennartz M., et al. 2023. “GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 Tumors.” Pathobiology
90, no. 4: 219–232. 10.1159/000527382.
</cite> [<a href="https://doi.org/10.1159/000527382" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10937041/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36649695/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pathobiology&amp;title=GATA3%20Expression%20in%20Human%20Tumors:%20A%20Tissue%20Microarray%20Study%20on%2016,557%20Tumors&amp;author=V.%20Reiswich&amp;author=C.%20E.%20Schmidt&amp;author=M.%20Lennartz&amp;volume=90&amp;issue=4&amp;publication_year=2023&amp;pages=219-232&amp;pmid=36649695&amp;doi=10.1159/000527382&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0151">
<cite>

Rochat, B.

2018. “Quantitative and Qualitative LC‐High‐Resolution MS: The Technological and Biological Reasons for a Shift of Paradigm.” In Recent Advances in Analytical Chemistry, edited by Ince M. and Kaplan Ince O.. IntechOpen. 10.5772/intechopen.81285.</cite> [<a href="https://doi.org/10.5772/intechopen.81285" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?title=Recent%20Advances%20in%20Analytical%20Chemistry&amp;author=B.%20Rochat&amp;publication_year=2018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0152">
<cite>

Sakamoto, S.
, Putalun W., Vimolmangkang S., et al. 2017. “Enzyme‐Linked Immunosorbent Assay for the Quantitative/Qualitative Analysis of Plant Secondary Metabolites.” Journal of Natural Medicines
72, no. 1: 32–42. 10.1007/s11418-017-1144-z.
</cite> [<a href="https://doi.org/10.1007/s11418-017-1144-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5775980/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29164507/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Natural%20Medicines&amp;title=Enzyme%E2%80%90Linked%20Immunosorbent%20Assay%20for%20the%20Quantitative/Qualitative%20Analysis%20of%20Plant%20Secondary%20Metabolites&amp;author=S.%20Sakamoto&amp;author=W.%20Putalun&amp;author=S.%20Vimolmangkang&amp;volume=72&amp;issue=1&amp;publication_year=2017&amp;pages=32-42&amp;pmid=29164507&amp;doi=10.1007/s11418-017-1144-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0153">
<cite>

Salles, D.
, Santino S. F., Ribeiro D. A., Malinverni A. C., and Stávale J. N.. 2022. “The Involvement of the MAPK Pathway in Pilocytic Astrocytomas.” Pathology
232: 153821. 10.1016/j.prp.2022.153821.</cite> [<a href="https://doi.org/10.1016/j.prp.2022.153821" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35231859/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pathology&amp;title=The%20Involvement%20of%20the%20MAPK%20Pathway%20in%20Pilocytic%20Astrocytomas&amp;author=D.%20Salles&amp;author=S.%20F.%20Santino&amp;author=D.%20A.%20Ribeiro&amp;author=A.%20C.%20Malinverni&amp;author=J.%20N.%20St%C3%A1vale&amp;volume=232&amp;publication_year=2022&amp;pages=153821&amp;pmid=35231859&amp;doi=10.1016/j.prp.2022.153821&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0154">
<cite>

Sharma, S.
, Mittal M., Shukla A., Khan J., Dinand V., and Saluja D.. 2024. “Exploring Serine‐Arginine Rich Splicing Factors: Potential Predictive Markers for Dysregulation in Oral Cancer.” BMC Cancer
24, no. 1: 1094. 10.1186/s12885-024-12750-4.
</cite> [<a href="https://doi.org/10.1186/s12885-024-12750-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11373262/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39227899/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Cancer&amp;title=Exploring%20Serine%E2%80%90Arginine%20Rich%20Splicing%20Factors:%20Potential%20Predictive%20Markers%20for%20Dysregulation%20in%20Oral%20Cancer&amp;author=S.%20Sharma&amp;author=M.%20Mittal&amp;author=A.%20Shukla&amp;author=J.%20Khan&amp;author=V.%20Dinand&amp;volume=24&amp;issue=1&amp;publication_year=2024&amp;pages=1094&amp;pmid=39227899&amp;doi=10.1186/s12885-024-12750-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0155">
<cite>

Sheikh, M. H.
, and Solito E.. 2018. “Annexin A1: Uncovering the Many Talents of An Old Protein.” International Journal of Molecular Sciences
19, no. 4: 1045. 10.3390/ijms19041045.
</cite> [<a href="https://doi.org/10.3390/ijms19041045" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5979524/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29614751/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Molecular%20Sciences&amp;title=Annexin%20A1:%20Uncovering%20the%20Many%20Talents%20of%20An%20Old%20Protein&amp;author=M.%20H.%20Sheikh&amp;author=E.%20Solito&amp;volume=19&amp;issue=4&amp;publication_year=2018&amp;pages=1045&amp;pmid=29614751&amp;doi=10.3390/ijms19041045&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0156">
<cite>

Siculella, L.
, Giannotti L., Di Chiara Stanca B., et al. 2022. “A Comprehensive Understanding of hnRNP A1 Role in Cancer: New Perspectives on Binding With Noncoding RNA.” Cancer Gene Therapy
30, no. 3: 394–403. 10.1038/s41417-022-00571-1.
</cite> [<a href="https://doi.org/10.1038/s41417-022-00571-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36460805/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Gene%20Therapy&amp;title=A%20Comprehensive%20Understanding%20of%20hnRNP%20A1%20Role%20in%20Cancer:%20New%20Perspectives%20on%20Binding%20With%20Noncoding%20RNA&amp;author=L.%20Siculella&amp;author=L.%20Giannotti&amp;author=B.%20Di%20Chiara%20Stanca&amp;volume=30&amp;issue=3&amp;publication_year=2022&amp;pages=394-403&amp;pmid=36460805&amp;doi=10.1038/s41417-022-00571-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0157">
<cite>

Sidoli, S.
, and Garcia B. A.. 2017. “Middle‐Down Proteomics: A Still Unexploited Resource for Chromatin Biology.” Expert Review of Proteomics
14, no. 7: 617–626. 10.1080/14789450.2017.1345632.
</cite> [<a href="https://doi.org/10.1080/14789450.2017.1345632" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5699467/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28649883/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Review%20of%20Proteomics&amp;title=Middle%E2%80%90Down%20Proteomics:%20A%20Still%20Unexploited%20Resource%20for%20Chromatin%20Biology&amp;author=S.%20Sidoli&amp;author=B.%20A.%20Garcia&amp;volume=14&amp;issue=7&amp;publication_year=2017&amp;pages=617-626&amp;pmid=28649883&amp;doi=10.1080/14789450.2017.1345632&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0158">
<cite>

Sinha, R.

2024. “The Role and Impact of New Technologies on Healthcare Systems.” Discover Health Systems
3, no. 1: 96. 10.1007/s44250-024-00163-w.</cite> [<a href="https://doi.org/10.1007/s44250-024-00163-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Discover%20Health%20Systems&amp;title=The%20Role%20and%20Impact%20of%20New%20Technologies%20on%20Healthcare%20Systems&amp;author=R.%20Sinha&amp;volume=3&amp;issue=1&amp;publication_year=2024&amp;pages=96&amp;doi=10.1007/s44250-024-00163-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0159">
<cite>

Son, A.
, Kim W., Park J., et al. 2024. “Mass Spectrometry Advancements and Applications for Biomarker Discovery, Diagnostic Innovations, and Personalized Medicine.” International Journal of Molecular Sciences
25, no. 18: 9880. 10.3390/ijms25189880.
</cite> [<a href="https://doi.org/10.3390/ijms25189880" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11432749/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39337367/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Molecular%20Sciences&amp;title=Mass%20Spectrometry%20Advancements%20and%20Applications%20for%20Biomarker%20Discovery,%20Diagnostic%20Innovations,%20and%20Personalized%20Medicine&amp;author=A.%20Son&amp;author=W.%20Kim&amp;author=J.%20Park&amp;volume=25&amp;issue=18&amp;publication_year=2024&amp;pages=9880&amp;pmid=39337367&amp;doi=10.3390/ijms25189880&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0160">
<cite>

Spiliotis, E. T.
, and Nakos K.. 2021. “Cellular Functions of Actin‐ and Microtubule‐Associated Septins.” Current Biology
31, no. 10: R651–R666. 10.1016/j.cub.2021.03.064.
</cite> [<a href="https://doi.org/10.1016/j.cub.2021.03.064" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8194058/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34033796/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Biology&amp;title=Cellular%20Functions%20of%20Actin%E2%80%90%20and%20Microtubule%E2%80%90Associated%20Septins&amp;author=E.%20T.%20Spiliotis&amp;author=K.%20Nakos&amp;volume=31&amp;issue=10&amp;publication_year=2021&amp;pages=R651-R666&amp;pmid=34033796&amp;doi=10.1016/j.cub.2021.03.064&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0161">
<cite>

Stachyra, P.
, and Grzybowska‐Szatkowska L.. 2025. “Signaling Pathways in Gliomas.” Genes
16, no. 5: 600. 10.3390/genes16050600.
</cite> [<a href="https://doi.org/10.3390/genes16050600" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12110932/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40428422/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genes&amp;title=Signaling%20Pathways%20in%20Gliomas&amp;author=P.%20Stachyra&amp;author=L.%20Grzybowska%E2%80%90Szatkowska&amp;volume=16&amp;issue=5&amp;publication_year=2025&amp;pages=600&amp;pmid=40428422&amp;doi=10.3390/genes16050600&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0162">
<cite>

Strickland, M.
, and Stoll E. A.. 2017. “Metabolic Reprogramming in Glioma.” Frontiers in Cell and Developmental Biology
5: 43. 10.3389/fcell.2017.00043.
</cite> [<a href="https://doi.org/10.3389/fcell.2017.00043" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5405080/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28491867/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Cell%20and%20Developmental%20Biology&amp;title=Metabolic%20Reprogramming%20in%20Glioma&amp;author=M.%20Strickland&amp;author=E.%20A.%20Stoll&amp;volume=5&amp;publication_year=2017&amp;pages=43&amp;pmid=28491867&amp;doi=10.3389/fcell.2017.00043&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0163">
<cite>
STRING database (Version 12.0). 2023. Academic Consortium. <a href="https://string-db.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://string‐db.org</a>.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=STRING%20database%20(Version%2012.0)&amp;publication_year=2023&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0164">
<cite>

Stupp, R.
, Hegi M. E., Gilbert M. R., and Chakravarti A.. 2007. “Chemoradiotherapy in Malignant Glioma: Standard of Care and Future Directions.” Journal of Clinical Oncology
25, no. 26: 4127–4136. 10.1200/jco.2007.11.8554.
</cite> [<a href="https://doi.org/10.1200/jco.2007.11.8554" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17827463/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Oncology&amp;title=Chemoradiotherapy%20in%20Malignant%20Glioma:%20Standard%20of%20Care%20and%20Future%20Directions&amp;author=R.%20Stupp&amp;author=M.%20E.%20Hegi&amp;author=M.%20R.%20Gilbert&amp;author=A.%20Chakravarti&amp;volume=25&amp;issue=26&amp;publication_year=2007&amp;pages=4127-4136&amp;pmid=17827463&amp;doi=10.1200/jco.2007.11.8554&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0165">
<cite>

Sugawara, K.
, Kurihara H., Negishi M., et al. 2002. “Nestin as a Marker for Proliferative Endothelium in Gliomas.” Laboratory Investigation
82, no. 3: 345–351. 10.1038/labinvest.3780428.
</cite> [<a href="https://doi.org/10.1038/labinvest.3780428" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11896213/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Laboratory%20Investigation&amp;title=Nestin%20as%20a%20Marker%20for%20Proliferative%20Endothelium%20in%20Gliomas&amp;author=K.%20Sugawara&amp;author=H.%20Kurihara&amp;author=M.%20Negishi&amp;volume=82&amp;issue=3&amp;publication_year=2002&amp;pages=345-351&amp;pmid=11896213&amp;doi=10.1038/labinvest.3780428&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0166">
<cite>

Sun, S.
, Wong T. S., Zhang X. Q., et al. 2011. “Protein Alterations Associated With Temozolomide Resistance in Subclones of Human Glioblastoma Cell Lines.” Journal of Neuro‐Oncology
107, no. 1: 89–100. 10.1007/s11060-011-0729-8.
</cite> [<a href="https://doi.org/10.1007/s11060-011-0729-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3273683/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21979894/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Neuro%E2%80%90Oncology&amp;title=Protein%20Alterations%20Associated%20With%20Temozolomide%20Resistance%20in%20Subclones%20of%20Human%20Glioblastoma%20Cell%20Lines&amp;author=S.%20Sun&amp;author=T.%20S.%20Wong&amp;author=X.%20Q.%20Zhang&amp;volume=107&amp;issue=1&amp;publication_year=2011&amp;pages=89-100&amp;pmid=21979894&amp;doi=10.1007/s11060-011-0729-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0167">
<cite>

Sun, Z.
, Huang P., Lin J., Jiang G., Chen J., and Liu Q.. 2025. “The Aggrephagy‐Related Gene TUBA1B Influences Clinical Outcomes in Glioma Patients by Regulating the Cell Cycle.” Frontiers in Oncology
15: 1531465. 10.3389/fonc.2025.1531465.
</cite> [<a href="https://doi.org/10.3389/fonc.2025.1531465" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11906671/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40094001/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Oncology&amp;title=The%20Aggrephagy%E2%80%90Related%20Gene%20TUBA1B%20Influences%20Clinical%20Outcomes%20in%20Glioma%20Patients%20by%20Regulating%20the%20Cell%20Cycle&amp;author=Z.%20Sun&amp;author=P.%20Huang&amp;author=J.%20Lin&amp;author=G.%20Jiang&amp;author=J.%20Chen&amp;volume=15&amp;publication_year=2025&amp;pages=1531465&amp;pmid=40094001&amp;doi=10.3389/fonc.2025.1531465&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0168">
<cite>

Suresh, R.
, and Diaz R. J.. 2021. “The Remodelling of Actin Composition as a Hallmark of Cancer.” Translational Oncology
14, no. 6: 101051. 10.1016/j.tranon.2021.101051.
</cite> [<a href="https://doi.org/10.1016/j.tranon.2021.101051" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8008238/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33761369/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Translational%20Oncology&amp;title=The%20Remodelling%20of%20Actin%20Composition%20as%20a%20Hallmark%20of%20Cancer&amp;author=R.%20Suresh&amp;author=R.%20J.%20Diaz&amp;volume=14&amp;issue=6&amp;publication_year=2021&amp;pages=101051&amp;pmid=33761369&amp;doi=10.1016/j.tranon.2021.101051&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0169">
<cite>

Szymańska‐Chabowska, A.
, Świątkowski F., Jankowska‐Polańska B., Mazur G., and Chabowski M.. 2021. “Nestin Expression as a Diagnostic and Prognostic Marker in Colorectal Cancer and Other Tumors.” Clinical Medicine Insights: Oncology
15: 11795549211038256. 10.1177/11795549211038256.
</cite> [<a href="https://doi.org/10.1177/11795549211038256" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8377314/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34421318/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Medicine%20Insights:%20Oncology&amp;title=Nestin%20Expression%20as%20a%20Diagnostic%20and%20Prognostic%20Marker%20in%20Colorectal%20Cancer%20and%20Other%20Tumors&amp;author=A.%20Szyma%C5%84ska%E2%80%90Chabowska&amp;author=F.%20%C5%9Awi%C4%85tkowski&amp;author=B.%20Jankowska%E2%80%90Pola%C5%84ska&amp;author=G.%20Mazur&amp;author=M.%20Chabowski&amp;volume=15&amp;publication_year=2021&amp;pages=11795549211038256&amp;pmid=34421318&amp;doi=10.1177/11795549211038256&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0170">
<cite>

Taylor, B. C.
, and Balko J. M.. 2022. “Mechanisms of MHC‐I Downregulation and Role in Immunotherapy Response.” Frontiers in Immunology
13: 844866. 10.3389/fimmu.2022.844866.
</cite> [<a href="https://doi.org/10.3389/fimmu.2022.844866" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8920040/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35296095/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Immunology&amp;title=Mechanisms%20of%20MHC%E2%80%90I%20Downregulation%20and%20Role%20in%20Immunotherapy%20Response&amp;author=B.%20C.%20Taylor&amp;author=J.%20M.%20Balko&amp;volume=13&amp;publication_year=2022&amp;pages=844866&amp;pmid=35296095&amp;doi=10.3389/fimmu.2022.844866&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0171">
<cite>

Teunissen, C.
, Koel‐Simmelink M., Pham T., et al. 2011. “Identification of Biomarkers for Diagnosis and Progression of MS by MALDI‐TOF Mass Spectrometry.” Multiple Sclerosis Journal
17, no. 7: 838–850. 10.1177/1352458511399614.
</cite> [<a href="https://doi.org/10.1177/1352458511399614" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21505015/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Multiple%20Sclerosis%20Journal&amp;title=Identification%20of%20Biomarkers%20for%20Diagnosis%20and%20Progression%20of%20MS%20by%20MALDI%E2%80%90TOF%20Mass%20Spectrometry&amp;author=C.%20Teunissen&amp;author=M.%20Koel%E2%80%90Simmelink&amp;author=T.%20Pham&amp;volume=17&amp;issue=7&amp;publication_year=2011&amp;pages=838-850&amp;pmid=21505015&amp;doi=10.1177/1352458511399614&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0172">
<cite>
The Human Protein Atlas (version 24.0). 2024. KTH, UU, SciLifeLab, Sweden. <a href="https://www.proteinatlas.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.proteinatlas.org/</a>.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=The%20Human%20Protein%20Atlas%20(version%2024.0)&amp;publication_year=2024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0173">
<cite>
The Thermo Scientific
. 2017. “Q Exactive HF‐X Hybrid Quadrupole‐Orbitrap‐MS System”, PRODUCT SPECIFICATION Data‐Sheet. Thermo Fisher Scientific Inc. Available On‐Line: <a href="https://assets.thermofisher.com/TFSAssets/CMD/Specification-Sheets/PS-64048-LC-MS-Q-Exactive-HF-Orbitrap-PS64048-EN.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://assets.thermofisher.com/TFSAssets/CMD/Specification‐Sheets/PS‐64048‐LC‐MS‐Q‐Exactive‐HF‐Orbitrap‐PS64048‐EN.pdf</a>.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=%E2%80%9CQ%20Exactive%20HF%E2%80%90X%20Hybrid%20Quadrupole%E2%80%90Orbitrap%E2%80%90MS%20System%E2%80%9D,%20PRODUCT%20SPECIFICATION%20Data%E2%80%90Sheet&amp;publication_year=2017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0174">
<cite>

Thomas, S. P.
, Haws S. A., Borth L. E., and Denu J. M.. 2019. “A Practical Guide for Analysis of Histone Post‐Translational Modifications by Mass Spectrometry: Best Practices and Pitfalls.” Methods
184: 53–60. 10.1016/j.ymeth.2019.12.001.
</cite> [<a href="https://doi.org/10.1016/j.ymeth.2019.12.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31816396/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Methods&amp;title=A%20Practical%20Guide%20for%20Analysis%20of%20Histone%20Post%E2%80%90Translational%20Modifications%20by%20Mass%20Spectrometry:%20Best%20Practices%20and%20Pitfalls&amp;author=S.%20P.%20Thomas&amp;author=S.%20A.%20Haws&amp;author=L.%20E.%20Borth&amp;author=J.%20M.%20Denu&amp;volume=184&amp;publication_year=2019&amp;pages=53-60&amp;pmid=31816396&amp;doi=10.1016/j.ymeth.2019.12.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0175">
<cite>

Thomas, S. N.
, French D., Jannetto P. J., Rappold B. A., and Clarke W. A.. 2022. “Liquid Chromatography–Tandem Mass Spectrometry for Clinical Diagnostics.” Nature Reviews Methods Primers
2, no. 1: 96. 10.1038/s43586-022-00175-x.
</cite> [<a href="https://doi.org/10.1038/s43586-022-00175-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9735147/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36532107/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews%20Methods%20Primers&amp;title=Liquid%20Chromatography%E2%80%93Tandem%20Mass%20Spectrometry%20for%20Clinical%20Diagnostics&amp;author=S.%20N.%20Thomas&amp;author=D.%20French&amp;author=P.%20J.%20Jannetto&amp;author=B.%20A.%20Rappold&amp;author=W.%20A.%20Clarke&amp;volume=2&amp;issue=1&amp;publication_year=2022&amp;pages=96&amp;pmid=36532107&amp;doi=10.1038/s43586-022-00175-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0176">
<cite>

Tong, D.
, Zhou J., Zhou J., et al. 2023. “LAMC2 Mitigates ER Stress by Enhancing ER‐Mitochondria Interaction via Binding to MYH9 and MYH10.” Cancer Gene Therapy
31, no. 1: 43–57. 10.1038/s41417-023-00680-5.
</cite> [<a href="https://doi.org/10.1038/s41417-023-00680-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10794146/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37891404/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Gene%20Therapy&amp;title=LAMC2%20Mitigates%20ER%20Stress%20by%20Enhancing%20ER%E2%80%90Mitochondria%20Interaction%20via%20Binding%20to%20MYH9%20and%20MYH10&amp;author=D.%20Tong&amp;author=J.%20Zhou&amp;author=J.%20Zhou&amp;volume=31&amp;issue=1&amp;publication_year=2023&amp;pages=43-57&amp;pmid=37891404&amp;doi=10.1038/s41417-023-00680-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0177">
<cite>

Torp, S. H.
, Solheim O., and Skjulsvik A. J.. 2022. “The WHO 2021 Classification of Central Nervous System Tumours: A Practical Update on What Neurosurgeons Need to Know—A Minireview.” Acta Neurochirurgica
164, no. 9: 2453–2464. 10.1007/s00701-022-05301-y.
</cite> [<a href="https://doi.org/10.1007/s00701-022-05301-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9427889/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35879477/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Neurochirurgica&amp;title=The%20WHO%202021%20Classification%20of%20Central%20Nervous%20System%20Tumours:%20A%20Practical%20Update%20on%20What%20Neurosurgeons%20Need%20to%20Know%E2%80%94A%20Minireview&amp;author=S.%20H.%20Torp&amp;author=O.%20Solheim&amp;author=A.%20J.%20Skjulsvik&amp;volume=164&amp;issue=9&amp;publication_year=2022&amp;pages=2453-2464&amp;pmid=35879477&amp;doi=10.1007/s00701-022-05301-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0178">
<cite>

Ullah, M. A.
, Tabassum T., Farzana M., Moin A. T., Zohora U. S., and Rahman M. S.. 2022. “Expression Analysis, Molecular Characterization and Prognostic Evaluation on <em>TMED4</em> and <em>TMED9</em> Gene Expression in Glioma.” Biomedical Signal Processing and Control
78: 103922. 10.1016/j.bspc.2022.103922.</cite> [<a href="https://doi.org/10.1016/j.bspc.2022.103922" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomedical%20Signal%20Processing%20and%20Control&amp;title=Expression%20Analysis,%20Molecular%20Characterization%20and%20Prognostic%20Evaluation%20on%20TMED4%20and%20TMED9%20Gene%20Expression%20in%20Glioma&amp;author=M.%20A.%20Ullah&amp;author=T.%20Tabassum&amp;author=M.%20Farzana&amp;author=A.%20T.%20Moin&amp;author=U.%20S.%20Zohora&amp;volume=78&amp;publication_year=2022&amp;pages=103922&amp;doi=10.1016/j.bspc.2022.103922&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0179">
<cite>

Unger, M.
, and Kather J. N.. 2024. “Deep Learning in Cancer Genomics and Histopathology.” Genome Medicine
16, no. 1: 44. 10.1186/s13073-024-01315-6.
</cite> [<a href="https://doi.org/10.1186/s13073-024-01315-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10976780/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38539231/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genome%20Medicine&amp;title=Deep%20Learning%20in%20Cancer%20Genomics%20and%20Histopathology&amp;author=M.%20Unger&amp;author=J.%20N.%20Kather&amp;volume=16&amp;issue=1&amp;publication_year=2024&amp;pages=44&amp;pmid=38539231&amp;doi=10.1186/s13073-024-01315-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0180">
<cite>

Uribe, D.
, Torres Á., Rocha J. D., et al. 2017. “Multidrug Resistance in Glioblastoma Stem‐Like Cells: Role of the Hypoxic Microenvironment and Adenosine Signaling.” Molecular Aspects of Medicine
55: 140–151. 10.1016/j.mam.2017.01.009.
</cite> [<a href="https://doi.org/10.1016/j.mam.2017.01.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28223127/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Aspects%20of%20Medicine&amp;title=Multidrug%20Resistance%20in%20Glioblastoma%20Stem%E2%80%90Like%20Cells:%20Role%20of%20the%20Hypoxic%20Microenvironment%20and%20Adenosine%20Signaling&amp;author=D.%20Uribe&amp;author=%C3%81.%20Torres&amp;author=J.%20D.%20Rocha&amp;volume=55&amp;publication_year=2017&amp;pages=140-151&amp;pmid=28223127&amp;doi=10.1016/j.mam.2017.01.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0181">
<cite>

Valdembri, D.
, and Serini G.. 2021. “The Roles of Integrins in Cancer.” Faculty Reviews
10: 45. 10.12703/r/10-45.
</cite> [<a href="https://doi.org/10.12703/r/10-45" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8170687/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34131655/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Faculty%20Reviews&amp;title=The%20Roles%20of%20Integrins%20in%20Cancer&amp;author=D.%20Valdembri&amp;author=G.%20Serini&amp;volume=10&amp;publication_year=2021&amp;pages=45&amp;pmid=34131655&amp;doi=10.12703/r/10-45&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0182">
<cite>

Valiente, M.
, Obenauf A. C., Jin X., et al. 2014. “Serpins Promote Cancer Cell Survival and Vascular Co‐Option in Brain Metastasis.” Cell
156, no. 5: 1002–1016. 10.1016/j.cell.2014.01.040.
</cite> [<a href="https://doi.org/10.1016/j.cell.2014.01.040" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3988473/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24581498/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Serpins%20Promote%20Cancer%20Cell%20Survival%20and%20Vascular%20Co%E2%80%90Option%20in%20Brain%20Metastasis&amp;author=M.%20Valiente&amp;author=A.%20C.%20Obenauf&amp;author=X.%20Jin&amp;volume=156&amp;issue=5&amp;publication_year=2014&amp;pages=1002-1016&amp;pmid=24581498&amp;doi=10.1016/j.cell.2014.01.040&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0183">
<cite>

Wang, Z.
, Tang W., Yuan J., Qiang B., Han W., and Peng X.. 2020. “Integrated Analysis of RNA‐Binding Proteins in Glioma.” Cancers
12, no. 4: 892. 10.3390/cancers12040892.
</cite> [<a href="https://doi.org/10.3390/cancers12040892" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7226056/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32272554/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers&amp;title=Integrated%20Analysis%20of%20RNA%E2%80%90Binding%20Proteins%20in%20Glioma&amp;author=Z.%20Wang&amp;author=W.%20Tang&amp;author=J.%20Yuan&amp;author=B.%20Qiang&amp;author=W.%20Han&amp;volume=12&amp;issue=4&amp;publication_year=2020&amp;pages=892&amp;pmid=32272554&amp;doi=10.3390/cancers12040892&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0184">
<cite>

Wang, Y.
, Wang Y., Wan R., Hu C., and Lu Y.. 2021. “Profilin 1 Protein and Its Implications for Cancers.” Oncology
35: 3507. 10.46883/onc.2021.3507.0402.</cite> [<a href="https://doi.org/10.46883/onc.2021.3507.0402" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34264570/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncology&amp;title=Profilin%201%20Protein%20and%20Its%20Implications%20for%20Cancers&amp;author=Y.%20Wang&amp;author=Y.%20Wang&amp;author=R.%20Wan&amp;author=C.%20Hu&amp;author=Y.%20Lu&amp;volume=35&amp;publication_year=2021&amp;pages=3507&amp;pmid=34264570&amp;doi=10.46883/onc.2021.3507.0402&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0185">
<cite>

Wang, H.
, Mao X., Ye L., Cheng H., and Dai X.. 2022. “The Role of the S100 Protein Family in Glioma.” Journal of Cancer
13, no. 10: 3022–3030. 10.7150/jca.73365.
</cite> [<a href="https://doi.org/10.7150/jca.73365" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9414020/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36046652/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Cancer&amp;title=The%20Role%20of%20the%20S100%20Protein%20Family%20in%20Glioma&amp;author=H.%20Wang&amp;author=X.%20Mao&amp;author=L.%20Ye&amp;author=H.%20Cheng&amp;author=X.%20Dai&amp;volume=13&amp;issue=10&amp;publication_year=2022&amp;pages=3022-3030&amp;pmid=36046652&amp;doi=10.7150/jca.73365&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0186">
<cite>

Wang, M.
, Shen S., Hou F., and Yan Y.. 2022. “Pathophysiological Roles of Integrins in Gliomas From the Perspective of Glioma Stem Cells.” Frontiers in Cell and Developmental Biology
10: 962481. 10.3389/fcell.2022.962481.
</cite> [<a href="https://doi.org/10.3389/fcell.2022.962481" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9523240/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36187469/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Cell%20and%20Developmental%20Biology&amp;title=Pathophysiological%20Roles%20of%20Integrins%20in%20Gliomas%20From%20the%20Perspective%20of%20Glioma%20Stem%20Cells&amp;author=M.%20Wang&amp;author=S.%20Shen&amp;author=F.%20Hou&amp;author=Y.%20Yan&amp;volume=10&amp;publication_year=2022&amp;pages=962481&amp;pmid=36187469&amp;doi=10.3389/fcell.2022.962481&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0187">
<cite>

Wang, Y.
, Ichinose T., and Nakada M.. 2022. “The Role of Collagens in Glioma: A Narrative Review.” Glioma
5, no. 2: 50–55. 10.4103/glioma.glioma_11_22.</cite> [<a href="https://doi.org/10.4103/glioma.glioma_11_22" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Glioma&amp;title=The%20Role%20of%20Collagens%20in%20Glioma:%20A%20Narrative%20Review&amp;author=Y.%20Wang&amp;author=T.%20Ichinose&amp;author=M.%20Nakada&amp;volume=5&amp;issue=2&amp;publication_year=2022&amp;pages=50-55&amp;doi=10.4103/glioma.glioma_11_22&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0188">
<cite>

Wang, Z.
, Chen G., Yuan D., et al. 2024. “Caveolin‐1 Promotes Glioma Proliferation and Metastasis by Enhancing EMT via Mediating PAI‐1 Activation and Its Correlation With Immune Infiltrates.” Heliyon
10, no. 2: e24464. 10.1016/j.heliyon.2024.e24464.
</cite> [<a href="https://doi.org/10.1016/j.heliyon.2024.e24464" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10827802/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38298655/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Heliyon&amp;title=Caveolin%E2%80%901%20Promotes%20Glioma%20Proliferation%20and%20Metastasis%20by%20Enhancing%20EMT%20via%20Mediating%20PAI%E2%80%901%20Activation%20and%20Its%20Correlation%20With%20Immune%20Infiltrates&amp;author=Z.%20Wang&amp;author=G.%20Chen&amp;author=D.%20Yuan&amp;volume=10&amp;issue=2&amp;publication_year=2024&amp;pages=e24464&amp;pmid=38298655&amp;doi=10.1016/j.heliyon.2024.e24464&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0189">
<cite>

Wenk, D.
, Zuo C., Kislinger T., and Sepiashvili L.. 2024. “Recent Developments in Mass‐Spectrometry‐Based Targeted Proteomics of Clinical Cancer Biomarkers.” Clinical Proteomics
21, no. 1: 6. 10.1186/s12014-024-09452-1.
</cite> [<a href="https://doi.org/10.1186/s12014-024-09452-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10826105/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38287260/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Proteomics&amp;title=Recent%20Developments%20in%20Mass%E2%80%90Spectrometry%E2%80%90Based%20Targeted%20Proteomics%20of%20Clinical%20Cancer%20Biomarkers&amp;author=D.%20Wenk&amp;author=C.%20Zuo&amp;author=T.%20Kislinger&amp;author=L.%20Sepiashvili&amp;volume=21&amp;issue=1&amp;publication_year=2024&amp;pages=6&amp;pmid=38287260&amp;doi=10.1186/s12014-024-09452-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0190">
<cite>

Wu, L.
, Saxena S., and Singh R. K.. 2020. “Neutrophils in the Tumor Microenvironment.” Advances in Experimental Medicine and Biology
1224: 1–20. 10.1007/978-3-030-35723-8_1.
</cite> [<a href="https://doi.org/10.1007/978-3-030-35723-8_1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7325741/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32036601/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Advances%20in%20Experimental%20Medicine%20and%20Biology&amp;title=Neutrophils%20in%20the%20Tumor%20Microenvironment&amp;author=L.%20Wu&amp;author=S.%20Saxena&amp;author=R.%20K.%20Singh&amp;volume=1224&amp;publication_year=2020&amp;pages=1-20&amp;pmid=32036601&amp;doi=10.1007/978-3-030-35723-8_1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0191">
<cite>

Wu, J.
, Lu F., Yu B., Wang W., and Ye X.. 2022. “The Oncogenic Role of SNRPB in Human Tumors: A Pan‐Cancer Analysis.” Frontiers in Molecular Biosciences
9: 994440. 10.3389/fmolb.2022.994440.
</cite> [<a href="https://doi.org/10.3389/fmolb.2022.994440" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9582665/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36275630/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Molecular%20Biosciences&amp;title=The%20Oncogenic%20Role%20of%20SNRPB%20in%20Human%20Tumors:%20A%20Pan%E2%80%90Cancer%20Analysis&amp;author=J.%20Wu&amp;author=F.%20Lu&amp;author=B.%20Yu&amp;author=W.%20Wang&amp;author=X.%20Ye&amp;volume=9&amp;publication_year=2022&amp;pages=994440&amp;pmid=36275630&amp;doi=10.3389/fmolb.2022.994440&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0192">
<cite>

Wu, Z.
, Omura I., Saito A., Imaizumi K., and Kamikawa Y.. 2024. “VPS4B Orchestrates Response to Nuclear Envelope Stress by Regulating ESCRT‐III Dynamics in Glioblastoma.” Nucleus
15, no. 1: 2423660. 10.1080/19491034.2024.2423660 2024 Nov 14. Erratum in: Nucleus. 2024 Dec;15(1):2436700.
</cite> [<a href="https://doi.org/10.1080/19491034.2024.2423660" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11572143/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39540606/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleus&amp;title=VPS4B%20Orchestrates%20Response%20to%20Nuclear%20Envelope%20Stress%20by%20Regulating%20ESCRT%E2%80%90III%20Dynamics%20in%20Glioblastoma&amp;author=Z.%20Wu&amp;author=I.%20Omura&amp;author=A.%20Saito&amp;author=K.%20Imaizumi&amp;author=Y.%20Kamikawa&amp;volume=15&amp;issue=1&amp;publication_year=2024&amp;pages=2423660&amp;pmid=39540606&amp;doi=10.1080/19491034.2024.2423660&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0193">
<cite>

Wu, H.
, Zhu X., Zhou H., Sha M., Ye J., and Yu H.. 2025. “Mitochondrial Ribosomal Proteins and Cancer.” Medicina (Kaunas)
61, no. 1: 96. 10.3390/medicina61010096.
</cite> [<a href="https://doi.org/10.3390/medicina61010096" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11766452/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39859078/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Medicina%20(Kaunas)&amp;title=Mitochondrial%20Ribosomal%20Proteins%20and%20Cancer&amp;author=H.%20Wu&amp;author=X.%20Zhu&amp;author=H.%20Zhou&amp;author=M.%20Sha&amp;author=J.%20Ye&amp;volume=61&amp;issue=1&amp;publication_year=2025&amp;pages=96&amp;pmid=39859078&amp;doi=10.3390/medicina61010096&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0194">
<cite>

Xiao, Z. Y.
, Chen X. J., Pan Q., Yang Q. Z., and Li K. Z.. 2018. “Expression of Nestin, CD133 and Sox2 in Meningiomas.” Turkish Neurosurgery
28, no. 6: 910–914. 10.5137/1019-5149.JTN.21234-17.2.
</cite> [<a href="https://doi.org/10.5137/1019-5149.JTN.21234-17.2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29368320/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Turkish%20Neurosurgery&amp;title=Expression%20of%20Nestin,%20CD133%20and%20Sox2%20in%20Meningiomas&amp;author=Z.%20Y.%20Xiao&amp;author=X.%20J.%20Chen&amp;author=Q.%20Pan&amp;author=Q.%20Z.%20Yang&amp;author=K.%20Z.%20Li&amp;volume=28&amp;issue=6&amp;publication_year=2018&amp;pages=910-914&amp;pmid=29368320&amp;doi=10.5137/1019-5149.JTN.21234-17.2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0195">
<cite>

Xu, C.
, Li F., Liu Z., Yan C., and Xiao J.. 2023. “Pan‐Cancer Analysis of the Prognostic and Immunological Role of SNX29: A Potential Target for Survival and Immunotherapy.” BMC Medical Genomics
16, no. 1: 34. 10.1186/s12920-023-01466-2.
</cite> [<a href="https://doi.org/10.1186/s12920-023-01466-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9951530/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36829159/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Medical%20Genomics&amp;title=Pan%E2%80%90Cancer%20Analysis%20of%20the%20Prognostic%20and%20Immunological%20Role%20of%20SNX29:%20A%20Potential%20Target%20for%20Survival%20and%20Immunotherapy&amp;author=C.%20Xu&amp;author=F.%20Li&amp;author=Z.%20Liu&amp;author=C.%20Yan&amp;author=J.%20Xiao&amp;volume=16&amp;issue=1&amp;publication_year=2023&amp;pages=34&amp;pmid=36829159&amp;doi=10.1186/s12920-023-01466-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0196">
<cite>

Xu, S.
, Cao B., Xuan G., et al. 2024. “Function and Regulation of Rab GTPases in Cancers.” Cell Biology and Toxicology
40, no. 1: 28. 10.1007/s10565-024-09866-5.
</cite> [<a href="https://doi.org/10.1007/s10565-024-09866-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11065922/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38695990/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Biology%20and%20Toxicology&amp;title=Function%20and%20Regulation%20of%20Rab%20GTPases%20in%20Cancers&amp;author=S.%20Xu&amp;author=B.%20Cao&amp;author=G.%20Xuan&amp;volume=40&amp;issue=1&amp;publication_year=2024&amp;pages=28&amp;pmid=38695990&amp;doi=10.1007/s10565-024-09866-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0197">
<cite>

Xu, J.
, Guo Y., Ning W., et al. 2025. “Comprehensive Analysis of Heat Shock Proteins in Glioma Revealed the Association With Glioma‐Associated Myeloid Cells.” Genes and Immunity
26: 200–212. 10.1038/s41435-025-00327-5.
</cite> [<a href="https://doi.org/10.1038/s41435-025-00327-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12170335/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40234584/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genes%20and%20Immunity&amp;title=Comprehensive%20Analysis%20of%20Heat%20Shock%20Proteins%20in%20Glioma%20Revealed%20the%20Association%20With%20Glioma%E2%80%90Associated%20Myeloid%20Cells&amp;author=J.%20Xu&amp;author=Y.%20Guo&amp;author=W.%20Ning&amp;volume=26&amp;publication_year=2025&amp;pages=200-212&amp;pmid=40234584&amp;doi=10.1038/s41435-025-00327-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0198">
<cite>

Xue, C.
, Gu X., Li G., Bao Z., and Li L.. 2021. “Expression and Functional Roles of Eukaryotic Initiation Factor 4A Family Proteins in Human Cancers.” Frontiers in Cell and Developmental Biology
9: 711965. 10.3389/fcell.2021.711965.
</cite> [<a href="https://doi.org/10.3389/fcell.2021.711965" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8640450/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34869305/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Cell%20and%20Developmental%20Biology&amp;title=Expression%20and%20Functional%20Roles%20of%20Eukaryotic%20Initiation%20Factor%204A%20Family%20Proteins%20in%20Human%20Cancers&amp;author=C.%20Xue&amp;author=X.%20Gu&amp;author=G.%20Li&amp;author=Z.%20Bao&amp;author=L.%20Li&amp;volume=9&amp;publication_year=2021&amp;pages=711965&amp;pmid=34869305&amp;doi=10.3389/fcell.2021.711965&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0199">
<cite>

Yang, B.
, Song J., Sun H., et al. 2018. “PSMB8 Regulates Glioma Cell Migration, Proliferation, and Apoptosis Through Modulating ERK1/2 and PI3K/AKT Signaling Pathways.” Biomedicine &amp; Pharmacotherapy
100: 205–212. 10.1016/j.biopha.2018.01.170.
</cite> [<a href="https://doi.org/10.1016/j.biopha.2018.01.170" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29428669/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomedicine%20&amp;%20Pharmacotherapy&amp;title=PSMB8%20Regulates%20Glioma%20Cell%20Migration,%20Proliferation,%20and%20Apoptosis%20Through%20Modulating%20ERK1/2%20and%20PI3K/AKT%20Signaling%20Pathways&amp;author=B.%20Yang&amp;author=J.%20Song&amp;author=H.%20Sun&amp;volume=100&amp;publication_year=2018&amp;pages=205-212&amp;pmid=29428669&amp;doi=10.1016/j.biopha.2018.01.170&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0200">
<cite>

Yang, Y.
, Liu S., Xie C., et al. 2022. “Trafficking Protein TMED3 Promotes Esophageal Squamous Cell Carcinoma.” Biomedical Journal
46, no. 2: 100528. 10.1016/j.bj.2022.03.013.
</cite> [<a href="https://doi.org/10.1016/j.bj.2022.03.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10267967/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35358714/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomedical%20Journal&amp;title=Trafficking%20Protein%20TMED3%20Promotes%20Esophageal%20Squamous%20Cell%20Carcinoma&amp;author=Y.%20Yang&amp;author=S.%20Liu&amp;author=C.%20Xie&amp;volume=46&amp;issue=2&amp;publication_year=2022&amp;pages=100528&amp;pmid=35358714&amp;doi=10.1016/j.bj.2022.03.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0201">
<cite>

Ye, H.
, and Zhang N.. 2021. “Identification of the Upregulation of MRPL13 as a Novel Prognostic Marker Associated With Overall Survival Time and Immunotherapy Response in Breast Cancer.” Computational and Mathematical Methods in Medicine
2021: 1–14. 10.1155/2021/1498924.</cite> [<a href="https://doi.org/10.1155/2021/1498924" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8639240/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34868337/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Computational%20and%20Mathematical%20Methods%20in%20Medicine&amp;title=Identification%20of%20the%20Upregulation%20of%20MRPL13%20as%20a%20Novel%20Prognostic%20Marker%20Associated%20With%20Overall%20Survival%20Time%20and%20Immunotherapy%20Response%20in%20Breast%20Cancer&amp;author=H.%20Ye&amp;author=N.%20Zhang&amp;volume=2021&amp;publication_year=2021&amp;pages=1-14&amp;pmid=34868337&amp;doi=10.1155/2021/1498924&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0202">
<cite>

Zaikin, V. G.
, and Borisov R. S.. 2021. “Mass Spectrometry as a Crucial Analytical Basis for Omics Sciences.” Journal of Analytical Chemistry
76, no. 14: 1567–1587. 10.1134/s1061934821140094.</cite> [<a href="https://doi.org/10.1134/s1061934821140094" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Analytical%20Chemistry&amp;title=Mass%20Spectrometry%20as%20a%20Crucial%20Analytical%20Basis%20for%20Omics%20Sciences&amp;author=V.%20G.%20Zaikin&amp;author=R.%20S.%20Borisov&amp;volume=76&amp;issue=14&amp;publication_year=2021&amp;pages=1567-1587&amp;doi=10.1134/s1061934821140094&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0203">
<cite>

Zawadka, P.
, Zielińska W., Gagat M., and Izdebska M.. 2024. “Role of Filamin A in Growth and Migration of Breast Cancer—Review.” Current Issues in Molecular Biology
46, no. 4: 3408–3423. 10.3390/cimb46040214.
</cite> [<a href="https://doi.org/10.3390/cimb46040214" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11049233/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38666944/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Issues%20in%20Molecular%20Biology&amp;title=Role%20of%20Filamin%20A%20in%20Growth%20and%20Migration%20of%20Breast%20Cancer%E2%80%94Review&amp;author=P.%20Zawadka&amp;author=W.%20Zieli%C5%84ska&amp;author=M.%20Gagat&amp;author=M.%20Izdebska&amp;volume=46&amp;issue=4&amp;publication_year=2024&amp;pages=3408-3423&amp;pmid=38666944&amp;doi=10.3390/cimb46040214&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0204">
<cite>

Zhang, Y. V.
, and Garg U.. 2023. “Mass Spectrometry in Clinical Laboratory: Applications in Therapeutic Drug Monitoring and Toxicology.” Methods in Molecular Biology 2737: 1–13. 10.1007/978-1-0716-3541-4_1.</cite> [<a href="https://doi.org/10.1007/978-1-0716-3541-4_1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38036805/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Methods%20in%20Molecular%20Biology&amp;title=Mass%20Spectrometry%20in%20Clinical%20Laboratory:%20Applications%20in%20Therapeutic%20Drug%20Monitoring%20and%20Toxicology&amp;author=Y.%20V.%20Zhang&amp;author=U.%20Garg&amp;publication_year=2023&amp;pages=1-13&amp;pmid=38036805&amp;doi=10.1007/978-1-0716-3541-4_1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0205">
<cite>

Zhang, Y.
, Cheng Y., Zhang L., et al. 2011. “Inhibition of eEF‐2 Kinase Sensitizes Human Glioma Cells to TRAIL and down‐Regulates Bcl‐xL Expression.” Biochemical and Biophysical Research Communications
414, no. 1: 129–134. 10.1016/j.bbrc.2011.09.038.
</cite> [<a href="https://doi.org/10.1016/j.bbrc.2011.09.038" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3210449/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21945617/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemical%20and%20Biophysical%20Research%20Communications&amp;title=Inhibition%20of%20eEF%E2%80%902%20Kinase%20Sensitizes%20Human%20Glioma%20Cells%20to%20TRAIL%20and%20down%E2%80%90Regulates%20Bcl%E2%80%90xL%20Expression&amp;author=Y.%20Zhang&amp;author=Y.%20Cheng&amp;author=L.%20Zhang&amp;volume=414&amp;issue=1&amp;publication_year=2011&amp;pages=129-134&amp;pmid=21945617&amp;doi=10.1016/j.bbrc.2011.09.038&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0206">
<cite>

Zhang, Y.
, Fonslow B. R., Shan B., Baek M., and Yates J. R.. 2013. “Protein Analysis by Shotgun/Bottom‐Up Proteomics.” Chemical Reviews
113, no. 4: 2343–2394. 10.1021/cr3003533.
</cite> [<a href="https://doi.org/10.1021/cr3003533" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3751594/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23438204/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chemical%20Reviews&amp;title=Protein%20Analysis%20by%20Shotgun/Bottom%E2%80%90Up%20Proteomics&amp;author=Y.%20Zhang&amp;author=B.%20R.%20Fonslow&amp;author=B.%20Shan&amp;author=M.%20Baek&amp;author=J.%20R.%20Yates&amp;volume=113&amp;issue=4&amp;publication_year=2013&amp;pages=2343-2394&amp;pmid=23438204&amp;doi=10.1021/cr3003533&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0207">
<cite>

Zhang, H.
, Li Z., Dai Z., et al. 2022. “Interaction of MRPL9 and GGCT Promotes Cell Proliferation and Migration by Activating the MAPK/ERK Pathway in Papillary Thyroid Cancer.” International Journal of Molecular Sciences
23, no. 19: 11989. 10.3390/ijms231911989.
</cite> [<a href="https://doi.org/10.3390/ijms231911989" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9570013/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36233293/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Molecular%20Sciences&amp;title=Interaction%20of%20MRPL9%20and%20GGCT%20Promotes%20Cell%20Proliferation%20and%20Migration%20by%20Activating%20the%20MAPK/ERK%20Pathway%20in%20Papillary%20Thyroid%20Cancer&amp;author=H.%20Zhang&amp;author=Z.%20Li&amp;author=Z.%20Dai&amp;volume=23&amp;issue=19&amp;publication_year=2022&amp;pages=11989&amp;pmid=36233293&amp;doi=10.3390/ijms231911989&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0208">
<cite>

Zhang, S.
, Lee S. H., Nie L., et al. 2022. “Lysosomal TMEM9‐LAMTOR4‐Controlled mTOR Signaling Integrity Is Required for Mammary Tumorigenesis.” Cancer Communications
43, no. 1: 159–163. 10.1002/cac2.12382.
</cite> [<a href="https://doi.org/10.1002/cac2.12382" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9859727/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36336962/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Communications&amp;title=Lysosomal%20TMEM9%E2%80%90LAMTOR4%E2%80%90Controlled%20mTOR%20Signaling%20Integrity%20Is%20Required%20for%20Mammary%20Tumorigenesis&amp;author=S.%20Zhang&amp;author=S.%20H.%20Lee&amp;author=L.%20Nie&amp;volume=43&amp;issue=1&amp;publication_year=2022&amp;pages=159-163&amp;pmid=36336962&amp;doi=10.1002/cac2.12382&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0209">
<cite>

Zhou, W.
, Yu X., Sun S., et al. 2019. “Increased Expression of MMP‐2 and MMP‐9 Indicates Poor Prognosis in Glioma Recurrence.” Biomedicine &amp; Pharmacotherapy
118: 109369. 10.1016/j.biopha.2019.109369.
</cite> [<a href="https://doi.org/10.1016/j.biopha.2019.109369" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31545229/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomedicine%20&amp;%20Pharmacotherapy&amp;title=Increased%20Expression%20of%20MMP%E2%80%902%20and%20MMP%E2%80%909%20Indicates%20Poor%20Prognosis%20in%20Glioma%20Recurrence&amp;author=W.%20Zhou&amp;author=X.%20Yu&amp;author=S.%20Sun&amp;volume=118&amp;publication_year=2019&amp;pages=109369&amp;pmid=31545229&amp;doi=10.1016/j.biopha.2019.109369&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0215">
<cite>

Zhou, X.
, Chen A., and Zhang T.. 2023. “YWHAB Knockdown Inhibits Cell Proliferation Whilst Promoting Cell Cycle Arrest and Apoptosis in Colon Cancer Cells Through PIK3R2.” Experimental and Therapeutic Medicine
25, 193. 10.3892/etm.2023.11892.
</cite> [<a href="https://doi.org/10.3892/etm.2023.11892" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10119628/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37090079/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Experimental%20and%20Therapeutic%20Medicine&amp;title=YWHAB%20Knockdown%20Inhibits%20Cell%20Proliferation%20Whilst%20Promoting%20Cell%20Cycle%20Arrest%20and%20Apoptosis%20in%20Colon%20Cancer%20Cells%20Through%20PIK3R2&amp;author=X.%20Zhou&amp;author=A.%20Chen&amp;author=T.%20Zhang&amp;volume=25&amp;publication_year=2023&amp;pages=193&amp;pmid=37090079&amp;doi=10.3892/etm.2023.11892&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0210">
<cite>

Zhou, Y.
, Zhou B., Pache L., et al. 2019. “Metascape Provides a Biologist‐Oriented Resource for the Analysis of Systems‐Level Datasets.” Nature Communications
10, no. 1: 1523. 10.1038/s41467-019-09234-6.</cite> [<a href="https://doi.org/10.1038/s41467-019-09234-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6447622/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30944313/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Communications&amp;title=Metascape%20Provides%20a%20Biologist%E2%80%90Oriented%20Resource%20for%20the%20Analysis%20of%20Systems%E2%80%90Level%20Datasets&amp;author=Y.%20Zhou&amp;author=B.%20Zhou&amp;author=L.%20Pache&amp;volume=10&amp;issue=1&amp;publication_year=2019&amp;pages=1523&amp;pmid=30944313&amp;doi=10.1038/s41467-019-09234-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0211">
<cite>

Zhou, L.
, Li H., Yao H., Dai X., Gao P., and Cheng H.. 2023. “TMED Family Genes and Their Roles in Human Diseases.” International Journal of Medical Sciences
20, no. 13: 1732–1743. 10.7150/ijms.87272.
</cite> [<a href="https://doi.org/10.7150/ijms.87272" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10620864/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37928880/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Medical%20Sciences&amp;title=TMED%20Family%20Genes%20and%20Their%20Roles%20in%20Human%20Diseases&amp;author=L.%20Zhou&amp;author=H.%20Li&amp;author=H.%20Yao&amp;author=X.%20Dai&amp;author=P.%20Gao&amp;volume=20&amp;issue=13&amp;publication_year=2023&amp;pages=1732-1743&amp;pmid=37928880&amp;doi=10.7150/ijms.87272&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0212">
<cite>

Zhu, Z.
, Zhang W., Huo S., Huang T., Cao X., and Zhang Y.. 2024. “TUBB, a Robust Biomarker With Satisfying Abilities in Diagnosis, Prognosis, and Immune Regulation via a Comprehensive Pan‐Cancer Analysis.” Frontiers in Molecular Biosciences
11: 1365655. 10.3389/fmolb.2024.1365655.
</cite> [<a href="https://doi.org/10.3389/fmolb.2024.1365655" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11096532/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38756529/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Molecular%20Biosciences&amp;title=TUBB,%20a%20Robust%20Biomarker%20With%20Satisfying%20Abilities%20in%20Diagnosis,%20Prognosis,%20and%20Immune%20Regulation%20via%20a%20Comprehensive%20Pan%E2%80%90Cancer%20Analysis&amp;author=Z.%20Zhu&amp;author=W.%20Zhang&amp;author=S.%20Huo&amp;author=T.%20Huang&amp;author=X.%20Cao&amp;volume=11&amp;publication_year=2024&amp;pages=1365655&amp;pmid=38756529&amp;doi=10.3389/fmolb.2024.1365655&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0213">
<cite>

Zhu, J.
, Wen N., Chen W., and Yu H.. 2025. “Mitochondrial Ribosomal Proteins: Potential Targets for Cancer Prognosis and Therapy.” Frontiers in Oncology
15: 1586137. 10.3389/fonc.2025.1586137.
</cite> [<a href="https://doi.org/10.3389/fonc.2025.1586137" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12074914/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40371222/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Oncology&amp;title=Mitochondrial%20Ribosomal%20Proteins:%20Potential%20Targets%20for%20Cancer%20Prognosis%20and%20Therapy&amp;author=J.%20Zhu&amp;author=N.%20Wen&amp;author=W.%20Chen&amp;author=H.%20Yu&amp;volume=15&amp;publication_year=2025&amp;pages=1586137&amp;pmid=40371222&amp;doi=10.3389/fonc.2025.1586137&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bmc70170-bib-0214">
<cite>

Zottel, A.
, Jovčevska I., Šamec N., and Komel R.. 2021. “Cytoskeletal Proteins as Glioblastoma Biomarkers and Targets for Therapy: A Systematic Review.” Critical Reviews in Oncology/Hematology
160: 103283. 10.1016/j.critrevonc.2021.103283.
</cite> [<a href="https://doi.org/10.1016/j.critrevonc.2021.103283" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33667657/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Critical%20Reviews%20in%20Oncology/Hematology&amp;title=Cytoskeletal%20Proteins%20as%20Glioblastoma%20Biomarkers%20and%20Targets%20for%20Therapy:%20A%20Systematic%20Review&amp;author=A.%20Zottel&amp;author=I.%20Jov%C4%8Devska&amp;author=N.%20%C5%A0amec&amp;author=R.%20Komel&amp;volume=160&amp;publication_year=2021&amp;pages=103283&amp;pmid=33667657&amp;doi=10.1016/j.critrevonc.2021.103283&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ol></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<p>
<strong>Data S1.</strong> Methodology of immunohistochemical staining.</p>
<p>
<strong>Figure S1.</strong> Venn diagram representation of the differently expressed genes in the analyzed human brain tumor tissues.</p>
<p>
<strong>Figure S2.</strong> Pathway enrichment analysis by METASCAPE of the differently expressed proteins in Grade IV astrocytoma brain tumor tissues.</p>
<p>
<strong>Figure S3.</strong> Pathway enrichment analysis by METASCAPE of the differently expressed proteins in meningioma brain tumor tissues.</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12326238/bin/BMC-39-e70170-s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">BMC-39-e70170-s001.pdf</a><sup> (615.5KB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Data that support the findings of this study, including peptide sequencing and protein identification, are available at the ProteomeXchange Consortium via the MassIVE partner repository (for shotgun proteomics data) at: <a href="https://massive.ucsd.edu/ProteoSAFe/QueryPXD?id=PXD054822" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://massive.ucsd.edu/ProteoSAFe/QueryPXD?id=PXD054822</a>. With the dataset identifier: Username: MSV000095574_reviewer. Password: REVIEWER105. The data are not publicly available due to privacy or ethical restrictions.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Biomedical Chromatography are provided here courtesy of <strong>Wiley</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1002/bmc.70170"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/BMC-39-e70170.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (6.9 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12326238/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12326238/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12326238%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12326238/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12326238/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12326238/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40765374/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12326238/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40765374/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12326238/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12326238/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="T8UxDgeAYVUp5zc2CcQxDzv82vYPMsp7BGiJtLO7SzPsYzvhYPHSAWoRjJbO7eU5">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
